Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009214	s-lh	u/l (u/l)	4612	5920	1.81%
3009214	s-lh	iu/l (u/l)	4024	5254	0.00%
3009214	p-lh	u/l (u/l)	3313	4368	0.00%
3009214	s-lh	— (—)	2782	3659	100.00%	Distribution not available
3009214	p-lh	— (—)	839	1017	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Used for control exclusion in common control thyroid runs

3469

8431

2.13

308.42

1.6

1.3

8.34

9.17

u/l

2.80

2817

6859

Irregular menses

2046

5093

3.36

307.65

1.4

1.2

10.51

13.08

u/l

11.08

1669

4220

Hypogonadotropic hypogonadism

652

399

37.80

307.65

2.2

1.4

3.53

5.14

u/l

4.38

506

334

Polycystic ovarian syndrome

698

1102

8.38

307.65

1.4

1.2

9.80

8.79

u/l

1.71

599

919

Polycystic ovarian syndrome, consortium definition

2620

5274

3.07

307.65

1.4

1.2

10.89

13.34

u/l

11.95

2156

4361

Testicular dysfunction

572

388

23.91

307.65

2.1

1.3

7.78

4.82

u/l

7.35

469

319

Endocrine, nutritional and metabolic diseases

3450

5950

3.06

307.65

1.6

1.3

8.47

9.07

u/l

1.57

2841

4870

Benign neoplasm: Pituitary gland, craniopharyngeal duct

643

539

16.81

307.65

2.0

1.4

7.01

9.66

u/l

3.67

530

440

Amenorrhoea

820

626

17.11

307.65

1.8

1.4

8.25

11.01

u/l

4.16

654

502

Female infertility, cervical, vaginal, other or unspecified origin

1885

1478

9.34

307.65

1.2

8.22

13.86

u/l

29.36

1591

1182

Hypothyroidism, levothyroxine purchases

1497

2417

3.73

307.65

1.5

1.3

8.27

7.77

u/l

0.59

1220

2052

Hypopituitarism

1221

828

24.31

307.65

2.2

1.4

5.76

6.99

u/l

2.24

952

628

Hyperfunction of pituitary gland

467

559

10.48

307.65

2.0

1.3

7.89

10.33

u/l

2.84

387

441

Disorders of other endocrine glands

3437

4992

7.76

307.65

1.9

1.3

9.19

9.59

u/l

0.70

2789

4062

Testicular hypofunction

524

345

25.26

307.65

2.1

1.3

8.01

4.66

u/l

8.43

431

287

Exclusions for E4_PCOS_CONSORTIUM

2899

6887

2.75

307.65

1.8

1.3

9.07

11.16

u/l

10.70

2324

5615

Polycystic ovarian syndrome, broad definition

1265

2076

7.70

307.65

1.3

1.2

9.54

9.85

u/l

0.28

1084

1736

Noninflammatory disorders of female genital tract

1636

1915

4.51

307.65

1.4

1.3

9.60

12.94

u/l

11.99

1365

1520

Female infertility, associated with anovulation

1005

813

16.25

307.65

1.3

1.2

9.49

11.46

u/l

2.20

855

659

Female infertility

2246

1537

10.11

307.65

1.2

8.75

13.74

u/l

22.44

1923

1229

Exclusions for E4_PCOS_BROAD

2009

2211

11.81

307.65

2.0

1.4

7.50

9.50

u/l

6.83

1601

1736

Hypothyroidism and >3 levothyroxin purchases

1497

2417

3.73

307.65

1.5

1.3

8.27

7.77

u/l

0.59

1220

2052

Hypothyroidism (congenital or acquired)

1514

2434

3.75

307.65

1.5

1.3

8.28

7.75

u/l

0.64

1233

2062

Benign neoplasm of other and unspecified endocrine glands

728

1091

7.52

307.65

1.9

1.3

7.74

11.15

u/l

7.49

604

895

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1946

3630

5.94

307.65

2.0

1.3

8.05

11.21

u/l

16.15

1554

2910

Medical treatment for female infertility

1420

3679

4.29

307.65

1.2

8.71

12.42

u/l

16.03

1259

3004

Ovarian dysfunction

869

1386

8.04

307.65

1.4

1.2

13.23

9.08

u/l

8.15

735

1156

Hyperprolactinaemia

347

409

10.87

283.30

1.7

1.2

7.68

11.26

u/l

4.03

284

335

Procreative management

1461

4557

2.82

262.23

1.6

1.5

8.95

8.98

u/l

0.02

1131

3652

Disorders of the thyroid gland

2833

9047

2.09

256.07

1.4

1.3

10.45

9.90

u/l

1.00

2290

7420

Genitourinary diseases

2033

4225

2.49

254.21

1.6

1.5

7.33

6.99

u/l

0.74

1633

3366

Hypothyroidism, other/unspecified

2660

8440

2.13

251.72

1.4

1.3

10.77

10.16

u/l

1.09

2152

6941

Hypothyreosis and Thyroxine purchase for inclusion criteria

2703

8686

2.09

245.52

1.4

1.3

10.91

10.30

u/l

1.06

2189

7136

Male infertility

411

685

7.25

245.06

1.8

1.6

6.43

4.36

u/l

7.89

319

577

Medical observation and evaluation for suspected diseases and conditions

2114

4759

2.33

233.24

1.6

1.3

8.76

8.89

u/l

0.16

1717

3872

Mood [affective] disorders

3071

10412

1.96

231.39

1.4

9.39

9.64

u/l

0.45

2421

8645

Mood disorders

3073

10413

1.95

230.72

1.4

9.38

9.64

u/l

0.47

2423

8644

Depression

2933

10285

1.98

230.64

1.4

9.25

9.64

u/l

0.83

2303

8545

Recurrent or chronic depression

1390

3733

2.71

226.95

1.4

9.35

10.06

u/l

0.98

1105

3151

Mood disorders, excluding more controls

2736

8210

2.04

226.32

1.4

9.32

9.80

u/l

1.01

2152

6889

Anxiety disorders, excluding more controls

2503

8007

2.09

224.81

1.4

9.81

9.80

u/l

0.01

1979

6719

Oxycodone

872

2420

3.36

222.63

1.4

12.80

11.01

u/l

2.44

711

1943

Oligomenorrhoea

235

222

12.31

221.58

1.4

1.2

9.17

12.47

u/l

2.02

189

170

Other antidepressants

2922

7800

1.96

209.75

1.4

8.68

9.55

u/l

2.88

2326

6482

Neurotic, stress-related and somatoform disorders

2775

10213

1.95

209.65

1.4

9.63

9.62

u/l

0.02

2193

8450

Depression or dysthymia

1869

4569

2.31

207.66

1.4

8.88

9.83

u/l

2.02

1494

3806

Sleep apnoea

2300

7309

2.08

206.52

1.5

1.4

8.71

11.17

u/l

11.38

1867

5969

Anxiety disorders

2780

10250

1.94

206.20

1.4

9.62

9.63

u/l

0.02

2195

8481

Excessive, frequent and irregular menstruation

1019

1834

3.14

200.32

1.2

1.3

10.84

13.17

u/l

4.42

844

1458

Panhypopituitarism

198

181

15.12

195.88

2.2

1.5

4.79

8.97

u/l

2.88

134

144

Neoplasms

2853

8132

1.91

189.52

1.7

1.3

8.33

8.04

u/l

0.60

2322

6632

Anxiety (asthma-related co-morbidities)

2123

8235

2.05

188.90

1.4

9.08

9.63

u/l

1.08

1671

6872

Behavioural syndromes associated with physiological disturbances and physical factors

2718

10511

1.88

184.20

1.5

1.4

8.68

9.86

u/l

5.30

2193

8623

Sleep disorders (combined)

3039

8889

1.83

178.73

1.4

8.71

10.26

u/l

7.11

2494

7276

Malignant neoplasm of testis

193

201

13.32

174.98

3.0

1.5

7.35

4.05

u/l

6.96

163

171

Sleep apnoea, including avohilmo

2411

7901

1.93

173.37

1.5

1.4

9.09

10.91

u/l

6.76

1956

6457

Depression medications

1294

2623

2.58

172.71

1.5

1.3

8.05

7.59

u/l

0.69

1045

2215

Malignant neoplasm of testis, including Hilmo

199

221

11.97

171.13

2.9

1.5

7.45

4.04

u/l

7.52

166

185

General symptoms and signs

3103

8830

1.79

169.63

1.5

1.4

9.81

9.15

u/l

1.72

2518

7211

All anxiety disorders

2171

9028

1.95

168.90

1.4

9.04

9.50

u/l

0.86

1708

7483

Other nutritional deficiencies

1997

9749

1.98

167.13

1.4

8.60

10.39

u/l

9.76

1629

8005

Non-small cell lung cancer

261

386

7.05

167.08

1.3

13.97

9.11

u/l

4.60

215

311

Non-small cell lung cancer, including Hilmo

343

626

5.37

164.43

1.3

14.87

9.53

u/l

6.40

286

497

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

515

1381

3.82

162.82

1.6

1.3

16.23

10.02

u/l

11.89

425

1096

Pain and other conditions associated with female genital organs and menstrual cycle

610

1693

3.45

161.54

1.2

1.3

9.91

12.74

u/l

5.45

497

1344

Use of cabergoline

164

159

14.57

156.59

1.9

1.3

6.19

9.81

u/l

2.08

134

131

Hypothyroidism, strict autoimmune

1949

6591

1.99

154.89

1.3

11.44

10.27

u/l

2.20

1587

5410

Lung cancer and mesothelioma

401

778

4.56

154.65

1.3

1.4

14.72

10.08

u/l

5.72

334

613

Other disorders of adrenal gland

245

386

7.19

152.12

1.7

1.3

13.58

9.11

u/l

3.08

195

279

Selective serotonin reuptake inhibitors

2686

7956

1.79

148.80

1.4

8.46

9.45

u/l

3.66

2149

6584

Obesity and other hyperalimentation

1866

9497

1.94

148.31

1.4

1.3

8.67

10.42

u/l

8.85

1522

7803

Obesity

1859

9476

1.94

147.75

1.4

1.3

8.67

10.42

u/l

8.78

1519

7783

Hirsutism in women

209

297

9.31

147.43

1.4

1.3

8.94

10.98

u/l

1.35

179

243

Hypertrichosis

224

344

8.41

146.72

1.4

1.3

9.08

10.76

u/l

1.10

193

279

Sleep disorders

2469

10224

1.78

142.55

1.4

8.97

9.96

u/l

3.56

2011

8439

Headache

1899

8127

1.91

139.30

1.4

1.3

9.55

9.44

u/l

0.14

1564

6656

General examination and investigation of persons without complaint and reported diagnosis

1793

4759

2.01

138.78

1.4

1.3

9.67

8.89

u/l

1.54

1501

3872

Malignant neoplasm of respiratory system and intrathoracic organs

402

831

4.15

136.54

1.3

13.17

9.22

u/l

5.06

337

656

Adrenocortical insufficiency

191

260

8.35

135.63

1.6

1.3

14.57

9.83

u/l

2.56

164

198

Liquid cancers, helper endpoint

756

2484

2.72

133.17

1.8

1.4

13.27

8.81

u/l

11.03

610

1973

Malignant neoplasm of bronchus and lung, including Hilmo

388

811

4.12

131.02

1.3

15.03

9.44

u/l

7.68

322

637

Opioids

2761

8575

1.70

127.27

1.4

9.26

9.31

u/l

0.06

2264

7056

Episodal and paroxysmal disorders

2997

9306

1.67

127.24

1.5

1.4

8.97

9.77

u/l

2.17

2453

7538

Thyrotropin deficiency

134

133

14.51

126.31

1.6

1.3

9.76

10.89

u/l

0.30

116

111

Insomnia

2411

10419

1.72

123.39

1.4

8.90

9.92

u/l

3.70

1965

8600

Diseases of male genital organs

1520

3832

2.05

123.12

1.7

1.5

5.63

5.27

u/l

1.40

1215

3103

Obesity due to excess calories

1400

7175

2.01

123.01

1.4

1.3

8.76

10.40

u/l

5.67

1142

5901

Malignant neoplasm of bronchus and lung

337

663

4.35

121.56

1.3

14.10

9.63

u/l

4.81

280

524

Other anxiety disorders

1667

7850

1.89

120.07

1.4

8.95

9.21

u/l

0.36

1311

6501

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

382

1050

3.80

119.68

1.7

1.3

15.45

8.84

u/l

10.38

314

833

Other endocrine disorders

299

669

4.80

118.58

2.3

1.5

6.52

7.02

u/l

0.29

201

476

Neurological diseases

2548

7683

1.70

115.13

1.5

1.4

8.76

9.37

u/l

1.25

2071

6224

Endometriosis

691

1507

2.75

112.07

1.2

12.54

14.18

u/l

1.70

597

1215

GASTRO-related operations

2410

7224

1.70

110.53

1.5

1.4

9.42

8.38

u/l

3.41

1975

5883

Any gastric operation

2410

7224

1.70

110.53

1.5

1.4

9.42

8.38

u/l

3.41

1975

5883

Other special examinations and investigations of persons without complaint or reported diagnosis

1726

4760

1.87

108.37

1.5

1.3

8.81

8.89

u/l

0.09

1428

3872

Fever of other and unknown origin

1398

6624

1.92

106.70

1.6

1.4

10.94

9.34

u/l

3.69

1151

5412

Any mental disorder

2684

8332

1.64

106.53

1.5

1.4

9.45

9.81

u/l

0.66

2144

6947

Malignant melanoma, including Hilmo

366

1060

3.57

105.68

1.3

13.98

10.17

u/l

4.55

305

846

Corticotropin deficiency

18.22

103.03

1.8

1.3

12.36

11.66

u/l

0.10

Codeine

2483

8320

1.65

102.86

1.4

1.3

9.37

9.39

u/l

0.01

2047

6852

L02BG Aromatase inhibitors

426

1372

3.17

102.69

1.5

1.2

15.79

19.81

u/l

4.86

365

1113

Anaemias

788

2184

2.44

102.04

1.5

1.3

10.54

7.82

u/l

5.82

644

1834

Osteoporosis

388

1099

3.38

101.97

1.5

1.4

13.94

14.62

u/l

0.28

314

898

Examination and observation for other reasons

1515

4738

1.88

100.90

1.4

1.3

9.79

8.90

u/l

1.53

1213

3854

Malignant melanoma

316

857

3.83

100.83

1.4

1.3

13.64

10.12

u/l

3.50

262

682

Malignant melanoma of skin, including Hilmo

322

885

3.78

100.76

1.4

1.3

14.28

10.04

u/l

4.82

267

706

Malignant melanoma of skin

268

652

4.30

99.73

1.4

1.3

13.96

9.78

u/l

4.02

220

524

Persons encountering health services in other circumstances, wide

2899

9599

1.58

99.48

1.5

1.4

9.67

9.45

u/l

0.31

2359

7802

Non-small cell lung cancer, adenocarcinoma

149

215

7.32

98.90

1.3

14.05

10.04

u/l

1.83

122

177

Psychiatric diseases

2378

7298

1.65

98.84

1.5

1.4

9.06

9.90

u/l

2.26

1898

6074

Parasetamol

2297

7091

1.67

98.38

1.5

1.4

8.79

8.45

u/l

0.63

1922

5776

Other medical care

907

3838

2.17

97.91

1.7

1.4

12.43

10.01

u/l

4.73

732

3055

Seminoma of testis, including Hilmo

105

106

13.47

97.06

3.1

1.5

7.31

3.98

u/l

3.60

Ovarian cyst

705

1649

2.52

96.20

1.2

12.22

13.67

u/l

1.58

591

1317

Neurological diseases, wide definition

1181

2962

2.06

96.05

1.6

1.4

7.95

8.34

u/l

0.54

950

2343

Diarrhoea and gastroenteritis of presumed infectious origin

2551

10745

1.59

94.98

1.4

9.26

9.76

u/l

1.14

2097

8698

Complications associated with artificial fertilization

115

133

10.01

93.74

1.2

9.06

12.06

u/l

1.14

102

108

Benign neoplasms

2761

9886

1.56

92.44

1.5

1.4

8.68

8.96

u/l

0.55

2249

8085

Hypothyroidism, strict autoimmune, 3 medication purchases required

1959

7992

1.68

92.09

1.3

11.76

10.65

u/l

2.01

1595

6575

Malaise and fatigue

1085

4475

1.99

90.94

1.4

1.3

11.11

9.87

u/l

1.85

872

3635

Disorders of puberty

159

281

7.22

90.92

3.3

1.6

5.01

5.87

u/l

0.70

123

207

Tramadol

1747

6288

1.73

90.07

1.4

9.90

10.03

u/l

0.13

1398

5176

Primary ovarian failure

141

222

7.58

88.87

1.6

1.2

30.06

13.22

u/l

5.31

115

175

Seminoma of testis

14.60

88.12

3.2

1.4

6.96

4.20

u/l

2.30

Non-seminoma of testis, including Hilmo

16.61

87.71

3.2

1.6

8.66

4.03

u/l

4.00

First line medication for Crohn's disease

2900

10401

1.53

87.54

1.5

1.4

10.09

8.95

u/l

4.15

2363

8449

Acute upper respiratory infections of multiple and unspecified sites

2018

9313

1.63

85.92

1.5

1.4

9.47

9.79

u/l

0.47

1638

7581

Medicines for HER+ breast cancer

534

2013

2.56

85.81

1.5

1.2

15.83

18.78

u/l

3.53

456

1645

Obesity related asthma

811

3896

2.14

85.19

1.4

9.21

10.60

u/l

2.35

654

3177

Non-small cell lung cancer, adenocarcinoma, helper endpoint

149

252

6.23

84.91

1.3

14.05

10.71

u/l

1.44

122

197

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2684

9595

1.54

84.44

1.5

1.4

9.92

9.45

u/l

0.82

2198

7799

Malignant neoplasm

1864

6688

1.67

83.96

1.7

1.3

13.63

9.65

u/l

19.39

1486

5433

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1156

5603

1.87

83.39

1.4

12.92

10.47

u/l

5.89

953

4511

Dental caries

670

2891

2.29

83.09

1.7

1.4

9.94

8.78

u/l

1.37

531

2373

Disorders of puberty, all

187

418

5.72

82.82

3.5

1.7

5.23

6.86

u/l

1.75

149

299

Malignant neoplasm, wide definition for exclusion

1982

7213

1.63

81.44

1.7

1.4

13.07

9.39

u/l

18.83

1589

5883

Personal history of malignant neoplasm

211

502

4.46

81.44

2.3

1.4

10.01

14.71

u/l

4.44

170

397

Codeine or tramadol medication

2760

10089

1.52

80.90

1.4

1.3

9.60

9.75

u/l

0.23

2275

8282

Benzodiazepine use

2412

10888

1.55

80.75

1.4

10.30

9.67

u/l

1.31

1895

9014

Endometriosis diagnosis and infertility diagnosis occurring together

389

1395

2.95

79.50

1.2

1.3

9.51

12.77

u/l

5.51

334

1151

Symptoms and signs involving the circulatory and respiratory systems

2746

9184

1.52

79.42

1.4

9.50

9.34

u/l

0.24

2242

7489

Unspecified/other endometriosis

264

749

3.68

79.19

1.2

1.3

10.25

13.50

u/l

3.05

223

601

Endometriosis of pelvic peritoneum

337

1052

3.14

78.77

1.2

11.95

15.58

u/l

3.95

296

842

Female infertility, tubal origin

155

293

5.62

78.73

1.2

1.3

8.66

17.60

u/l

9.51

132

229

Caries of dentine

598

2562

2.34

77.89

1.6

1.4

9.97

8.72

u/l

1.43

483

2106

Obesity, other/unspecified

949

5001

1.95

77.02

1.4

1.3

8.83

11.12

u/l

7.90

774

4129

Persons encountering health services in circumstances related to reproduction

1563

6300

1.70

76.76

1.6

1.5

8.69

8.54

u/l

0.17

1217

5073

Special screening examination for infectious and parasitic diseases

941

3596

1.98

75.93

1.4

1.3

7.63

8.12

u/l

0.70

723

2956

Pain in joint

1503

5688

1.71

74.95

1.4

10.06

8.89

u/l

2.58

1245

4616

Dysplasia of cervi uteri

486

1401

2.57

73.57

1.2

11.64

13.94

u/l

2.36

411

1121

Bronchitis

2573

10959

1.50

73.16

1.4

9.82

9.81

u/l

0.01

2094

8928

Persons encountering health services for examination and investigation

1588

4760

1.70

72.77

1.5

1.3

9.01

8.89

u/l

0.14

1284

3872

Any reimbursement code in KELA

1924

6074

1.62

72.45

1.5

1.3

9.18

8.28

u/l

1.74

1558

5009

Pain, not elsewhere classified

691

3339

2.12

71.54

1.5

1.3

10.91

9.84

u/l

1.04

574

2732

Solid cancers, helper endpoint

1748

6418

1.63

71.35

1.6

1.3

13.88

9.81

u/l

19.01

1401

5225

Personality disorders, excluding more controls

841

4389

1.97

70.59

1.4

1.3

9.04

9.00

u/l

0.03

629

3731

Impotence

192

477

4.33

70.40

1.6

1.4

5.29

5.43

u/l

0.13

153

392

Abnormal findings on diagnostic imaging of lung

716

3382

2.06

69.15

1.3

13.33

10.66

u/l

4.56

595

2704

Endometriosis of ovary

305

1004

3.04

68.05

1.1

1.2

12.02

16.52

u/l

5.07

261

804

Dorsalgia

2561

9351

1.49

67.93

1.4

9.72

9.28

u/l

0.88

2088

7624

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

300

1008

3.05

67.83

1.5

1.3

18.88

9.51

u/l

12.50

256

800

Migraine

1435

7115

1.67

67.23

1.4

10.67

10.49

u/l

0.19

1184

5828

Abdominal and pelvic pain

2470

8395

1.50

66.95

1.5

1.4

9.18

8.84

u/l

0.63

2022

6812

Factors influencing health status and contact with health services

694

1632

2.17

65.94

1.5

1.4

7.48

7.70

u/l

0.18

555

1347

Primary_lymphoid and hematopoietic malignant neoplasms

448

1875

2.45

65.73

1.9

1.4

10.91

9.63

u/l

1.03

352

1496

Symptoms and signs involving the digestive system and abdomen

2464

8395

1.49

65.15

1.5

1.4

9.08

8.84

u/l

0.41

2010

6812

Habitual aborter

104

163

7.09

64.82

1.2

1.3

7.28

12.47

u/l

3.16

131

Any event in cancer register

2128

8354

1.52

64.18

1.7

1.3

12.66

9.28

u/l

17.64

1709

6873

Other dorsopathies, not elsewhere classified

2604

9421

1.46

63.99

1.4

9.21

9.25

u/l

0.06

2144

7680

Other reaction to severe stress, and adjustment disorders

1113

6516

1.75

63.91

1.4

10.30

9.65

u/l

0.89

893

5423

Non-selective monoamine reuptake inhibitors

586

2666

2.15

63.62

1.4

1.3

11.43

12.65

u/l

1.04

463

2213

KRA_PSY_EATING, excluding more controls

452

1960

2.45

62.52

1.7

1.3

7.36

8.94

u/l

2.21

359

1661

Acromegaly and pituitary gigantism

15.21

62.51

2.5

1.1

7.80

7.63

u/l

0.03

Other headache syndromes

973

5520

1.79

61.73

1.4

1.3

9.90

11.34

u/l

2.63

787

4564

Supervision of high-risk pregnancy

688

2047

2.09

61.07

1.2

1.3

11.24

13.19

u/l

2.93

624

1618

Delayed puberty

132

8.89

60.60

3.3

1.7

4.83

5.78

u/l

0.53

108

Asthma, excluding more controls

1829

6202

1.56

60.39

1.4

9.72

9.43

u/l

0.39

1481

5095

Autoimmune diseases

2797

10074

1.43

59.97

1.4

9.33

8.93

u/l

0.74

2285

8167

Asthma

1842

6306

1.55

59.70

1.4

9.72

9.44

u/l

0.38

1490

5178

Intestinal infectious diseases

2643

10637

1.43

59.61

1.4

9.92

9.73

u/l

0.29

2174

8612

Asthma (mode)

1815

6343

1.55

59.25

1.4

9.88

9.42

u/l

0.68

1473

5210

Intestinal infectious diseases

2251

11815

1.46

59.09

1.5

1.4

9.31

9.54

u/l

0.35

1856

9582

Polyp of the female genital tract

432

1007

2.50

58.91

1.2

1.3

15.03

17.43

u/l

1.67

359

803

Short stature, not elsewhere classified

167

404

4.47

57.93

2.6

1.7

3.90

5.89

u/l

3.60

110

262

Pain (limb, back, neck, head abdominally)

1784

5828

1.55

57.58

1.4

8.58

8.78

u/l

0.28

1447

4694

Acute upper respiratory infections

2311

9879

1.46

57.43

1.4

10.14

10.07

u/l

0.08

1907

8011

Other soft tissue disorders, not elsewhere classified

2346

9571

1.45

57.03

1.4

10.35

9.16

u/l

3.52

1902

7762

Osteopathies and chondropathies

1069

5919

1.71

56.76

1.5

1.4

10.61

10.44

u/l

0.13

859

4804

Nonorganic sleeping disorders, excluding more controls

579

2869

2.08

56.57

1.4

1.3

8.53

9.56

u/l

1.32

447

2417

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1084

3141

1.76

56.53

1.5

1.4

8.68

8.03

u/l

0.86

866

2588

L01XE Protein kinase inhibitors

134

298

4.75

56.38

1.5

1.3

15.12

10.40

u/l

2.02

112

238

Other menopausal disorders

372

805

2.65

56.27

1.3

1.2

20.49

19.82

u/l

0.22

301

643

Malignant neoplasm of urinary organs

183

511

3.70

56.14

1.5

1.3

16.75

8.08

u/l

6.54

142

415

Disorders of skin appendages

1279

8012

1.62

56.01

1.4

10.01

9.46

u/l

0.82

1050

6587

Fentanyl

168

445

3.87

55.31

1.4

1.3

16.20

10.93

u/l

2.50

137

356

Bacterial infection, other or unspecified

908

4503

1.77

54.82

1.5

1.4

11.73

10.08

u/l

2.35

688

3652

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1149

6851

1.65

54.42

1.4

9.32

9.72

u/l

0.46

915

5612

Primary amenorrhea

172

7.70

54.23

2.4

1.5

7.55

8.60

u/l

0.44

130

Persons encountering health services in other circumstances

1004

5941

1.71

54.10

1.4

10.13

9.37

u/l

0.95

807

4822

Abnormalities of breathing

2250

9122

1.45

53.85

1.4

9.75

9.36

u/l

0.66

1852

7438

Disorders of adult personality and behaviour

942

5541

1.75

53.61

1.4

8.49

9.04

u/l

0.72

712

4635

Use of hypnotics and sedatives

2296

9242

1.44

53.30

1.4

9.76

10.00

u/l

0.35

1827

7599

Substance abuse, excluding more controls

1261

6756

1.61

53.11

1.4

9.01

8.88

u/l

0.13

975

5655

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

190

566

3.47

52.81

1.5

1.3

15.30

8.20

u/l

5.16

147

458

Asthma (only as main-diagnosis)

1654

6306

1.54

52.72

1.4

9.88

9.44

u/l

0.65

1355

5178

Type 2 diabetes, definitions combined

1935

7733

1.48

52.66

1.4

1.3

9.15

10.84

u/l

7.62

1577

6407

Asthma (only as main-diagnosis), excluding more controls

1647

6202

1.54

52.44

1.4

9.88

9.43

u/l

0.65

1352

5095

Non-small cell lung cancer, squamous

152

6.22

52.44

1.3

14.49

7.64

u/l

3.97

122

Malignant neoplasm of kidney, except renal pelvis

170

474

3.71

52.33

1.5

1.4

16.15

8.05

u/l

5.42

131

391

Type 2 diabetes, strict (exclude DM1)

1938

7758

1.48

52.32

1.4

1.3

9.15

10.87

u/l

7.83

1580

6429

Ovarian hyperstimulation (induction)

112

234

5.51

52.24

1.2

1.3

9.06

13.26

u/l

2.29

186

Pregnancy examination and test

621

1961

2.05

51.95

1.2

1.3

10.46

11.99

u/l

1.94

519

1560

Routine general health check-up of defined subpopulation

105

206

5.60

51.87

2.3

1.3

7.99

11.15

u/l

1.40

173

Bacterial infection, other or unspecified

1003

5061

1.70

51.61

1.5

1.4

11.55

10.00

u/l

2.36

764

4103

Type 2 diabetes

2110

8570

1.45

51.50

1.4

9.30

10.47

u/l

4.16

1722

7114

Dentofacial anomalies [including malocclusion]

1793

9835

1.49

51.12

1.4

10.13

10.00

u/l

0.16

1465

8038

Caries of enamel

2144

10886

1.44

51.06

1.4

10.00

9.61

u/l

0.60

1692

8945

Type 2 diabetes, definitions combined, including avohilmo

1962

7849

1.47

50.91

1.4

1.3

9.18

10.82

u/l

7.23

1604

6504

Symptoms and signs concerning food and fluid intake

262

961

2.82

50.78

1.7

1.4

8.25

9.16

u/l

0.62

222

747

Endocrine disorders, other/unspecified

150

6.52

50.60

1.5

1.3

11.53

9.03

u/l

0.63

121

Menorrhagia

495

1266

2.20

50.47

1.2

1.3

14.49

15.30

u/l

0.43

411

1010

Oedema, not elsewhere classified

545

2703

2.02

50.37

1.4

1.3

12.47

10.49

u/l

2.19

442

2187

Dorsopathies

2606

9556

1.40

50.33

1.4

9.13

9.20

u/l

0.11

2151

7765

Abnormalities of heart beat

743

4065

1.82

49.91

1.4

10.62

10.32

u/l

0.21

615

3329

Other (not insulin) diabetes medications

1963

8056

1.46

49.33

1.4

1.3

8.82

10.83

u/l

11.83

1603

6666

Hypertrophy of breast in women and men

458

2191

2.15

49.08

1.5

1.3

11.00

13.88

u/l

4.28

372

1797

Other noninflammatory disorders of vulva and perineum

182

553

3.39

49.02

1.2

1.3

13.37

15.43

u/l

0.74

150

433

Continuous positive airway pressure

362

1304

2.39

48.96

1.4

1.5

8.30

8.81

u/l

0.31

285

1019

Soft tissue disorders

2613

9771

1.39

48.66

1.4

9.14

9.09

u/l

0.07

2153

7923

Diabetes insipidus

10.05

48.34

2.3

1.1

7.72

9.16

u/l

0.36

Complications of medical and surgical care

1412

8568

1.53

48.29

1.5

1.3

11.59

10.74

u/l

1.29

1149

7004

Other functional intestinal disorders

873

4766

1.72

48.22

1.4

1.5

11.10

10.26

u/l

0.98

702

3794

Antihypertensive medication - note that there are other indications

2070

7687

1.45

48.18

1.5

1.4

8.54

8.88

u/l

0.60

1705

6250

Low back pain

1793

8866

1.47

47.94

1.4

10.23

9.41

u/l

1.71

1466

7274

Certain infectious and parasitic diseases

2376

8518

1.41

47.88

1.5

1.4

10.16

9.38

u/l

1.92

1947

6952

Drug-induced adrenocortical insufficiency

142

6.54

47.65

1.5

1.4

14.34

11.01

u/l

0.85

116

Care involving use of rehabilitation procedures

1278

7618

1.56

47.54

1.6

1.4

10.04

10.02

u/l

0.01

1054

6159

Disease of hard tissues of teeth, NOS

1101

3519

1.66

47.21

1.4

9.39

9.50

u/l

0.09

912

2899

Biguanides

1867

7886

1.46

46.73

1.4

1.3

8.74

10.97

u/l

13.95

1531

6513

Rare circulating lymphoid malignancy, including Hilmo

109

241

4.89

46.65

2.8

1.6

7.51

7.42

u/l

0.03

190

Lower back pain or/and sciatica

2364

11192

1.39

46.54

1.4

10.36

9.61

u/l

1.75

1933

9195

Testicular dysfunction, other/unspecified

13.67

46.05

2.3

1.5

5.96

4.40

u/l

1.02

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

566

2986

1.93

45.84

1.4

1.3

8.44

11.12

u/l

6.68

458

2450

Glucagon-like peptide-1 (GLP-1) analogues

566

2986

1.93

45.84

1.4

1.3

8.44

11.12

u/l

6.68

458

2450

Symptoms and signs involving the skin and subcutaneous tissue

1446

9514

1.51

45.73

1.4

10.85

10.40

u/l

0.60

1175

7766

Persons encountering health services for specific procedures and health care

2518

11068

1.38

45.59

1.5

1.4

11.00

9.21

u/l

7.39

2037

9015

Dental pulpitis, including avohilmo

2330

10983

1.39

45.56

1.4

9.54

9.42

u/l

0.15

1895

9039

Eating disorder

455

2258

2.13

45.48

1.6

1.4

7.36

9.14

u/l

2.77

359

1869

Other pulmonary diagnosis

1842

6382

1.46

44.89

1.4

9.75

9.48

u/l

0.36

1499

5241

Other diseases of blood and blood-forming organs, wide

439

2144

2.10

44.46

1.6

1.4

10.72

10.50

u/l

0.11

356

1719

Diseases of the skin and subcutaneous tissue

2383

8675

1.39

44.32

1.5

1.4

9.16

9.38

u/l

0.35

1924

7078

Viral hepatitis, IBD co-morbidity

192

645

3.12

44.24

1.5

1.4

7.80

8.45

u/l

0.33

136

541

Nausea and vomiting

584

3083

1.89

44.12

1.5

10.65

9.26

u/l

1.28

467

2433

ILD differential diagnosis

1826

6343

1.46

43.90

1.4

9.94

9.42

u/l

0.83

1484

5210

Anorexia (incl.atypical)

285

1186

2.56

43.86

1.7

1.4

6.21

9.38

u/l

7.10

220

972

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1111

7036

1.58

43.74

1.4

1.3

11.24

10.97

u/l

0.24

899

5748

COPD differential diagnosis

1825

6348

1.46

43.58

1.4

9.94

9.42

u/l

0.83

1484

5212

Ovarian dysfunction, other/unspecified

11.35

43.39

1.4

1.1

21.39

9.28

u/l

4.10

Isolated growth hormone deficiency

197

6.64

43.32

3.2

2.2

4.35

5.13

u/l

0.58

121

Non-small cell lung cancer, squamous, helper endpoint

182

5.19

43.27

1.3

14.49

8.64

u/l

2.98

145

Secondary uncertain malignant neoplasm

225

832

2.77

42.92

1.6

1.4

14.29

8.54

u/l

5.13

181

666

Eating disorders

474

2434

2.04

42.74

1.6

1.4

7.42

9.06

u/l

2.50

373

2009

Excluding asthma or asthma-COPD overlap

1827

6382

1.45

42.67

1.4

9.98

9.48

u/l

0.79

1485

5241

Symptoms and signs involving the nervous and musculoskeletal systems

1128

7307

1.56

42.67

1.5

1.4

10.99

10.30

u/l

0.87

940

5907

Other diseases of intestines

2592

10959

1.36

42.59

1.4

10.09

9.19

u/l

2.61

2093

8924

Somatoform disorder

402

1938

2.13

42.38

1.4

1.3

10.18

10.44

u/l

0.14

312

1603

Personality disorders

841

5114

1.69

42.31

1.4

9.04

9.06

u/l

0.02

629

4283

Mouth breathing

847

5144

1.67

42.11

1.5

7.58

9.07

u/l

4.02

695

4107

Adenomyosis (Endometriosis of uterus)

179

589

3.10

42.10

1.2

1.3

14.70

18.59

u/l

2.29

160

462

Sciatica+with lumbago

1009

5873

1.60

41.90

1.3

10.92

10.61

u/l

0.26

829

4824

Disorders of pituitary gland, other and/or unspecified

12.66

41.89

2.0

1.2

4.57

7.82

u/l

1.12

Gastrointestinal diseases

1728

6021

1.46

41.18

1.5

1.4

9.03

8.73

u/l

0.43

1412

4902

Molar incisor enamel hypoplasia, with caries

210

5.95

41.14

3.2

2.4

4.84

4.68

u/l

0.06

120

Hyperkinetic disorders, excluding more controls

526

2713

1.94

40.73

1.6

1.4

6.87

7.87

u/l

1.45

384

2244

Specific personality disorders

739

4414

1.72

39.92

1.4

1.3

8.87

9.23

u/l

0.33

549

3682

Diarrhoea and gastroenteritis of presumed infectious origin

1682

10742

1.43

39.87

1.5

1.4

9.23

9.26

u/l

0.03

1381

8731

Metabolic disorders

1855

8069

1.42

39.85

1.6

1.4

10.34

10.29

u/l

0.04

1489

6591

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

790

4775

1.68

39.83

1.3

9.62

9.31

u/l

0.28

610

4050

Myalgia

555

3058

1.85

39.41

1.4

1.3

11.24

10.70

u/l

0.32

433

2505

Irritable bowel syndrome

617

3509

1.79

39.33

1.3

10.35

10.70

u/l

0.25

495

2892

ILD medications

2674

10944

1.34

39.28

1.5

1.4

10.18

9.11

u/l

3.46

2203

8865

372

1796

2.14

39.24

1.5

1.4

10.67

9.75

u/l

0.54

290

1471

Other diseases of upper respiratory tract

2390

9241

1.36

39.08

1.4

9.73

9.57

u/l

0.23

1940

7490

Diabetes mellitus

2287

9903

1.36

38.69

1.4

9.24

9.97

u/l

2.07

1860

8110

Complications of procedures, not elsewhere classified

1613

9431

1.43

38.44

1.4

1.3

11.06

10.18

u/l

1.68

1322

7726

Diabetes, varying definitions

2269

9856

1.36

38.37

1.4

9.22

9.98

u/l

2.20

1847

8072

Asthma-related infections

1263

8392

1.49

38.34

1.5

1.4

9.43

9.71

u/l

0.32

1009

6850

Asthma, hospital admission 2, infections

1263

8392

1.49

38.34

1.5

1.4

9.43

9.71

u/l

0.32

1009

6850

Coxibs

657

1944

1.81

38.29

1.4

7.76

8.75

u/l

1.34

551

1573

Acute lymphocytic leukaemia, including Hilmo

116

7.39

38.24

3.0

1.9

6.72

8.00

u/l

0.36

Acute lymphocytic leukaemia, helper endpoint

116

7.39

38.24

3.0

1.9

6.72

8.00

u/l

0.36

Acute lymphocytic leukaemia

116

7.39

38.24

3.0

1.9

6.72

8.00

u/l

0.36

Any operation in hilmo

138

180

4.03

38.22

1.6

1.4

6.50

5.81

u/l

0.33

117

138

Diseases of the musculoskeletal system and connective tissue

1625

5693

1.45

37.90

1.4

8.21

8.61

u/l

0.70

1329

4575

Other disorders of fluid, electrolyte and acid-base balance

441

2170

1.96

37.56

1.5

1.4

12.71

10.83

u/l

1.46

358

1765

Lumbar disc prolapse

1253

6492

1.50

37.46

1.4

9.96

10.13

u/l

0.16

1041

5339

Chronic rhinitis, nasopharyngitis and pharyngitis

703

4204

1.70

37.36

1.4

9.60

10.55

u/l

1.08

554

3416

Visual disturbances and blindness

990

6426

1.56

37.23

1.6

1.4

10.32

10.26

u/l

0.04

783

5216

Substance use, excluding alcohol

567

3210

1.81

37.10

1.5

1.4

8.55

8.12

u/l

0.35

421

2663

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1005

6552

1.55

36.82

1.4

1.3

11.18

11.11

u/l

0.05

815

5347

Diabetes medication

2257

9977

1.35

36.74

1.4

9.04

10.03

u/l

3.59

1834

8172

COPD/asthma/ILD related infections

2262

8410

1.36

36.57

1.4

10.51

9.96

u/l

0.99

1862

6859

COPD/asthma related infections

2262

8410

1.36

36.57

1.4

10.51

9.96

u/l

0.99

1862

6859

Cushing syndrome

7.78

36.48

2.5

1.3

10.53

11.53

u/l

0.16

Chronic diseases of tonsils and adenoids

1904

8773

1.39

36.32

1.4

9.61

9.52

u/l

0.12

1575

7143

1054

6925

1.53

36.29

1.5

9.28

9.41

u/l

0.12

843

5646

Implicit viral Sepsis

520

2878

1.84

36.20

1.4

9.26

9.85

u/l

0.51

414

2327

Gestational diabetes (for exclusion)

1176

5499

1.52

36.19

1.2

10.08

12.02

u/l

5.46

996

4545

Exposure to unspecified factor

2235

12060

1.35

36.18

1.5

1.4

9.15

9.64

u/l

0.99

1782

9835

Secondary and unspecified malignant neoplasm of lymph nodes

167

584

2.95

35.64

1.6

1.4

11.44

8.46

u/l

1.76

132

480

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1992

10137

1.37

35.59

1.5

1.4

11.22

9.80

u/l

3.84

1591

8265

Disorders of parathyroid gland

221

876

2.53

35.50

1.5

1.3

12.83

14.37

u/l

0.69

186

698

Pain in throat and chest

1897

8319

1.38

35.39

1.4

9.99

9.55

u/l

0.71

1548

6796

Haemorrhage from respiratory passages

529

2658

1.82

35.28

1.4

10.71

9.56

u/l

1.07

400

2111

Hypothyroidism, drug reimbursement

326

1068

2.20

35.22

1.4

1.3

14.45

9.60

u/l

4.71

265

912

Triptan medication for migraine, single purchase ok

1896

9428

1.38

35.10

1.4

10.55

9.70

u/l

1.81

1590

7688

Migraine, single triptan purchase ok & required. ICD-code if available is included

1896

9428

1.38

35.10

1.4

10.55

9.70

u/l

1.81

1590

7688

Persistent mood disorders

431

2278

1.93

34.99

1.3

10.50

9.95

u/l

0.35

336

1879

Symptoms and signs involving the urinary system

1332

7040

1.45

34.66

1.4

10.43

9.88

u/l

0.69

1070

5705

Other abnormal uterine and vaginal bleeding

267

821

2.36

34.49

1.2

1.3

15.02

17.34

u/l

1.13

210

648

Visual disturbances

929

6055

1.55

34.45

1.5

1.4

10.54

10.24

u/l

0.25

735

4923

Hodgkin lymphoma, hilmo

117

342

3.71

34.45

1.7

1.5

11.75

8.13

u/l

1.67

280

Enlarged lymph nodes

346

1705

2.08

34.37

1.5

1.4

11.69

9.31

u/l

2.19

281

1374

ILD medications: prednisolone, methylprednisolone, prednisone

2481

10583

1.32

34.22

1.4

10.51

9.18

u/l

4.70

2045

8604

Polyuria

371

1875

2.01

34.20

1.4

8.19

9.77

u/l

2.28

297

1515

Dermatitis and eczema

2438

11527

1.32

34.18

1.5

1.4

9.99

9.51

u/l

0.95

1989

9370

Asthma, including avohilmo

2664

11524

1.31

34.16

1.4

9.39

9.54

u/l

0.24

2162

9380

Hypoplasia of dental enamel

253

4.91

34.05

3.2

2.5

4.16

4.19

u/l

0.01

147

Infections, IBD-co-morbidities

326

1099

2.16

33.82

1.5

1.4

10.90

10.39

u/l

0.25

274

886

Other joint disorders

2346

9368

1.33

33.81

1.4

9.11

9.05

u/l

0.08

1936

7609

Hypo-osmolality and hyponatraemia

233

979

2.41

33.61

1.5

1.4

12.65

10.91

u/l

0.80

186

788

Panic disorder

504

2852

1.82

33.30

1.4

8.65

9.03

u/l

0.29

390

2382

1884

8406

1.37

33.24

1.5

1.4

10.34

9.96

u/l

0.54

1492

6856

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1884

8406

1.37

33.24

1.5

1.4

10.34

9.96

u/l

0.54

1492

6856

Spondylosis

764

3883

1.62

33.08

1.3

12.14

11.74

u/l

0.27

609

3149

Deviated nasal septum

643

3881

1.68

32.87

1.4

7.92

8.32

u/l

0.37

505

3165

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

10.93

32.79

2.9

1.5

13.47

3.71

u/l

5.29

Disorders of lacrimal system

701

4322

1.64

32.60

1.5

1.4

12.67

11.80

u/l

0.67

566

3522

Clear cell adenocarcinoma of kidney

221

4.20

32.54

1.4

1.3

14.85

7.17

u/l

3.49

182

Certain infectious and parasitic diseases

1658

5981

1.40

32.47

1.4

10.11

9.52

u/l

0.93

1341

4906

Other bacterial diseases

1800

8910

1.37

32.47

1.6

1.4

10.55

9.76

u/l

1.46

1414

7282

Other metabolic disorders

299

1428

2.15

32.43

2.0

1.3

13.42

12.31

u/l

0.52

243

1180

Infections of the skin and subcutaneous tissue

1363

9604

1.42

32.33

1.6

1.4

8.59

8.85

u/l

0.36

1101

7832

Nonorganic sleeping disorders

579

3433

1.73

32.25

1.4

8.53

9.24

u/l

0.81

447

2810

Postprocedural endocrine and metabolic disorders, not elsewhere classified

276

1281

2.21

32.23

2.0

1.3

13.95

12.58

u/l

0.64

225

1068

2376

9364

1.32

32.19

1.4

10.59

10.01

u/l

1.09

1964

7601

Other intervertebral disc disorders

1648

7193

1.39

32.17

1.4

10.40

9.89

u/l

0.73

1364

5909

Mycoses

1863

12110

1.35

31.81

1.4

9.64

9.60

u/l

0.04

1501

9908

Other specific joint derangements/joint disorders

1897

9132

1.36

31.81

1.4

10.42

9.12

u/l

3.76

1575

7429

Bipolar affective disorders

533

3101

1.76

31.77

1.4

1.3

8.95

9.41

u/l

0.38

427

2591

Lymphoid leukaemia

129

418

3.22

31.68

2.5

1.6

8.47

8.22

u/l

0.09

327

Other maternal disorders predominantly related to pregnancy

1224

5307

1.46

31.64

1.2

1.3

12.44

13.22

u/l

1.01

1042

4333

Cervical disc disorders

546

3190

1.73

31.52

1.4

11.00

11.51

u/l

0.34

439

2593

Disorders of thyroid, IBD co-morbidities

455

1743

1.87

31.48

1.4

1.3

12.02

9.67

u/l

2.63

375

1429

Congenital malformations, deformations and chromosomal abnormalities

1627

11022

1.38

31.37

1.6

1.4

9.98

9.43

u/l

0.85

1324

8999

Other disorders of lacrimal gland

583

3478

1.70

31.26

1.5

1.3

13.07

11.90

u/l

0.87

461

2842

Other diseases of hard tissues of teeth

1034

3551

1.52

31.23

1.4

9.25

9.55

u/l

0.28

842

2913

Mental and behavioural disorders due to sedatives or hypnotics

220

949

2.43

31.07

1.5

1.4

8.02

8.21

u/l

0.07

153

773

Other/unspecified dorsalgia

723

4526

1.60

30.84

1.4

11.11

10.39

u/l

0.65

574

3711

Hernia of abdominal wall, postoperative

299

1454

2.09

30.69

1.3

9.89

9.06

u/l

0.53

243

1180

Sexual dysfunction

187

4.64

30.62

1.7

1.3

5.50

7.69

u/l

1.33

159

Dysphagia

377

1996

1.92

30.29

1.4

11.78

10.51

u/l

0.83

300

1609

Nerve, nerve root and plexus disorders

2096

9773

1.32

29.80

1.4

1.3

10.78

9.88

u/l

2.08

1729

8039

Diseases of the eye and adnexa

2235

8568

1.32

29.65

1.5

1.4

9.11

8.88

u/l

0.30

1823

7020

Other symptoms and signs involving the nervous and musculoskeletal systems

823

5405

1.54

29.58

1.5

1.4

11.20

10.16

u/l

1.22

695

4367

Complications of surgical and medical care, not elsewhere classified

1967

10211

1.33

29.40

1.5

1.4

11.06

9.86

u/l

3.21

1614

8369

Hypoparathyroidism

173

4.47

29.34

1.5

1.3

12.41

12.18

u/l

0.04

133

Hypertensive diseases (excluding secondary)

1250

5102

1.44

29.30

1.5

1.4

9.91

9.89

u/l

0.02

1023

4186

Poisoning by drugs, medicaments and biological substances

673

4251

1.62

29.17

1.4

9.70

8.97

u/l

0.71

508

3514

Inflammatory diseases of prostate (prostatitis)

247

1145

2.21

28.94

1.5

1.4

6.38

5.94

u/l

0.44

206

937

Non-Hodgkin lymphoma, all, including Hilmo

186

764

2.48

28.75

1.7

1.3

10.71

8.80

u/l

1.22

156

607

Cough

743

4534

1.57

28.71

1.5

1.4

10.52

10.60

u/l

0.05

589

3639

Pain in limb

1798

9032

1.34

28.69

1.4

10.83

9.33

u/l

4.11

1462

7341

Cardiovascular diseases

1971

8030

1.33

28.64

1.5

1.4

8.62

8.64

u/l

0.02

1617

6547

Chronic sinusitis

833

5529

1.52

28.37

1.4

1.3

10.36

10.56

u/l

0.14

682

4563

Hyperhidrosis

114

370

3.27

28.26

1.5

1.3

10.90

9.80

u/l

0.38

312

Asthma, unspecified (mode)

1017

5254

1.47

28.21

1.4

11.00

10.05

u/l

1.20

811

4330

Asthma, unspecified (mode), excluding more controls

1011

5188

1.47

28.07

1.4

10.94

10.03

u/l

1.12

807

4275

Vasomotor and allergic rhinitis

972

6558

1.48

28.04

1.5

1.4

9.19

9.67

u/l

0.56

789

5323

Weight loss

204

887

2.37

28.00

1.6

1.5

8.86

9.49

u/l

0.31

174

699

Mental and behavioural disorders due to psychoactive substance use

1301

8710

1.40

27.98

1.4

9.05

8.40

u/l

1.11

1007

7195

Implicit viral Sepsis

356

1903

1.90

27.93

1.4

8.88

9.53

u/l

0.47

291

1528

Influenza and pneumonia

2330

11557

1.29

27.85

1.5

1.4

9.75

9.52

u/l

0.35

1863

9439

Viral Sepsis

357

1912

1.90

27.84

1.4

8.90

9.52

u/l

0.44

292

1537

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

885

5339

1.52

27.74

1.6

1.5

7.26

7.80

u/l

0.91

669

4366

Substance abuse

1261

8536

1.40

27.68

1.4

9.01

8.36

u/l

1.07

975

7049

Gastro-oesophageal reflux disease

1207

7425

1.41

27.66

1.4

10.50

u/l

0.00

957

6029

Generalized anxiety disorder

533

3227

1.70

27.66

1.4

9.62

8.86

u/l

0.57

398

2706

Polyneuropathies and other disorders of the peripheral nervous system

331

1734

1.94

27.59

1.5

1.4

11.63

9.74

u/l

1.26

254

1400

Aplastic and other anaemias

598

3445

1.63

27.54

1.5

1.4

13.61

10.36

u/l

4.46

481

2754

Rotator cuff syndrome

930

4510

1.49

27.51

1.4

1.3

10.69

11.15

u/l

0.43

782

3667

Precocious central puberty

6.43

27.48

3.6

1.4

6.47

7.76

u/l

0.45

Mental and behavioural disorders due to opioids

172

708

2.60

27.45

1.6

1.4

7.10

7.08

u/l

0.01

116

584

Other obstetric conditions, not elsewhere classified

1155

5187

1.45

27.43

1.2

1.3

9.98

11.20

u/l

2.37

974

4286

Other noninflammatory disorders of uterus, except cervix

189

516

2.49

27.31

1.2

1.3

14.65

22.96

u/l

8.66

157

413

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1147

5146

1.44

27.16

1.2

1.3

9.85

11.04

u/l

2.35

966

4253

Tonsillectomy and adenotomy

1743

9171

1.34

27.12

1.5

1.4

8.75

9.33

u/l

1.24

1463

7448

Certain disorders involving the immune mechanism

377

2076

1.85

27.05

1.8

1.4

10.31

9.95

u/l

0.17

313

1676

Concussion

1124

6484

1.43

26.97

1.5

1.4

9.04

9.49

u/l

0.59

897

5269

Emotionally unstable personality disorder

443

2575

1.78

26.94

1.4

1.3

9.27

9.42

u/l

0.09

320

2145

Malignant neoplasm of skin

535

2184

1.69

26.93

1.4

1.3

13.83

10.59

u/l

4.75

432

1735

Other and unspecified anaemias

542

3136

1.66

26.91

1.5

1.4

13.80

10.47

u/l

4.10

431

2502

Other problems related to primary support group, including family circumstances

406

2238

1.83

26.89

1.8

1.5

9.28

8.88

u/l

0.26

309

1767

Asthma-related pneumonia

591

3673

1.63

26.79

1.5

10.02

9.91

u/l

0.07

465

2955

Spontaneous abortion

986

4574

1.47

26.66

1.2

1.3

11.56

12.53

u/l

1.27

824

3779

Spinal stenosis

572

2656

1.65

26.55

1.4

1.3

11.79

12.01

u/l

0.12

470

2120

Asthma, hospital admissions 3, pneumonia

592

3689

1.62

26.55

1.5

10.06

9.90

u/l

0.10

466

2968

Asthma-related pneumonia or sepsis

592

3689

1.62

26.55

1.5

10.06

9.90

u/l

0.10

466

2968

Injuries to the wrist and hand

2197

11882

1.29

26.52

1.4

9.02

9.71

u/l

1.77

1792

9676

Triptan medication for migraine, min. 3 purchases

1446

8163

1.37

26.30

1.3

11.50

10.63

u/l

1.39

1225

6697

Other anaemias

544

3162

1.65

26.26

1.5

1.4

13.76

10.50

u/l

4.00

433

2524

Hypertension, essential

1479

6157

1.37

26.26

1.5

1.4

10.27

10.76

u/l

0.63

1209

5087

Type 2 diabetes, wide definition

1184

5400

1.41

25.93

1.4

9.17

10.99

u/l

5.23

926

4456

Congenital malformations, deformations and chromosomal abnormalities

1495

10656

1.35

25.90

1.6

1.4

10.11

9.34

u/l

1.33

1211

8714

Diabetes mellitus in pregnancy

1042

4669

1.46

25.88

1.2

10.51

12.01

u/l

2.97

882

3823

Disorders of puberty, other/unspecified

8.29

25.84

3.5

1.8

5.02

5.99

u/l

0.27

Constipation

1524

7854

1.35

25.83

1.4

11.12

10.80

u/l

0.34

1172

6365

Inflammatory bowel disease treatment related agents

2537

11264

1.27

25.79

1.4

10.41

9.27

u/l

3.79

2076

9165

Benign neoplasm of colon, rectum, anus and anal canal

766

4405

1.52

25.78

1.4

1.3

11.76

11.33

u/l

0.33

623

3560

Acetic acid derivatives and related substances

589

1865

1.66

25.76

1.4

7.95

8.83

u/l

1.03

491

1511

Acute sinusitis

1216

8171

1.39

25.55

1.4

9.31

9.79

u/l

0.68

1003

6693

Other bacterial diseases

2028

9981

1.30

25.36

1.6

1.4

10.49

9.73

u/l

1.51

1605

8165

Other eating disorders

246

1214

2.15

25.34

1.7

1.4

6.43

9.19

u/l

4.92

203

986

Poisoning by medicine

606

3864

1.60

25.34

1.4

9.70

8.87

u/l

0.82

463

3178

Chromosomal abnormalities, not elsewhere classified

120

432

3.07

25.33

2.6

1.8

9.41

7.65

u/l

0.84

312

Exposure to other specified factors

1686

11814

1.32

25.22

1.4

8.91

9.47

u/l

1.19

1350

9658

Other abnormal products of conception

919

4182

1.48

25.18

1.2

10.85

11.90

u/l

1.45

788

3459

Gingivitis and periodontal diseases

2083

8335

1.30

25.14

1.4

9.33

9.65

u/l

0.50

1667

6784

Osteoporosis with pathological fracture (FG)

180

4.02

25.11

1.3

1.2

21.92

21.09

u/l

0.10

141

Other sleep disorders

232

1111

2.14

25.11

1.4

9.13

10.18

u/l

0.64

185

898

Shoulder lesions

1292

5687

1.39

25.04

1.4

10.66

10.49

u/l

0.16

1064

4656

Excessive attrition of teeth

1271

9343

1.38

24.99

1.4

10.02

9.90

u/l

0.12

1039

7654

Spondylopathies

1290

5598

1.39

24.96

1.4

10.92

10.55

u/l

0.38

1058

4567

Premenstrual syndrome

6.28

24.92

1.3

8.88

12.83

u/l

0.79

Pneumonia, organism unspecified

1839

9918

1.31

24.89

1.5

1.4

10.12

9.65

u/l

0.74

1445

8090

Postpartum care and examination

494

1872

1.72

24.89

1.2

1.3

10.01

11.69

u/l

2.28

436

1490

Cystitis

1723

7783

1.33

24.89

1.3

1.4

11.96

10.73

u/l

2.57

1371

6387

Disorders of lipoprotein metabolism and other lipidaemias

1227

5483

1.40

24.84

1.4

9.19

10.53

u/l

2.76

974

4517

Endometriosis of rectovaginal septum and vagina

112

384

2.98

24.80

1.2

1.3

11.50

16.63

u/l

3.06

299

Other diseases of blood and blood-forming organs

140

542

2.67

24.79

1.6

1.4

8.18

9.20

u/l

0.48

108

446

Other septicaemia

541

3228

1.63

24.76

1.8

1.4

11.27

9.78

u/l

1.39

421

2581

Drug-induced osteoporosis with pathological fracture

6.39

24.54

1.3

16.49

10.87

u/l

0.71

Asthma, hospital admissions , main diagnosis only

1737

11778

1.31

24.52

1.4

9.73

9.79

u/l

0.06

1403

9574

Other disorders of male genital organs

119

429

2.92

24.47

2.0

1.5

5.94

4.70

u/l

1.49

102

358

Other and unspecified iron deficiency

553

3470

1.61

24.32

1.4

10.94

10.62

u/l

0.18

437

2795

Thyroiditis, ILD-related definition

277

1437

1.98

24.13

1.5

1.4

13.14

11.36

u/l

0.91

221

1172

Oxicams

397

1263

1.81

24.01

1.4

9.21

9.46

u/l

0.15

329

1036

Covid-19 confirmed case

669

4401

1.54

24.00

1.4

11.36

9.41

u/l

2.44

533

3589

Gender identity disorders

317

3.42

23.94

1.9

1.6

6.81

8.21

u/l

0.81

255

Diseases of oral cavity, salivary glands and jaws

992

3554

1.45

23.69

1.4

9.08

9.55

u/l

0.51

803

2916

Cervicalgia

352

1976

1.81

23.65

1.3

1.4

10.51

11.33

u/l

0.51

290

1605

Arthropathies

2344

9425

1.27

23.58

1.4

8.83

9.03

u/l

0.35

1924

7632

Monoamine oxidase A inhibitors

194

887

2.23

23.56

1.4

1.3

8.60

11.49

u/l

2.44

153

728

Transport accidents

1109

6905

1.40

23.52

1.4

8.24

9.36

u/l

2.89

906

5708

Diseases of the ear and mastoid process

2631

10623

1.25

23.45

1.4

9.51

9.63

u/l

0.17

2123

8692

Benign neoplasm: Colon

618

3823

1.56

23.41

1.4

1.3

11.81

11.31

u/l

0.34

501

3078

Fibromyalgia

209

992

2.17

23.27

1.2

1.3

14.93

13.28

u/l

0.61

168

816

Follow-up examination after treatment for malignant neoplasms

113

403

2.85

23.23

1.5

1.3

13.76

13.98

u/l

0.05

328

Schizophrenia or delusion, excluding more controls

644

4199

1.54

23.03

1.3

1.4

8.55

8.89

u/l

0.32

487

3521

Disorders of mineral metabolism

156

658

2.43

23.00

1.7

1.4

11.74

10.25

u/l

0.48

127

533

Abnormal weight loss

173

766

2.32

22.84

1.6

1.5

9.25

9.24

u/l

0.00

149

602

Other and unspecified polyneuropathies, also in other diseases

269

1403

1.95

22.83

1.4

12.27

9.62

u/l

1.83

208

1128

Diseases of the respiratory system

1367

5071

1.36

22.82

1.4

10.20

9.76

u/l

0.53

1106

4141

Atopic dermatitis

1493

9304

1.33

22.80

1.5

1.4

9.20

9.76

u/l

0.90

1195

7570

Iron deficiency anaemia

657

4293

1.52

22.58

1.4

11.39

10.81

u/l

0.41

518

3464

Inflammatory diseases of female pelvic organs

1206

6524

1.37

22.53

1.2

1.3

13.35

12.55

u/l

0.90

980

5402

Use of pramipexole

287

1535

1.90

22.52

1.3

10.06

12.00

u/l

1.43

229

1253

Oral corticosteroids

2199

10376

1.27

22.30

1.4

11.08

9.46

u/l

5.82

1809

8489

Malignant neoplasm of bladder, including Hilmo

138

553

2.52

22.22

1.3

12.94

8.10

u/l

3.76

112

442

Intracranial trauma

1274

6659

1.36

22.10

1.5

1.4

8.88

9.47

u/l

0.95

1018

5412

Hypertension

1542

6615

1.33

22.07

1.5

1.4

10.15

10.54

u/l

0.49

1260

5419

Migraine without aura

589

3855

1.56

22.01

1.4

10.97

10.37

u/l

0.46

470

3169

Disorders of tooth development and eruption

432

2107

1.69

21.99

1.5

1.4

8.91

8.89

u/l

0.01

344

1721

Secondary polycythaemia

201

3.75

21.91

1.7

1.4

6.12

7.92

u/l

0.76

164

Hypertensive diseases

1542

6628

1.32

21.81

1.5

1.4

10.15

10.53

u/l

0.48

1260

5426

Septicaemia

603

3694

1.54

21.81

1.8

1.4

11.15

9.54

u/l

1.78

474

2941

Disturbances of skin sensation

613

4050

1.54

21.76

1.4

1.3

10.04

10.16

u/l

0.08

493

3326

Other symptoms and signs involving the digestive system and abdomen

265

1398

1.93

21.76

1.5

1.4

13.25

12.20

u/l

0.50

216

1120

Pain in thoracic spine

305

1687

1.84

21.68

1.4

1.3

9.58

10.94

u/l

1.10

252

1368

Injuries to the ankle and foot

1684

11663

1.29

21.63

1.4

9.54

9.33

u/l

0.28

1390

9484

Other disorders of penis

209

1022

2.10

21.53

1.6

1.5

5.63

5.38

u/l

0.20

169

811

Disturbance of activity and attention

512

3214

1.61

21.50

1.6

6.70

7.76

u/l

1.67

376

2606

Speech and linguistic disorders, excluding more controls

293

1516

1.88

21.42

2.0

1.5

7.42

7.36

u/l

0.03

212

1212

Transplanted organ and tissue status

220

1100

2.06

21.37

2.0

1.5

11.74

7.68

u/l

2.95

184

862

Unspecified haematuria

591

3198

1.55

21.34

1.4

11.57

9.24

u/l

3.37

485

2558

Pneumonias (Asthma/COPD co-morbidities)

2095

11214

1.26

21.26

1.5

1.4

9.85

9.57

u/l

0.43

1665

9156

Anomalies of dental arch relationship, including avohilmo

569

3350

1.56

21.23

1.7

1.5

8.14

9.09

u/l

1.27

454

2701

Convulsions, not elsewhere classified

533

3391

1.58

21.15

1.5

1.4

8.80

8.00

u/l

0.75

420

2746

Psychotic depression

145

617

2.42

21.08

1.6

1.4

8.64

9.42

u/l

0.35

121

517

All pneumoniae

2108

11264

1.26

20.87

1.5

1.4

9.87

9.57

u/l

0.46

1675

9201

Agranulocytosis

194

936

2.12

20.67

1.6

1.5

12.66

11.34

u/l

0.49

164

753

Visual field defects

147

635

2.37

20.58

1.9

1.4

9.68

9.96

u/l

0.08

111

519

Nutritional anaemias

719

4766

1.47

20.58

1.4

11.62

10.89

u/l

0.59

569

3847

Pure hypercholesterolaemia

1001

4715

1.39

20.56

1.4

9.42

10.56

u/l

1.71

798

3875

Syncope and collapse

704

4120

1.48

20.46

1.4

10.43

9.29

u/l

1.47

566

3368

Hyperparathyroidism

160

710

2.25

20.20

1.5

1.2

13.59

14.76

u/l

0.38

135

562

351

2.97

20.15

1.3

10.89

10.26

u/l

0.19

292

Chronic lower respiratory diseases

2636

11496

1.23

20.14

1.4

9.57

9.49

u/l

0.11

2126

9378

Follow-up examination after treatment for conditions other than malignant neoplasms

824

3824

1.44

20.12

1.3

12.07

9.71

u/l

4.22

673

3128

Renal cell carcinoma of kidney

112

4.51

20.00

1.3

21.43

8.94

u/l

2.61

Asthma (diagnoses ohter than nonallergic)

1780

11679

1.27

19.99

1.4

9.98

9.82

u/l

0.20

1425

9510

Unspecified mental disorder

915

6623

1.40

19.94

1.3

1.4

8.95

8.97

u/l

0.02

728

5468

Dyspnoea

1615

9313

1.29

19.87

1.4

10.87

10.20

u/l

1.08

1321

7592

Cardiovascular diseases (excluding rheumatic etc)

1850

8414

1.28

19.86

1.5

1.4

9.59

8.88

u/l

1.42

1516

6875

Hypoplasia of dental enamel , including avohilmo

174

809

2.25

19.76

2.6

1.9

5.31

6.88

u/l

1.89

119

574

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2009

10969

1.26

19.76

1.5

1.4

9.96

9.59

u/l

0.59

1598

8967

Other diseases of urinary system

2043

9178

1.26

19.75

1.3

1.4

10.99

9.87

u/l

2.85

1631

7522

Dermatitis

1088

8069

1.35

19.71

1.5

1.4

10.47

10.50

u/l

0.03

902

6571

Candidiasis

585

3910

1.52

19.68

1.4

1.3

10.92

10.33

u/l

0.41

452

3214

Molar incisor enamel hypoplasia

182

855

2.21

19.67

2.5

1.9

5.43

7.16

u/l

2.17

122

607

Missing teeth due to accident, extraction or parodontitis

783

5196

1.43

19.63

1.4

12.79

10.83

u/l

2.52

611

4211

Endometriosis of intestine

119

4.46

19.60

1.1

1.3

8.07

12.55

u/l

1.50

Explicit Sepsis

684

4391

1.47

19.58

1.7

1.4

11.01

9.68

u/l

1.52

544

3509

Hyperkinetic disorders

534

3453

1.56

19.58

1.6

6.82

7.59

u/l

1.03

388

2782

Post-traumatic stress disorder

309

1783

1.79

19.51

1.4

9.34

9.06

u/l

0.15

243

1488

Disorders of ocular muscles, binocular movement, accommodation and refraction

1069

7889

1.36

19.50

1.6

1.4

10.08

9.59

u/l

0.38

861

6406

Dental operations

996

3697

1.39

19.45

1.3

1.4

9.27

9.72

u/l

0.50

815

3001

Radiculopathy

216

1107

1.98

19.36

1.3

12.47

11.90

u/l

0.20

172

899

Benign neoplasm of meninges

130

546

2.43

19.33

1.6

1.3

11.99

14.67

u/l

1.12

104

435

Other disorders of optic [2nd] nerve and visual pathways

151

683

2.29

19.17

2.1

1.5

10.70

9.29

u/l

0.43

117

533

Other bacterial intestinal infections

385

2351

1.66

19.16

1.4

10.74

9.95

u/l

0.50

308

1909

Implicit Sepsis

1234

7046

1.33

19.13

1.4

10.08

9.62

u/l

0.57

988

5739

Benign neoplasm: Cerebral meninges

119

483

2.51

19.07

1.6

1.3

12.46

14.65

u/l

0.75

383

Emotional disorders starting during childhood or adolecense, excluding more controls

213

1078

2.03

19.07

1.8

1.5

7.19

7.88

u/l

0.72

164

874

Other symptoms and signs involving cognitive functions and awareness

589

3595

1.50

19.06

1.4

10.56

10.66

u/l

0.06

472

2920

Primary adrenocortical insufficiency

115

4.59

18.92

1.6

1.2

16.93

10.96

u/l

1.13

Localized swelling, mass and lump of skin and subcutaneous tissue

541

3590

1.52

18.79

1.4

11.37

10.22

u/l

1.07

440

2892

Provisional assignment of new diseases of uncertain etiology

1083

8111

1.35

18.74

1.4

11.46

9.47

u/l

3.87

866

6650

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

177

859

2.11

18.67

1.6

1.4

12.86

10.44

u/l

1.02

150

707

Hyperplasia of prostate

550

2038

1.55

18.66

1.4

6.17

6.21

u/l

0.05

441

1662

Codes for special purposes

1083

8118

1.34

18.63

1.4

11.46

9.48

u/l

3.85

866

6656

Redundant prepuce, phimosis and paraphimosis

440

2770

1.60

18.62

1.6

4.82

5.00

u/l

0.38

361

2261

Disorders of psychological development

453

2699

1.60

18.57

2.0

1.6

7.13

7.15

u/l

0.01

339

2128

Vocal cord dysfunction

253

1239

1.86

18.47

1.3

1.4

13.09

11.16

u/l

1.04

203

1018

Persons with potential health hazards related to communicable diseases

1106

8283

1.34

18.44

1.4

8.91

8.87

u/l

0.04

936

6732

Diseases of pulp and periapical tissues, including avohilmo

2283

9628

1.24

18.44

1.4

9.37

9.33

u/l

0.05

1839

7831

Carpal tunnel syndrome

929

5995

1.38

18.43

1.4

1.3

11.91

11.67

u/l

0.18

783

4911

Abnormal results of function studies

183

905

2.07

18.39

1.7

1.5

13.02

8.97

u/l

2.32

146

732

Paralytic ileus and intestinal obstruction

315

1841

1.73

18.38

1.4

12.14

10.58

u/l

1.08

260

1491

Nonalcoholic fatty liver disease

197

1002

2.01

18.29

1.5

1.4

9.74

9.87

u/l

0.04

157

809

Thyrotoxicosis, other and/or unspecified

329

1960

1.70

18.06

1.3

12.84

11.78

u/l

0.59

266

1608

Other diseases of pleura

531

3089

1.52

17.97

1.4

11.15

10.06

u/l

1.01

417

2468

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

790

5691

1.41

17.97

1.3

1.4

9.62

9.38

u/l

0.21

610

4736

Viral infections characterized by skin and mucous membrane lesions

1773

12147

1.26

17.94

1.5

1.4

9.54

9.68

u/l

0.17

1423

9895

malignant neoplasm of female genital organs

114

463

2.47

17.91

1.6

1.2

24.62

17.48

u/l

3.29

101

361

Postmenopausal bleeding

195

503

2.08

17.82

1.2

1.3

28.65

24.79

u/l

1.48

161

403

Precocious puberty

111

4.95

17.72

3.4

1.6

4.91

6.88

u/l

1.63

Constitutional tall stature

102

5.10

17.72

2.7

1.5

4.70

6.23

u/l

0.96

Restless leg syndrome

218

1158

1.92

17.72

1.4

1.3

10.85

11.32

u/l

0.17

168

955

Mixed and other personality disorders

224

1207

1.91

17.68

1.4

8.71

9.24

u/l

0.24

169

999

Other complications of surgical and medical care, not elsewhere classified

188

952

2.02

17.65

1.5

1.4

11.50

10.83

u/l

0.25

160

776

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

241

1333

1.87

17.63

1.6

1.5

7.11

7.16

u/l

0.03

170

1094

Other specified and unspecified personality disorders

244

1353

1.86

17.54

1.4

1.3

8.52

9.24

u/l

0.46

172

1111

Diseases of middle ear and mastoid

1483

9552

1.28

17.52

1.5

1.4

8.60

8.70

u/l

0.11

1211

7806

COPD (mode)

322

1492

1.71

17.51

1.4

1.3

10.12

9.28

u/l

0.55

243

1191

Chronic laryngitis and laryngotracheitis

210

1106

1.93

17.48

1.4

1.3

13.11

11.79

u/l

0.58

173

919

Other general symptoms and signs

137

613

2.29

17.47

1.5

10.34

9.11

u/l

0.40

102

471

Disorders of calcium metabolism

106

427

2.54

17.39

1.6

1.4

14.53

11.53

u/l

0.84

345

Non-invasive ventilation

414

2345

1.59

17.35

1.5

1.4

9.30

9.86

u/l

0.38

364

1946

Other acute lower respiratory infections

1040

7468

1.34

17.35

1.5

9.12

8.85

u/l

0.28

836

6043

Brain meningioma

216

3.23

17.33

1.5

1.3

12.68

11.89

u/l

0.15

171

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

455

2973

1.56

17.32

1.3

1.4

9.68

8.86

u/l

0.65

336

2455

Sequelae of external causes of morbidity and mortality

395

2490

1.61

17.32

1.4

10.92

10.31

u/l

0.37

313

2020

Other extrapyramidal and movement disorders in other diseases

336

2037

1.67

17.25

1.4

1.3

10.60

11.08

u/l

0.25

267

1652

Brain meningioma, including Hilmo

227

3.16

17.24

1.5

1.3

13.14

11.64

u/l

0.32

180

Other and unspecified dermatitis

897

6630

1.36

17.14

1.5

1.4

10.45

10.72

u/l

0.24

736

5412

Implicit Sepsis

1411

8069

1.29

17.09

1.4

10.20

9.75

u/l

0.60

1127

6613

Spondylolisthesis/Spondylolysis

255

1439

1.80

16.99

1.3

1.4

12.97

12.18

u/l

0.32

216

1175

Other diseases of anus and rectum

416

2660

1.58

16.92

1.4

10.56

10.54

u/l

0.01

340

2146

Other disorders starting during childhood or adolecense, excluding more controls

199

1005

1.98

16.90

1.8

1.6

6.11

7.72

u/l

2.72

146

781

Abnormal findings on examination of blood, without diagnosis

718

4703

1.41

16.84

1.4

9.21

9.11

u/l

0.07

587

3769

Other adrenocortical overactivity

4.96

16.80

2.2

1.5

10.64

7.77

u/l

0.47

Viral infections characterized by skin and mucous membrane lesions

821

6004

1.38

16.79

1.6

1.4

8.78

9.23

u/l

0.45

669

4817

Diseases of salivary glands

564

3871

1.47

16.66

1.4

11.09

10.69

u/l

0.28

460

3154

Cerebral cysts

153

738

2.15

16.63

1.5

1.4

9.64

9.06

u/l

0.20

129

598

Other and unspecified drugs and medicaments

165

817

2.07

16.56

1.6

1.4

13.04

10.52

u/l

1.01

142

665

Fissure and fistula of anal and rectal regions

417

2691

1.57

16.56

1.3

1.4

10.25

9.82

u/l

0.24

340

2191

Uterine polyps

101

406

2.52

16.54

1.1

1.3

17.91

21.32

u/l

0.93

320

Malignant neoplasm of heart, mediastinum and pleura

5.47

16.51

1.6

1.3

8.16

7.54

u/l

0.13

Intestinal stricture

379

2391

1.60

16.51

1.4

12.16

10.57

u/l

1.18

314

1935

Other diseases of liver

305

1827

1.70

16.49

1.5

1.4

10.73

10.69

u/l

0.01

242

1480

Haemorrhoids and perianal venous thrombosis

422

2724

1.56

16.46

1.3

10.58

10.57

u/l

0.01

358

2212

DVT of lower extremities and pulmonary embolism

501

3347

1.50

16.45

1.5

1.3

12.38

10.84

u/l

1.37

420

2718

Malignant neoplasm of ovary, including Hilmo

228

3.08

16.43

1.9

1.3

21.45

17.65

u/l

1.00

176

Implicit bacterial Sepsis

499

2957

1.51

16.38

1.4

10.71

9.86

u/l

0.65

393

2373

Internal derangement of knee

700

4985

1.41

16.38

1.4

9.28

9.93

u/l

0.76

561

4073

Viral hepatitis

206

1109

1.92

16.38

1.4

7.80

7.91

u/l

0.05

146

896

Immunodeficiencies

116

505

2.38

16.23

1.7

1.6

10.16

9.99

u/l

0.04

392

Kela-code for severe mental illness

783

5723

1.38

16.23

1.3

1.4

8.83

8.82

u/l

0.00

615

4716

Other and unspecified nerve root and plexus disorders, also in other diseases

351

2188

1.63

16.22

1.4

1.3

10.29

10.35

u/l

0.03

294

1821

Diseases of liver

529

3604

1.48

16.20

1.5

1.4

10.18

10.15

u/l

0.02

416

2916

Deforming dorsopathies

486

3260

1.51

16.12

1.5

1.4

11.84

10.45

u/l

1.13

402

2626

Other hypertrichosis

7.74

16.04

1.6

1.3

9.90

8.73

u/l

0.19

Motor disorders, excluding more controls

291

2.92

16.02

2.7

2.0

4.56

5.94

u/l

1.38

200

Venous thromboembolism

676

4655

1.41

15.99

1.5

1.3

12.14

11.17

u/l

0.89

555

3766

Abnormal involuntary movements

237

1341

1.80

15.79

1.4

10.20

9.78

u/l

0.21

194

1075

Other follicular disorders

189

1002

1.94

15.73

1.4

11.56

9.00

u/l

1.54

161

843

Rheumatism, unspecified

166

837

2.01

15.70

1.2

1.3

17.49

16.23

u/l

0.40

137

685

Cervicobrachial syndrome

355

2237

1.61

15.65

1.3

11.65

11.90

u/l

0.10

288

1830

Diaphragmatic hernia

402

2603

1.56

15.64

1.3

11.68

12.23

u/l

0.31

323

2121

Orchitis and epididymitis

173

889

1.99

15.62

1.6

1.5

6.39

5.61

u/l

0.77

145

727

Brachial plexus disorders

213

1174

1.86

15.60

1.4

1.3

11.72

11.35

u/l

0.13

184

983

Acute bronchitis

706

5002

1.40

15.56

1.4

9.82

9.31

u/l

0.46

572

4008

Pulmonary embolism

340

2121

1.62

15.54

1.5

1.3

12.80

11.04

u/l

1.24

285

1718

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1959

10463

1.23

15.41

1.6

1.4

10.50

9.79

u/l

1.37

1604

8517

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

4.51

15.40

1.8

1.4

9.08

7.96

u/l

0.26

Propionic acid derivatives

651

2292

1.44

15.38

1.5

1.6

7.61

8.25

u/l

0.80

531

1812

Pulmonary heart disease

340

2127

1.61

15.36

1.5

1.3

12.80

11.04

u/l

1.24

285

1723

Temporomandibular joint disorders, including avohilmo

1051

7977

1.31

15.30

1.4

1.3

10.90

10.47

u/l

0.44

857

6586

Undetermined asthma

224

1259

1.81

15.21

1.5

1.4

10.99

10.06

u/l

0.39

180

1020

Suicide or other Intentional self-harm

579

4071

1.44

15.21

1.4

9.63

9.16

u/l

0.38

432

3349

Erosion of teeth , including avohilmo

617

4391

1.43

15.17

1.5

1.4

8.91

9.24

u/l

0.26

481

3594

Dissociative [conversion] disorders

129

607

2.22

15.12

1.4

10.00

9.36

u/l

0.21

104

500

Functional dyspepsia

435

2895

1.52

15.03

1.3

11.55

11.16

u/l

0.22

357

2358

Hypokalaemia

160

810

2.01

15.02

1.4

12.47

11.63

u/l

0.27

130

660

Any death

727

3772

1.39

15.01

1.4

13.83

9.86

u/l

8.46

572

3040

Migraine without aura and triptan purchases

468

3175

1.50

14.98

1.4

1.3

11.37

10.19

u/l

0.94

378

2615

Other enthesopathies

458

3084

1.50

14.91

1.4

1.3

11.12

11.86

u/l

0.50

383

2514

Undetermined asthma, excluding more controls

224

1267

1.79

14.90

1.5

1.4

10.99

10.08

u/l

0.38

180

1026

Drug-induced polyneuropathy

4.86

14.89

3.0

2.1

8.00

7.60

u/l

0.06

Falls/tendency to fall

2454

10293

1.20

14.88

1.4

9.73

9.45

u/l

0.48

1982

8409

Bulimia nervosa (incl. atypical)

151

764

2.09

14.78

1.3

9.05

10.19

u/l

0.48

119

633

Melanocytic naevi

587

4157

1.43

14.76

1.4

10.26

10.02

u/l

0.15

478

3399

Other bacterial intestinal infections

266

1585

1.70

14.69

1.5

1.4

11.07

10.16

u/l

0.44

218

1283

Implicit bacterial Sepsis

546

3283

1.45

14.59

1.4

10.56

9.74

u/l

0.67

422

2634

Abnormal findings on diagnostic imaging of central nervous system

117

536

2.26

14.55

1.6

1.4

9.32

10.08

u/l

0.27

424

Contact with and exposure to communicable diseases

947

7222

1.32

14.52

1.4

9.07

8.83

u/l

0.25

817

5862

Disorders of vestibular function (Vertigo)

585

4074

1.42

14.52

1.3

11.31

12.23

u/l

0.86

479

3301

Problems related to lifestyle

260

1551

1.71

14.50

1.5

1.4

8.16

7.93

u/l

0.13

205

1276

Phobic anxiety disorders

418

2788

1.53

14.50

1.5

7.88

8.31

u/l

0.34

311

2295

Elevated blood glucose level

164

852

1.97

14.44

1.5

8.61

8.51

u/l

0.03

132

683

Pulmonary heart disease, diseases of pulmonary circulation

361

2327

1.56

14.37

1.5

1.3

13.09

10.94

u/l

1.74

299

1885

Other disorders of skin and subcutaneous tissue

1023

7012

1.30

14.31

1.4

11.16

10.94

u/l

0.18

802

5707

Voice disturbances

382

2500

1.54

14.30

1.3

12.93

12.27

u/l

0.35

301

2035

Non-follicular lymphoma

123

576

2.17

14.28

1.7

1.4

10.35

9.77

u/l

0.20

106

466

Bacterial Sepsis

605

3681

1.41

14.28

1.5

1.4

10.91

9.52

u/l

1.58

478

2959

Dental caries, including avohilmo

1271

5101

1.28

14.27

1.4

9.70

9.65

u/l

0.05

1025

4162

Bacterial intestinal infections, IBD co-morbidities

266

1599

1.68

14.23

1.5

1.4

11.00

10.23

u/l

0.36

220

1292

Other viral hepatitis

187

1024

1.89

14.20

1.4

7.54

7.76

u/l

0.10

131

833

Other diseases of lip and oral mucosa

642

4647

1.39

14.14

1.4

11.05

10.60

u/l

0.32

514

3779

Secondary hypertension

151

758

2.01

14.10

1.9

1.5

10.63

8.16

u/l

1.17

127

607

Pain associated with micturition

194

1071

1.84

14.09

1.4

10.67

10.50

u/l

0.05

154

858

Subjective visual disturbances

430

2898

1.50

14.05

1.5

1.4

10.96

10.26

u/l

0.48

346

2375

Benign neoplasm: Sigmoid colon

212

1201

1.79

14.02

1.4

1.3

10.34

11.00

u/l

0.30

167

976

Allergic rhinitis

824

6147

1.34

14.01

1.5

1.4

8.62

9.28

u/l

0.84

666

4983

Symptoms and signs involving speech and voice

461

3149

1.48

14.00

1.4

1.3

12.52

11.92

u/l

0.36

361

2567

Primary hyperparathyroidism

112

509

2.23

13.98

1.4

1.3

13.97

15.15

u/l

0.29

400

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

792

5877

1.35

13.98

1.6

1.4

9.34

9.52

u/l

0.16

610

4798

Early onset COPD, excluding more controls

253

1506

1.70

13.97

1.4

1.3

9.67

8.99

u/l

0.37

192

1222

Other disorders of skin and subcutaneous tissue, not elsewhere classified

209

1183

1.79

13.92

1.4

10.88

10.12

u/l

0.36

171

968

Cellulitis

415

2784

1.51

13.91

1.5

1.4

8.52

8.99

u/l

0.36

324

2253

Chronic gastritis

280

1713

1.65

13.91

1.3

12.31

11.81

u/l

0.23

226

1388

Melanocytic naevi of trunk

244

1447

1.72

13.89

1.4

10.96

9.79

u/l

0.61

200

1184

Migraine with aura

604

4350

1.41

13.86

1.4

1.3

10.36

10.44

u/l

0.05

513

3601

Benign paroxysmal vertigo

354

2294

1.56

13.84

1.3

11.49

12.44

u/l

0.59

290

1863

Caries of dentine, including avohilmo

1426

5819

1.26

13.83

1.4

9.77

9.47

u/l

0.36

1154

4732

Lack of expected normal physiological development

113

457

2.31

13.82

2.5

1.8

5.41

6.60

u/l

1.01

330

Epilepsy

528

3700

1.44

13.79

1.5

10.16

9.53

u/l

0.46

426

2945

All influenza

464

3186

1.47

13.78

1.5

8.91

8.25

u/l

0.53

376

2582

Disorders of refraction and accommodation

627

4532

1.40

13.75

1.6

1.5

9.79

9.43

u/l

0.26

490

3634

Mycoses

454

3107

1.48

13.74

1.5

1.4

11.52

9.83

u/l

1.46

358

2522

Anti-inflammatory and antirheumatic products, non-steroids

640

2295

1.41

13.72

1.5

1.6

7.73

8.24

u/l

0.57

520

1813

Cluster headache, wide

415

2.39

13.72

1.4

1.3

11.42

9.71

u/l

0.55

342

malignant neoplasm of male genital organs

408

1637

1.53

13.68

2.2

1.4

7.57

6.12

u/l

2.71

332

1319

Zoster [herpes zoster]

234

1374

1.72

13.67

1.7

1.4

10.45

11.29

u/l

0.39

197

1122

Haemorrhage in early pregnancy

568

3946

1.42

13.66

1.2

11.14

13.22

u/l

3.24

487

3249

Cervicocranial syndrome

171

918

1.89

13.57

1.3

10.14

12.51

u/l

1.31

137

752

Crossbite

240

1321

1.74

13.57

2.0

1.9

7.32

7.23

u/l

0.05

182

995

Paracetamol or NSAID medication

456

1541

1.51

13.53

1.5

1.7

7.34

7.61

u/l

0.23

363

1184

Undescended testicle

183

3.31

13.52

2.8

2.0

6.94

4.04

u/l

1.58

125

Impingement syndrome of shoulder

310

1961

1.60

13.49

1.4

1.3

11.28

11.60

u/l

0.15

256

1575

Cluster headache, strict

400

2.41

13.47

1.4

11.35

9.79

u/l

0.48

331

Disorders of optic nerve and visual pathways

208

1192

1.78

13.45

1.9

1.4

10.47

9.72

u/l

0.26

165

964

Sequelae with surgical and medical care as external cause

280

1731

1.64

13.45

1.4

1.3

11.21

10.86

u/l

0.15

218

1411

Hernia of abdominal wall

702

5196

1.36

13.45

1.4

8.77

9.52

u/l

1.01

578

4221

Spermatocele

122

585

2.13

13.40

1.5

1.4

6.32

6.20

u/l

0.07

104

484

Other disorders involving the immune mechanism, not elsewhere classified

365

2.49

13.40

3.0

1.5

9.54

7.94

u/l

0.52

291

Other diseases of intestine

178

971

1.86

13.38

1.3

1.4

11.26

10.89

u/l

0.11

132

785

Other CVD

199

1122

1.79

13.36

1.4

12.78

10.43

u/l

1.23

161

900

Optic atrophy

162

3.33

13.31

2.8

1.7

6.40

9.04

u/l

0.75

130

Malignant neoplasm of mesothelium and soft tissue

197

3.02

13.30

1.8

1.3

14.14

7.89

u/l

2.02

157

Misadventures to patients during surgical and medical care

220

1282

1.74

13.28

1.5

1.3

12.97

10.86

u/l

1.31

183

1054

Other shoulder lesions

190

1064

1.82

13.25

1.5

1.3

11.06

10.61

u/l

0.16

152

876

Extrapyramidal and movement disorders

461

3190

1.46

13.09

1.4

10.14

10.95

u/l

0.66

370

2581

Candidiasis

244

1472

1.69

13.01

1.4

1.3

13.12

10.55

u/l

1.33

184

1219

Cutaneous abscess, furuncle and carbuncle

539

3850

1.42

13.00

1.5

1.4

8.97

8.80

u/l

0.12

445

3143

External causes of morbidity and mortality

1484

6012

1.24

12.95

1.4

9.58

9.68

u/l

0.10

1211

4943

Turner's syndrome

7.25

12.95

2.7

1.7

6.56

11.86

u/l

0.77

Mixed hyperlipidaemia

239

2.79

12.93

1.6

1.3

7.42

7.89

u/l

0.18

196

Obsessive-compulsive disorder

239

1448

1.70

12.83

1.5

7.43

7.82

u/l

0.32

189

1195

Viral and other specified intestinal infections

818

6025

1.33

12.83

1.6

1.5

7.74

7.99

u/l

0.30

680

4880

Benign neoplasm: Colon, unspecified

260

1596

1.64

12.82

1.4

1.3

11.53

10.83

u/l

0.31

214

1282

Thyrotoxicosis

386

2595

1.50

12.79

1.3

13.15

11.96

u/l

0.76

311

2110

Sleep disorders, other/unspecified

108

507

2.22

12.79

1.4

1.5

10.27

10.21

u/l

0.01

406

Other external causes of accidental injury

1773

7325

1.22

12.76

1.4

10.04

9.77

u/l

0.36

1437

6011

Intracranial injury

1114

8358

1.27

12.70

1.5

1.4

8.88

9.08

u/l

0.22

890

6779

Immunodeficiency with predominantly antibody defects

302

2.60

12.65

1.9

1.6

10.15

9.57

u/l

0.11

239

Oter anti-inflammatory and antirheumatic agents, non-steroids

240

776

1.72

12.62

1.4

9.86

11.16

u/l

0.74

188

639

Malignant neoplasm of brain, including Hilmo

417

2.31

12.61

2.4

1.5

6.11

7.70

u/l

0.94

339

Malignant neoplasm of bladder

270

2.63

12.57

1.2

1.3

15.09

7.54

u/l

4.25

218

Dermatophytosis

1146

9132

1.26

12.57

1.4

9.15

9.41

u/l

0.30

938

7474

Condition for Implicit Sepsis (Organ dysfunction codes)

1470

8457

1.23

12.56

1.4

9.98

9.70

u/l

0.33

1178

6934

Premature rupture of membranes

636

3342

1.38

12.54

1.2

1.3

10.47

11.55

u/l

1.21

554

2696

Ectopic pregnancy

296

1891

1.59

12.49

1.2

14.59

14.04

u/l

0.22

255

1561

Erysipelas

766

5125

1.33

12.47

1.4

9.14

9.45

u/l

0.31

619

4206

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1112

6984

1.27

12.42

1.2

1.3

11.87

11.93

u/l

0.04

907

5783

Injuries to the neck

514

3675

1.42

12.39

1.3

1.4

10.17

8.71

u/l

1.79

434

3023

Allergic asthma (mode)

571

4068

1.39

12.29

1.4

9.14

9.34

u/l

0.15

464

3323

Other disorders of bladder

166

912

1.85

12.28

1.3

1.4

8.45

8.64

u/l

0.08

134

741

Collagenous colitis

143

750

1.94

12.27

1.3

1.4

11.92

11.07

u/l

0.25

115

605

Colonic or urogenital fistula

436

3029

1.45

12.25

1.3

1.4

10.56

10.12

u/l

0.25

356

2466

Bilateral cryptorchidism (undescended testicles)

6.31

12.25

3.4

2.2

6.91

3.59

u/l

0.91

Later onset COPD, excluding more controls

142

563

1.96

12.23

1.2

1.3

10.77

10.84

u/l

0.02

104

435

Other or unspecified ileus, impaction or obstruction

209

1227

1.72

12.22

1.4

11.75

10.41

u/l

0.69

178

993

Atypical facial pain

391

2.33

12.22

1.4

1.3

12.08

12.63

u/l

0.11

326

Allergic asthma (mode), excluding more controls

571

4072

1.39

12.21

1.4

9.14

9.31

u/l

0.12

464

3325

Diverticular disease of intestine

837

4075

1.32

12.20

1.4

1.3

11.35

11.57

u/l

0.15

682

3323

Pleural effusion

164

901

1.84

12.09

1.4

12.98

10.07

u/l

1.52

135

727

Other noninfective gastroenteritis and colitis

451

3160

1.44

12.08

1.5

10.34

9.58

u/l

0.53

371

2496

Specific development disorders of scholastic skills

189

1083

1.80

12.05

2.2

1.7

6.78

6.72

u/l

0.03

140

825

Emotional disorders and disorders of social functioning with onset specific to childhood

238

1446

1.69

12.02

1.8

1.7

6.92

7.23

u/l

0.29

183

1147

Optic atrophy

173

3.10

11.94

2.8

1.6

6.40

9.38

u/l

0.90

140

Accidents

1762

7325

1.21

11.93

1.4

9.86

9.77

u/l

0.10

1423

6011

Tinnitus

336

2229

1.52

11.92

1.4

1.3

9.69

10.77

u/l

0.63

272

1840

Coagulation defects, purpura and other haemorrhagic conditions

349

2337

1.51

11.90

1.4

11.12

9.76

u/l

0.93

274

1898

Other arthrosis

712

3699

1.34

11.87

1.4

1.3

11.26

11.57

u/l

0.21

592

3002

Malignant neoplasm of head and neck

101

472

2.17

11.86

1.3

1.4

14.09

7.72

u/l

3.18

389

Personal history of medical treatment

4.15

11.81

2.0

1.4

6.34

8.90

u/l

1.15

Personal history of other diseases and conditions

328

2170

1.54

11.79

1.6

1.4

8.67

9.19

u/l

0.37

263

1720

Condition for Implicit Sepsis (Organ dysfunction codes)

1658

9490

1.21

11.78

1.4

9.96

9.68

u/l

0.36

1337

7774

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

350

2.42

11.74

3.1

1.6

9.70

7.99

u/l

0.54

280

Speech and linguistic disorders

311

1966

1.56

11.70

2.1

1.7

7.25

6.85

u/l

0.28

226

1514

Chronic viral hepatitis

161

897

1.86

11.69

1.5

1.4

6.69

7.76

u/l

0.79

111

730

Abnormal findings on diagnostic imaging of other body structures

178

1014

1.78

11.68

1.5

1.3

14.74

11.74

u/l

1.41

144

834

Conjunctivitis

1580

10953

1.21

11.62

1.5

1.4

10.29

9.83

u/l

0.50

1277

8897

Retention of urine

407

2304

1.46

11.50

1.4

10.58

9.10

u/l

1.24

318

1847

Other pleural conditions

109

531

2.08

11.48

1.4

13.14

10.00

u/l

1.16

421

Other CVD (FINNGEN)

147

607

1.90

11.47

1.4

11.08

10.29

u/l

0.25

122

486

Congenital malformations and deformations of the musculoskeletal system

313

2063

1.54

11.40

1.7

1.6

8.45

8.39

u/l

0.03

243

1614

Other noninflammatory disorders of vagina

389

2.27

11.39

1.3

11.50

16.77

u/l

2.34

298

Injury of muscle and tendon at shoulder and upper arm level

479

3430

1.41

11.36

1.4

7.90

9.17

u/l

1.87

400

2775

Postprocedural disorders of nervous system

192

1135

1.74

11.28

1.4

1.3

11.67

10.05

u/l

0.76

163

938

L04AD Calcineurin inhibitors

229

1415

1.65

11.27

1.7

1.6

11.21

8.23

u/l

1.96

190

1111

Disorders of continuity of bone

184

1074

1.75

11.20

1.5

1.4

9.95

10.48

u/l

0.19

149

875

Hypotension

161

901

1.80

11.18

1.4

11.71

10.23

u/l

0.58

132

727

Drug-induced neutropenia

105

512

2.09

11.13

1.7

1.4

13.24

11.52

u/l

0.55

415

Maternal care related to the fetus and amniotic cavity and possible delivery problems

933

4292

1.29

11.10

1.2

1.3

12.79

12.96

u/l

0.13

807

3466

Wide developmental disorders, excluding more controls

128

667

1.97

11.02

1.8

1.6

7.34

7.49

u/l

0.06

513

Abnormalities of gait and mobility

154

856

1.82

11.02

1.6

1.5

10.52

9.64

u/l

0.34

119

671

Social phobias

279

1820

1.57

11.02

1.5

7.58

7.81

u/l

0.15

209

1490

Alcohol use disorder, Swedish definition

1006

7357

1.26

10.99

1.4

9.07

8.32

u/l

1.19

787

6048

Anankastic personality disorder

108

538

2.08

10.98

1.5

1.3

8.78

10.08

u/l

0.41

442

Gout

296

1710

1.53

10.81

1.5

1.4

8.98

8.90

u/l

0.04

230

1354

Autoimmune diseases related-to ILD

1635

11727

1.20

10.81

1.4

10.54

9.56

u/l

2.07

1329

9595

Infections with a predominantly sexual mode of transmission

1088

8187

1.25

10.80

1.4

9.23

9.15

u/l

0.07

873

6798

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

390

2.22

10.78

1.2

1.3

15.23

10.17

u/l

1.95

309

Disorders of adrenal gland, other and/or unspecified

8.59

10.77

1.6

1.2

8.94

9.31

u/l

0.03

Anosmia

3.95

10.77

1.2

13.01

12.60

u/l

0.04

Salpingitis and oophoritis

199

1197

1.68

10.74

1.2

15.12

17.63

u/l

1.22

152

978

Other and unspecified follicular disorders

455

2.16

10.70

1.5

1.4

11.69

8.14

u/l

1.24

379

Diseases of pulp and periapical tissues and dental caries

1109

4549

1.26

10.67

1.4

9.67

9.63

u/l

0.03

888

3705

Umbilical hernia

466

3365

1.40

10.61

1.4

7.42

8.60

u/l

1.94

377

2772

Asthma and allergy, excluding more controls

365

2496

1.47

10.59

1.4

8.42

8.88

u/l

0.33

295

2035

Specific developmental disorder of motor function

369

2.35

10.56

2.7

2.1

4.56

5.55

u/l

0.97

244

Heart failure, not strict

932

5000

1.27

10.55

1.4

11.92

10.29

u/l

2.61

750

4025

Other viral diseases

948

7510

1.26

10.54

1.5

1.4

9.40

8.95

u/l

0.51

788

6102

Gonarthrosis

878

3911

1.28

10.49

1.4

1.3

10.99

11.64

u/l

0.63

720

3178

Asthma and allergy

365

2501

1.46

10.49

1.4

8.42

8.94

u/l

0.38

295

2045

Zoster [herpes zoster]

635

4734

1.33

10.48

1.5

1.4

10.73

11.10

u/l

0.27

510

3852

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

4.12

10.47

1.9

1.6

10.22

7.69

u/l

0.47

Diseases of the digestive system

660

5006

1.32

10.44

1.4

11.38

9.51

u/l

2.36

542

3999

Other disorders of eye and adnexa

270

1765

1.55

10.42

1.5

1.4

13.05

10.23

u/l

0.87

206

1435

Non-allergic asthma (mode)

303

2006

1.51

10.41

1.6

1.5

7.94

9.60

u/l

1.85

235

1616

Other symptoms and signs involving the urinary system

158

902

1.78

10.39

1.6

1.5

8.54

8.42

u/l

0.05

137

735

Malignant neoplasm of ovary

158

2.96

10.38

2.1

1.3

18.52

16.08

u/l

0.43

121

Maternal care for other known or suspected fetal problems

745

3640

1.31

10.37

1.2

1.3

10.28

11.55

u/l

1.96

644

2941

Hyperlipidaemia, other/unspecified

397

2568

1.43

10.36

1.3

1.4

9.92

10.23

u/l

0.19

309

2088

Mental and behavioural disorders due to alcohol, excluding acute intoxication

813

6351

1.28

10.34

1.3

1.4

9.27

7.95

u/l

2.51

626

5237

Other congenital malformations

232

1472

1.61

10.33

2.0

1.6

8.85

8.95

u/l

0.04

164

1140

Enterocolitis due to Clostridium difficile

130

700

1.88

10.32

1.4

13.13

10.28

u/l

1.05

109

569

Congenital malformations and deformations of the musculoskeletal system

261

1694

1.57

10.31

1.7

1.6

8.29

8.20

u/l

0.04

195

1316

Mental and behavioural disorders due to alcohol

967

7449

1.26

10.26

1.4

9.18

8.18

u/l

1.78

753

6153

Migraine with aura and triptan purchases

421

3015

1.42

10.24

1.4

1.3

10.40

10.07

u/l

0.19

362

2486

Other skin changes

237

1508

1.59

10.23

1.4

12.20

11.09

u/l

0.55

202

1211

Neuralgia and neuritis, unspecified

442

2.13

10.21

1.4

1.3

10.16

10.36

u/l

0.05

356

Noninfectious colitis NAS

251

1622

1.57

10.20

1.4

1.5

9.98

9.68

u/l

0.12

211

1304

Other hearing loss

259

1644

1.55

10.16

1.4

10.82

11.65

u/l

0.42

202

1341

Heart failure and antihypertensive medication

294

1266

1.53

10.14

1.4

10.31

9.73

u/l

0.26

229

1030

Arthrosis

1149

5107

1.24

10.13

1.4

1.3

10.61

10.65

u/l

0.03

956

4161

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

154

881

1.78

10.09

1.5

1.3

11.35

10.19

u/l

0.41

126

719

Non-allergic asthma (mode), excluding more controls

303

2020

1.50

10.09

1.6

1.5

7.94

9.62

u/l

1.88

235

1626

Dislocation, sprain and strain of joints and ligaments at neck level

373

2622

1.45

10.08

1.3

1.4

10.54

8.86

u/l

1.56

314

2159

Unspecified misadventure during surgical and medical care

451

2.11

10.08

1.7

1.4

12.21

10.00

u/l

0.85

362

Diseases of inner ear

669

4962

1.31

10.08

1.3

10.98

11.72

u/l

0.72

547

4034

False labour

801

3903

1.29

10.04

1.2

1.3

11.26

12.21

u/l

1.11

701

3143

Inflammatory disease of uterus

313

2129

1.49

10.04

1.2

1.3

14.42

11.65

u/l

2.03

256

1776

Endometriosis ASRM stages 3,4

378

2660

1.44

10.03

1.2

11.88

13.33

u/l

1.19

322

2192

Neuromuscular dysfunction of bladder

136

751

1.84

10.02

1.4

12.70

9.69

u/l

1.13

115

614

Symptoms and signs involving cognition, perception, emotional state and behaviour

1757

10148

1.19

10.02

1.4

11.06

9.91

u/l

2.61

1429

8305

Diagnoses used for exclusion with ILD

323

2206

1.48

9.99

1.4

11.85

10.09

u/l

1.16

268

1785

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1631

8262

1.19

9.98

1.4

9.04

10.37

u/l

4.26

1301

6750

Other inflammation of eyelid

202

1246

1.64

9.97

1.4

12.38

11.15

u/l

0.38

148

1000

Volume depletion

115

603

1.93

9.92

1.5

11.32

8.83

u/l

1.02

483

Special screening examination for other diseases and disorders

197

1209

1.65

9.91

1.3

1.4

10.39

8.83

u/l

0.88

163

988

Benign neoplasm of other and ill-defined parts of digestive system

199

1224

1.64

9.89

1.4

1.3

13.86

12.46

u/l

0.56

154

996

1143

8239

1.23

9.86

1.4

9.05

8.37

u/l

1.10

898

6796

ILD medications: immunosuppressive drugs

1192

9108

1.22

9.84

1.5

1.4

10.99

9.40

u/l

3.24

996

7391

Cardiac arrhythmias

1241

6629

1.22

9.84

1.4

10.56

9.90

u/l

0.84

1011

5457

Other peripheral vascular diseases

131

720

1.85

9.83

1.5

1.3

9.56

11.17

u/l

0.66

108

589

Malignant neoplasm of corpus uteri, including Hilmo

163

2.84

9.79

1.2

25.02

21.34

u/l

0.63

121

Other disorders of breast

210

1315

1.62

9.78

1.3

12.87

13.79

u/l

0.39

176

1076

Diseases of oesophagus, stomach and duodenum

1991

10197

1.17

9.78

1.4

10.58

9.73

u/l

1.95

1616

8334

Drug-induced cataract

193

2.74

9.78

1.4

1.5

14.63

9.53

u/l

0.95

155

Assault

360

2532

1.45

9.75

1.4

1.5

8.41

7.43

u/l

0.88

274

2083

Mental and behavioural disorders due to use of other stimulants, including caffeine

109

572

2.00

9.75

1.5

6.06

7.24

u/l

0.80

479

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

170

1014

1.72

9.73

1.5

1.4

10.65

8.54

u/l

0.94

136

819

Benign neoplasm of brain and other parts of central nervous system

109

567

1.96

9.72

2.0

1.4

7.53

9.69

u/l

1.02

456

Alcohol use disorder, ICD-based

755

5925

1.28

9.68

1.3

1.4

9.40

7.96

u/l

2.64

584

4884

Injuries to the head

2239

11908

1.16

9.68

1.4

8.93

9.71

u/l

2.16

1801

9711

Chronic apical periodontitis

2243

11048

1.16

9.62

1.4

10.53

9.55

u/l

2.47

1787

9092

Hypermetropia

163

963

1.73

9.61

1.9

1.7

9.14

8.01

u/l

0.58

125

727

Diplopia

194

1197

1.64

9.59

1.4

11.92

10.30

u/l

0.67

156

985

Urticaria and erythema

714

5573

1.29

9.58

1.5

1.4

10.66

10.18

u/l

0.43

598

4508

Bleeding

1223

7166

1.22

9.57

1.4

10.79

9.55

u/l

2.29

975

5795

Disorders of conjunctiva

1677

11436

1.18

9.55

1.4

10.47

9.72

u/l

1.08

1361

9291

Other neurological diseases

970

6141

1.25

9.53

1.5

1.4

10.98

10.61

u/l

0.34

782

4963

Artificial opening status

388

2.16

9.48

1.5

9.54

8.64

u/l

0.27

304

Noninfective enteritis and colitis

881

7053

1.26

9.44

1.4

1.5

9.51

9.30

u/l

0.19

727

5707

Intestinal adhesions without obstruction

503

2.00

9.39

1.5

1.4

12.80

11.34

u/l

0.42

403

Cerebral palsy and other paralytic syndromes

192

1189

1.64

9.39

1.8

1.4

10.08

9.50

u/l

0.26

148

943

Other and unspecified mood [affective] disorders

210

1334

1.61

9.39

1.4

7.87

8.59

u/l

0.46

164

1098

Enthesopathies of lower limb, excluding foot

342

2393

1.44

9.38

1.4

9.60

11.11

u/l

1.34

269

1938

Seborrhoeic dermatitis

161

955

1.71

9.32

1.6

1.4

10.12

8.75

u/l

0.62

130

766

Sequelae of injuries, of poisoning and of other consequences of external causes

420

3051

1.39

9.32

1.3

1.4

9.24

9.16

u/l

0.04

332

2505

Erysipelas

1044

6487

1.23

9.31

1.4

9.13

9.78

u/l

0.98

844

5338

Abnormal findings in secretions and smears from cervix uteri vagina vulva

964

5889

1.25

9.25

1.2

12.33

12.83

u/l

0.45

799

4889

Dizziness and giddiness

1166

7618

1.22

9.24

1.4

12.06

10.72

u/l

2.14

945

6233

Astigmatism

160

952

1.72

9.23

1.8

1.6

8.61

7.99

u/l

0.29

123

713

Injuries to the abdomen, lower back, lumbar spine and pelvis

653

5009

1.30

9.19

1.4

9.99

9.11

u/l

0.93

518

4084

Other and unspecified trigeminal disorders

101

3.40

9.16

1.3

1.1

4.87

12.60

u/l

4.20

Disorders of synovium and tendon

924

6531

1.25

9.15

1.3

10.89

10.15

u/l

0.91

764

5369

Disorder of lipoprotein metabolism, unspecified

139

795

1.77

9.09

1.4

1.3

10.74

10.05

u/l

0.20

106

646

Family history of malignant neoplasm

207

1318

1.60

9.06

1.4

1.3

15.40

12.10

u/l

2.05

183

1094

Malignant neoplasm of tongue, including Hilmo

138

2.98

9.06

1.3

14.47

6.73

u/l

2.04

113

Papilloedema, unspecified

281

2.38

9.05

2.1

1.4

10.44

9.23

u/l

0.31

228

Open bite

181

1123

1.66

9.05

1.7

1.6

7.69

8.48

u/l

0.50

142

871

Bell's palsy

186

1154

1.63

9.04

1.3

1.4

11.32

10.05

u/l

0.59

144

954

Pruritus

177

1085

1.65

9.03

1.3

1.4

10.00

11.51

u/l

0.82

152

886

Malignant cancer of tonsil and base of tongue, including Hilmo

144

2.94

9.01

1.4

10.67

6.28

u/l

1.45

120

Other and unspecified visual disturbances

158

941

1.70

9.01

1.5

1.4

10.13

10.51

u/l

0.13

130

774

Acne

359

2564

1.43

8.98

1.4

1.6

7.68

7.62

u/l

0.04

289

2130

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

436

2.05

8.98

1.3

11.93

11.62

u/l

0.06

352

Postpartum haemorrhage

626

4076

1.31

8.95

1.2

1.3

10.67

12.39

u/l

2.94

550

3301

Malignant cancer of tonsil and base of tongue

118

3.16

8.93

1.4

10.04

6.07

u/l

1.29

100

Purpura and other haemorrhagic conditions

219

1417

1.57

8.91

1.4

1.5

11.48

9.13

u/l

1.56

172

1138

Other disorders of bone

381

2746

1.40

8.91

1.5

1.4

8.60

9.62

u/l

0.96

304

2237

Other and unspecified nonorganic psychotic disorders

474

3541

1.36

8.90

1.3

1.5

7.96

8.18

u/l

0.19

361

2939

Short stature starting before birth

124

3.52

8.89

2.8

2.5

3.40

5.97

u/l

1.38

Malignant neoplasm of bone and articular cartilage

3.77

8.87

1.8

1.9

10.65

7.32

u/l

0.51

Single delivery by caesarean section

545

2360

1.35

8.86

1.2

1.3

11.09

11.02

u/l

0.04

477

1861

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

627

4869

1.30

8.85

1.4

1.5

9.67

9.10

u/l

0.48

511

4000

Fenamates

250

1116

1.54

8.83

1.4

1.3

9.64

9.81

u/l

0.07

205

928

Malnutrition

186

2.68

8.83

2.3

1.9

8.55

8.65

u/l

0.01

135

Hypercalcemia

251

2.40

8.82

1.8

1.4

17.55

11.34

u/l

1.17

195

Fracture of rib(s), sternum and thoracic spine

398

2891

1.39

8.80

1.3

1.4

9.20

9.01

u/l

0.11

314

2342

Paroxysmal tachycardia

396

2398

1.39

8.78

1.4

10.74

9.99

u/l

0.44

316

1942

All influenza (not pneumonia)

291

2005

1.47

8.76

1.5

8.88

7.59

u/l

0.97

243

1616

Autism spe, excluding more controls

480

2.03

8.75

1.6

1.5

8.02

8.00

u/l

0.01

381

Malignant neoplasm of breast, HER-positive

231

1171

1.55

8.73

1.2

23.73

19.92

u/l

2.43

194

922

Injury, poisoning and certain other consequences of external causes

1193

4937

1.22

8.73

1.4

9.76

u/l

0.00

979

4011

Delayed milestone in childhood

421

2.09

8.72

2.7

2.4

5.16

5.28

u/l

0.05

255

Systemic connective tissue disorders

445

3295

1.36

8.71

1.3

12.33

11.99

u/l

0.17

361

2687

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

104

382

1.94

8.71

1.4

11.51

11.89

u/l

0.09

318

Nontoxic multinodular goitre

159

955

1.68

8.70

1.3

1.2

15.35

15.38

u/l

0.01

124

776

Congenital malformations of genital organs

256

1719

1.51

8.65

1.7

1.5

10.50

9.86

u/l

0.29

204

1378

Motor disorders

408

2.15

8.64

2.7

2.1

4.56

5.81

u/l

1.24

259

Cramp and spasm

514

1.96

8.64

1.4

10.13

8.49

u/l

0.73

420

Complications of internal orthopaedic prosthetic devices, implants and grafts

198

1258

1.59

8.64

1.4

1.3

11.02

11.95

u/l

0.42

153

1010

Cluster headache, wide,, including avohilmo

123

694

1.82

8.63

1.4

10.97

9.70

u/l

0.49

111

571

Diseases of external ear

548

4192

1.32

8.62

1.5

1.4

9.24

9.57

u/l

0.27

439

3346

Benign lipomatous neoplasm

382

2769

1.39

8.57

1.4

10.62

11.15

u/l

0.32

314

2264

Varicella [chickenpox]

131

756

1.79

8.57

1.8

1.5

4.93

6.45

u/l

2.71

109

596

Dermatitis due to substances taken internally

106

572

1.89

8.54

1.6

1.5

12.37

9.48

u/l

1.22

458

Sarcoidosis

190

1202

1.60

8.53

1.4

11.41

10.58

u/l

0.28

161

977

Lateral epicondylitis

202

1296

1.58

8.53

1.4

1.3

11.92

12.01

u/l

0.03

169

1060

Lesion of ulnar nerve

210

1360

1.56

8.52

1.4

1.3

10.82

9.81

u/l

0.43

180

1126

Childhood asthma (age<16)

515

3083

1.34

8.48

1.5

1.4

8.24

7.69

u/l

0.50

403

2519

Childhood asthma (age<16), excluding more controls

515

3082

1.34

8.47

1.5

1.4

8.24

7.69

u/l

0.50

403

2515

Other and unspecified tonsillitis

999

6903

1.23

8.45

1.5

1.4

7.44

7.72

u/l

0.35

820

5638

Early lumbar disc prolapse, operated

261

1779

1.49

8.42

1.4

8.41

8.43

u/l

0.01

218

1465

Emotional disorders starting during childhood or adolescence

216

1413

1.57

8.40

1.8

1.7

7.11

7.17

u/l

0.05

167

1099

Vasomotor rhinitis (mode)

116

647

1.83

8.39

1.3

12.62

11.11

u/l

0.48

527

Cluster headache, strict, including avohilmo

120

679

1.81

8.37

1.4

10.91

9.54

u/l

0.53

109

559

Fall on same level

2427

11641

1.14

8.35

1.4

9.74

9.45

u/l

0.50

1936

9511

Benign neoplasm of mouth and pharynx

150

901

1.69

8.31

1.4

11.56

9.97

u/l

0.59

125

732

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

214

1385

1.56

8.30

1.7

1.8

6.81

7.36

u/l

0.35

154

1074

Persons encountering health services for specific procedures, not carried out

178

1122

1.62

8.21

1.4

9.92

8.78

u/l

0.43

116

919

Raynaud syndrome

165

1021

1.65

8.21

1.6

1.3

9.71

10.76

u/l

0.42

132

850

Dialysis, with operation codes

194

1247

1.58

8.17

1.6

1.5

13.30

7.58

u/l

3.60

156

986

Malignant neoplasm of eye, brain and central nervous system

358

2.11

8.16

2.2

1.5

7.41

7.57

u/l

0.04

295

Pollen allergy

547

4173

1.31

8.15

1.6

1.5

8.17

8.57

u/l

0.36

435

3339

Other and unspecified disorders of skin and subcutaneous tissue

475

1.95

8.09

1.3

12.41

10.91

u/l

0.44

388

Endometriosis ASRM stages 1,2

344

2482

1.40

8.07

1.2

12.17

12.78

u/l

0.35

301

2043

Atrial fibrillation and flutter

433

2077

1.36

8.05

1.4

10.20

9.76

u/l

0.23

343

1737

Chronic periodontitis, complicated

701

5527

1.26

8.05

1.3

1.4

11.60

10.37

u/l

1.35

545

4527

Other disorders of patella

327

2341

1.41

8.01

1.4

1.3

9.77

10.64

u/l

0.55

260

1904

Malignant neoplasm of breast, ER-positive, including Hilmo

234

1200

1.51

8.00

1.2

23.93

19.99

u/l

2.56

196

945

Other heart diseases

1025

5520

1.22

8.00

1.5

1.4

10.80

9.51

u/l

1.80

822

4480

Melanoma in situ

225

2.40

7.99

1.1

1.2

11.44

11.75

u/l

0.05

174

Malignant neoplasm of oral cavity

171

2.63

7.98

1.3

15.78

6.76

u/l

2.08

140

Rash and other nonspecific skin eruption

147

889

1.68

7.97

1.4

10.38

11.10

u/l

0.26

115

715

Ventral hernia

284

1982

1.44

7.96

1.3

1.4

10.43

11.22

u/l

0.48

232

1616

Schizoaffective disorder

168

1054

1.63

7.95

1.2

1.4

8.63

9.12

u/l

0.22

127

870

Insulin, intermediate and long-acting

857

6785

1.23

7.93

1.4

1.5

9.37

8.58

u/l

1.11

666

5485

Viral and other specified intestinal infections

618

4752

1.28

7.90

1.7

1.5

7.17

7.50

u/l

0.44

514

3836

Alcohol abuse, main dg, excluding more controls

271

1882

1.46

7.88

1.4

8.71

7.86

u/l

0.54

210

1569

Malignant neoplasm of oral cavity, including Hilmo

239

2.34

7.86

1.5

1.3

15.44

7.56

u/l

2.26

198

Viral warts

470

3574

1.33

7.85

1.4

8.41

8.72

u/l

0.23

371

2888

Medial epicondylitis

298

2.20

7.80

1.6

1.3

16.08

10.95

u/l

1.31

244

Melanocytic naevi, other sites/unspecified

146

888

1.67

7.80

1.3

1.4

11.04

9.94

u/l

0.47

127

727

Thyroiditis

119

685

1.77

7.77

1.6

1.3

14.23

12.17

u/l

0.66

557

Trigeminal neuralgia

433

1.97

7.76

1.3

15.36

12.04

u/l

0.78

357

Meniscus derangement

801

4353

1.25

7.74

1.4

9.88

10.71

u/l

0.99

670

3542

Small fibre neuropathy

223

2.40

7.73

1.4

12.73

9.28

u/l

0.59

177

Urolithiasis

432

3249

1.34

7.70

1.4

9.59

9.26

u/l

0.23

363

2636

Mental retardation, excluding more controls

513

1.89

7.70

2.5

1.7

7.23

7.35

u/l

0.04

378

Other disorders of eyelid

394

2778

1.36

7.67

1.3

12.92

13.32

u/l

0.19

304

2242

Dipeptidyl peptidase 4 (DPP-4) inhibitors

557

3458

1.30

7.67

1.4

1.3

9.69

11.11

u/l

1.97

425

2816

Osteonecrosis

408

1.99

7.63

1.6

1.4

9.34

9.95

u/l

0.17

334

1060

7996

1.20

7.63

1.4

8.99

8.28

u/l

1.14

830

6594

Varicose veins of other sites

119

690

1.76

7.60

1.7

1.5

7.60

6.81

u/l

0.25

102

557

Insulin medication

956

6642

1.22

7.60

1.4

1.5

9.57

8.95

u/l

0.81

750

5379

Galactorrhea

137

2.88

7.59

1.2

13.59

12.65

u/l

0.12

111

Acne vulgaris

288

2047

1.44

7.58

1.5

1.6

7.58

7.27

u/l

0.24

238

1704

Benign neoplasm: Rectum, anus and anal canal

197

1291

1.54

7.58

1.4

1.3

11.97

10.89

u/l

0.46

161

1045

Schizophrenia, schizotypal and delusional disorders

645

5129

1.27

7.58

1.3

1.4

8.53

8.58

u/l

0.04

488

4226

Injuries to the knee and lower leg

2371

11625

1.14

7.56

1.4

9.80

9.59

u/l

0.31

1928

9471

Other systemic involvement of connective tissue

340

2473

1.38

7.54

1.3

12.74

12.42

u/l

0.14

285

2014

Implicit fungal Sepsis

473

1.91

7.52

1.5

1.3

12.45

10.71

u/l

0.51

382

Schizophrenia or delusion

644

5125

1.27

7.52

1.3

1.4

8.55

u/l

0.00

487

4225

Disorders of eyelid, lacrimal system and orbit

1360

8799

1.18

7.52

1.5

1.4

12.13

10.61

u/l

2.78

1067

7189

Female genital prolapse

218

809

1.53

7.51

1.2

17.34

19.79

u/l

1.14

164

641

Other local infections of skin and subcutaneous tissue

171

1091

1.59

7.50

1.7

1.4

8.75

9.13

u/l

0.15

135

876

Other diseases of the digestive system

378

2798

1.36

7.49

1.4

11.26

9.32

u/l

1.77

321

2242

Nephropathy related operations

190

1242

1.55

7.48

1.6

1.5

12.81

7.62

u/l

3.27

154

983

Dislocation, sprain and strain of joints and ligaments of knee

1253

9805

1.18

7.46

1.4

9.14

9.50

u/l

0.47

1038

8064

Other viral diseases, not elsewhere classified

612

4823

1.27

7.44

1.5

8.70

9.10

u/l

0.37

510

3880

Other viral diseases

698

5599

1.25

7.44

1.5

9.73

8.70

u/l

1.24

573

4526

Conduction disorders

342

2013

1.39

7.43

1.4

1.5

10.79

9.51

u/l

0.86

267

1607

GI-bleeding

378

2801

1.36

7.43

1.4

11.42

9.27

u/l

2.10

323

2239

Deep endometriosis

167

1063

1.60

7.42

1.2

10.26

12.58

u/l

1.69

143

884

Postpartum hemorraghe, parous women as controls

626

4228

1.27

7.42

1.2

10.67

12.30

u/l

2.82

550

3556

Other disorders of white blood cells

469

1.91

7.42

1.6

1.4

9.97

9.55

u/l

0.09

371

Statin medication

1346

6430

1.18

7.40

1.4

9.19

10.58

u/l

3.11

1092

5313

Unspecified kidney failure

100

554

1.82

7.38

1.8

1.5

12.44

8.56

u/l

1.34

455

Other respiratory disorders and diseases

204

1355

1.52

7.38

1.5

9.86

9.97

u/l

0.04

158

1082

Other diseases of the respiratory system

204

1355

1.52

7.38

1.5

9.86

9.97

u/l

0.04

158

1082

Other chronic obstructive pulmonary disease, including avohilmo

531

3402

1.30

7.37

1.3

1.4

10.72

10.36

u/l

0.24

402

2743

Other and unspecified local infections of skin and subcutaneous tissue

164

1042

1.60

7.34

1.7

1.4

8.36

9.21

u/l

0.44

130

838

Other systemic involvement of connective tissue (FG)

328

2352

1.39

7.32

1.3

12.96

12.65

u/l

0.13

275

1923

Antenatal screening

516

2228

1.31

7.30

1.2

1.3

12.53

12.84

u/l

0.18

433

1770

Vulvovaginal ulceration/inflammation in other diseases

151

945

1.63

7.30

1.3

11.47

11.14

u/l

0.07

116

777

Pure hyperglyceridaemia

162

2.61

7.27

1.6

1.2

7.68

8.52

u/l

0.20

136

Melanocytic naevi of lower limb, including hip

466

1.91

7.27

1.3

1.4

10.74

10.14

u/l

0.12

375

Abrasion of teeth

494

3819

1.30

7.26

1.3

11.99

11.80

u/l

0.09

405

3114

Hypertrophic disorders of skin

127

761

1.71

7.26

1.4

10.33

9.99

u/l

0.09

616

Other and unspecified disorders of white blood cells

341

2.07

7.25

1.6

1.4

9.83

9.55

u/l

0.06

271

Stomatitis and related lesions

359

2656

1.37

7.24

1.4

10.80

9.58

u/l

0.88

282

2148

Hypertrophic scar

120

709

1.73

7.24

1.4

9.94

10.09

u/l

0.04

570

Protozoal diseases

237

2.30

7.19

1.7

1.4

13.59

9.36

u/l

0.98

182

Injuries to the shoulder and upper arm

1417

9804

1.17

7.18

1.5

1.4

8.90

9.58

u/l

1.31

1187

7961

Malignant neoplasm of adrenal gland, including Hilmo

3.72

7.17

3.5

2.2

14.03

8.81

u/l

0.65

Torsion of testis

318

2.13

7.16

1.6

1.7

5.17

4.39

u/l

0.66

263

Injuries to the thorax

670

5380

1.25

7.15

1.4

9.11

8.85

u/l

0.24

522

4418

Faecal incontinence

452

1.90

7.15

1.2

1.3

12.91

14.43

u/l

0.41

364

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

112

649

1.75

7.15

1.3

1.4

12.02

10.09

u/l

0.58

533

In situ neoplasms

457

3504

1.31

7.13

1.3

11.85

12.08

u/l

0.13

374

2880

COPD

426

2633

1.33

7.13

1.3

1.4

10.16

9.97

u/l

0.11

317

2116

Atopic dermatitis, strict definition with reimbursement

800

6335

1.23

7.12

1.5

1.4

9.23

9.35

u/l

0.09

633

5142

Thrombocytopenia, unspecified

105

599

1.78

7.10

1.5

1.4

12.42

8.90

u/l

1.42

488

Gout, FINNGEN

296

2120

1.40

7.09

1.5

1.4

8.98

8.43

u/l

0.36

230

1692

Varicella [chickenpox]

149

937

1.63

7.09

1.8

1.6

5.15

6.35

u/l

1.81

117

705

Adjustment and management of implanted device

165

1056

1.57

7.08

1.3

1.4

11.47

9.37

u/l

0.92

116

835

Nontoxic goitre/thyroid nodule

272

1926

1.42

7.07

1.2

1.3

14.75

15.02

u/l

0.09

215

1581

Familial hypercholesterolemia

144

893

1.63

7.07

1.4

10.10

9.91

u/l

0.05

119

723

Mixed specific developmental disorders

498

1.87

7.06

2.5

2.1

6.13

5.79

u/l

0.18

329

Gingival hyperplasia

422

1.95

7.05

1.8

8.38

8.10

u/l

0.06

324

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1073

8794

1.19

7.02

1.4

10.32

10.50

u/l

0.12

878

7207

Postviral fatigue syndrome

144

2.77

6.98

1.3

11.30

10.88

u/l

0.05

116

Urticaria

597

4757

1.27

6.94

1.5

1.4

10.43

10.14

u/l

0.21

503

3830

Myeloid leukaemia

178

2.48

6.93

2.5

1.4

12.79

8.30

u/l

0.74

140

Renal failure

476

3249

1.30

6.93

1.5

1.4

12.74

9.27

u/l

3.77

372

2587

Calculus of kidney and ureter

404

3061

1.33

6.91

1.4

9.32

9.24

u/l

0.05

339

2486

Other and unspecified types of non-Hodgkin lymphoma, hilmo

228

2.28

6.88

1.4

1.3

11.03

9.69

u/l

0.30

176

Adrenogenital disorders

5.99

6.84

2.6

1.2

7.63

6.97

u/l

0.07

Other benign neoplasms of skin

453

3491

1.31

6.83

1.4

11.88

11.42

u/l

0.26

352

2848

Acute pancreatitis

261

1850

1.42

6.81

1.5

1.4

9.65

9.21

u/l

0.21

205

1512

Soft tissue disorders related to use, overuse and pressure

328

2415

1.37

6.79

1.3

10.82

11.25

u/l

0.21

271

1962

Fracture of lumbar spine and pelvis

237

1648

1.45

6.79

1.4

11.47

9.94

u/l

0.85

185

1330

Thyrotoxicosis with diffuse goitre

206

1399

1.49

6.78

1.4

1.3

11.39

12.49

u/l

0.50

171

1153

Recurrent aphthous stomatitis , including avohilmo

238

1665

1.45

6.73

1.5

11.33

9.71

u/l

0.92

189

1343

Acute pancreatitis (for exclusion)

261

1855

1.42

6.71

1.5

1.4

9.65

9.17

u/l

0.23

205

1513

Acute laryngitis and tracheitis

345

2533

1.36

6.68

1.7

1.5

7.46

7.64

u/l

0.12

282

2020

Allergic conjunctivitis

1122

9295

1.18

6.68

1.4

10.43

10.49

u/l

0.03

919

7606

Benign neoplasm: Adrenal gland

485

1.84

6.68

1.4

1.3

10.48

11.70

u/l

0.38

391

Other and unspecified rosacea

122

739

1.67

6.66

1.4

1.3

8.90

12.21

u/l

2.05

100

615

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

366

2757

1.34

6.63

1.2

1.3

10.90

10.95

u/l

0.02

291

2289

Hidradenitis suppurativa

533

1.81

6.63

1.3

1.4

11.79

9.37

u/l

1.00

450

Anorexia

177

2.48

6.62

1.6

1.5

8.21

10.25

u/l

0.48

142

Follicular cysts of skin and subcutaneous tissue

282

2038

1.40

6.61

1.5

1.4

10.79

9.42

u/l

0.85

229

1667

Alcohol dependence

417

3197

1.31

6.59

1.4

9.34

7.94

u/l

1.62

318

2625

Other and unspecified diseases of blood and blood-forming organs

195

2.37

6.59

1.6

1.3

8.38

9.74

u/l

0.30

159

Other and unspecified effects of external causes

590

4729

1.26

6.57

1.5

1.4

9.60

9.28

u/l

0.22

482

3851

AV-block

172

988

1.54

6.55

1.4

10.17

9.29

u/l

0.33

134

801

6-mercaptopurine

543

1.80

6.53

2.0

1.5

8.22

7.67

u/l

0.17

438

Complications following infusion, transfusion and therapeutic injection

107

2.90

6.52

1.5

1.3

10.40

8.69

u/l

0.26

Pregnancy with abortive outcome

1159

5129

1.18

6.51

1.2

1.3

12.38

12.23

u/l

0.12

974

4223

Other congenital malformations

296

2166

1.39

6.50

1.8

1.5

8.49

9.13

u/l

0.41

218

1720

Benign neoplasm: Brain, supratentorial

166

2.51

6.50

2.6

1.4

7.48

9.53

u/l

0.38

128

Poisoning by narcotics and psychodysleptics [hallucinogens]

290

2.14

6.49

1.5

10.41

6.72

u/l

0.88

245

Respiratory insufficiency

353

1.97

6.48

1.6

1.5

10.48

9.25

u/l

0.39

281

Diseases of the myoneural junction and muscle

156

1009

1.56

6.48

1.7

1.4

9.22

9.18

u/l

0.01

123

817

Nontoxic single thyroid nodule

454

1.85

6.46

1.2

1.3

13.57

13.52

u/l

0.01

369

Embedded and impacted teeth

892

6158

1.21

6.46

1.5

1.4

8.36

7.80

u/l

0.48

739

5042

Otitis externa

389

2966

1.32

6.44

1.5

1.4

9.77

9.67

u/l

0.06

317

2393

Ethmoidectomy

217

1506

1.46

6.44

1.4

1.3

10.85

9.61

u/l

0.61

181

1235

Hyperaldosteronism

172

2.44

6.44

1.8

1.2

9.86

9.41

u/l

0.07

135

Atrial fibrillation and flutter with reimbursement

280

1276

1.40

6.41

1.4

1.3

10.45

9.53

u/l

0.49

223

1059

Skin changes due to chronic exposure to nonionizing radiation

249

1627

1.42

6.40

1.4

1.3

12.90

12.92

u/l

0.01

195

1290

L02BA Anti-estrogens

152

979

1.56

6.40

1.4

1.2

17.85

19.48

u/l

0.56

125

792

Iron deficiency anaemia secondary to blood loss (chronic)

171

1131

1.52

6.39

1.3

1.4

12.23

11.39

u/l

0.28

133

917

Benign neoplasm: Rectum

173

1147

1.52

6.39

1.4

1.3

11.12

10.75

u/l

0.14

142

927

Malignant neoplasm of endocrine gland

537

1.78

6.36

1.7

1.4

14.28

10.65

u/l

1.28

436

Sudden idiopathic hearing loss

121

740

1.65

6.36

1.6

1.3

10.45

10.06

u/l

0.12

100

610

Benign neoplasm: Stomach

529

1.78

6.36

1.3

13.15

13.00

u/l

0.03

423

Other disorders of nervous system

457

1.84

6.35

1.6

1.3

12.25

9.80

u/l

0.74

367

Other disorders starting during childhood or adolescence

201

1375

1.49

6.33

1.8

6.11

7.09

u/l

1.35

146

1040

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

137

2.60

6.33

1.3

9.01

15.01

u/l

1.29

110

Presbycusis

374

1.92

6.32

1.2

12.30

12.91

u/l

0.13

293

Blepharochalasis

219

1524

1.44

6.32

1.2

1.3

13.58

15.39

u/l

0.93

167

1219

Complications of labour and delivery

1044

4899

1.19

6.31

1.2

1.3

12.36

13.29

u/l

1.22

900

3970

Diabetes, insulin treatment (Kela reimbursement)

1665

8802

1.15

6.30

1.4

9.05

10.35

u/l

4.23

1328

7191

Insulin, combination of fast acting with intermediate-acting or long-acting

956

7361

1.19

6.29

1.4

1.5

9.57

8.72

u/l

1.32

750

5954

Sequelae of other external causes

503

1.80

6.28

1.4

9.35

9.86

u/l

0.14

411

Unspecified fall

813

6660

1.21

6.28

1.5

9.63

9.22

u/l

0.41

640

5363

Postmenopausal osteoporosis with pathological fracture

103

2.84

6.26

1.2

1.3

30.07

26.41

u/l

0.43

Deep bite

282

1804

1.39

6.26

1.9

1.7

7.73

8.28

u/l

0.36

221

1391

FESS (DNB20)

210

1457

1.46

6.26

1.4

1.3

10.98

9.61

u/l

0.68

177

1195

Insulin, fast-acting

633

5135

1.24

6.26

1.4

1.5

9.68

8.19

u/l

2.34

496

4148

Explicit bacterial Sepsis

148

955

1.57

6.23

1.6

1.4

12.02

8.45

u/l

2.34

112

764

Acute bronchiolitis

202

1257

1.48

6.22

2.1

1.9

6.65

6.80

u/l

0.07

147

933

Disorders of sclera, cornea, iris and ciliary body

919

7736

1.19

6.22

1.4

10.20

9.82

u/l

0.32

764

6318

Mental and behavioural disorders due to tobacco

141

902

1.59

6.21

1.4

1.3

11.10

9.76

u/l

0.57

107

743

279

1858

1.38

6.21

1.4

1.3

12.63

12.88

u/l

0.10

219

1482

Squamous cell neoplasms and carcinomas of the skin

231

2.18

6.20

1.1

1.3

14.24

9.41

u/l

1.29

180

Disorders of muscles

163

1077

1.53

6.19

1.6

1.4

9.08

9.56

u/l

0.22

127

882

Other chronic obstructive pulmonary disease

398

2510

1.31

6.19

1.3

1.4

10.23

10.04

u/l

0.10

298

2009

Torsion of ovary, ovarian pedicle and fallopian tube

133

2.61

6.17

1.3

1.4

11.88

13.02

u/l

0.20

104

Somnolence, stupor and coma

376

1.92

6.17

1.4

11.36

8.19

u/l

0.75

310

Algoneurodystrophy

363

1.95

6.17

1.5

1.3

9.38

10.71

u/l

0.37

295

Fall on and from stairs and steps

389

2988

1.31

6.11

1.4

10.64

10.06

u/l

0.33

300

2425

Acute generalized exanthematous pustulosis

428

1.86

6.10

1.6

1.5

12.97

10.28

u/l

0.78

343

Other disorders of glucose regulation and pancreatic internal secretion

150

978

1.56

6.09

1.5

11.28

8.40

u/l

1.32

114

777

Extreme obesity with alveolar hypoventilation

274

2.08

6.09

1.3

9.58

10.26

u/l

0.15

222

Malignant neoplasm, without specification of site

105

2.80

6.08

1.6

1.3

17.26

8.30

u/l

1.87

Excessive vomiting in pregnancy

184

1255

1.49

6.06

1.2

1.3

13.20

11.12

u/l

1.04

153

1026

ILD medications: azathioprine

291

2148

1.37

6.06

1.6

1.5

8.64

8.67

u/l

0.02

245

1744

Adhesive capsulitis of shoulder

180

1219

1.49

6.03

1.4

1.3

11.43

12.34

u/l

0.35

144

992

Other congenital malformations of male genital organs

162

2.54

6.03

2.5

2.2

5.29

4.01

u/l

0.58

108

Non-Hodgkin lymphoma, all

177

2.35

6.02

1.4

11.28

8.32

u/l

0.78

146

Acute renal failure

225

1590

1.42

6.02

1.4

11.17

8.98

u/l

1.25

159

1282

Other disorders of kidney and ureter

154

1011

1.54

6.01

1.5

1.4

11.68

9.72

u/l

0.90

128

805

Fitting and adjustment of other devices

311

2086

1.35

6.01

1.4

11.97

10.76

u/l

0.85

267

1657

Visual impairment including blindness (binocular or monocular)

502

1.78

6.01

2.2

1.5

7.39

9.50

u/l

1.37

400

Fibroblastic disorders

248

1783

1.40

6.00

1.4

1.3

10.55

11.09

u/l

0.24

200

1441

Viral infections of the central nervous system

142

919

1.57

5.98

1.5

1.4

9.23

9.48

u/l

0.08

117

745

Smoking dependency

141

911

1.57

5.97

1.4

1.3

11.10

9.73

u/l

0.58

107

747

Unknown and unspecified causes of morbidity

106

639

1.68

5.94

1.5

1.3

9.80

9.68

u/l

0.03

527

Other and unspecified immunodeficiencies with predominantly antibody defects

137

2.60

5.93

2.4

1.7

9.97

9.78

u/l

0.02

109

Other bursopathies

155

1022

1.53

5.93

1.3

11.35

10.62

u/l

0.26

131

826

Cytomegalovirus infection, IBD co-morbidity

205

2.26

5.92

1.7

1.5

10.54

9.33

u/l

0.27

170

Amblyopia ex anopsia

103

620

1.70

5.91

1.8

1.7

9.11

7.72

u/l

0.48

477

Malignant neoplasm of oropharynx

3.03

5.91

1.5

1.3

13.68

6.29

u/l

1.87

Obstructive hydrocephalus

131

2.61

5.89

3.4

1.6

4.45

7.68

u/l

2.67

101

Maternal care for known or suspected abnormality of pelvic organs

614

3394

1.24

5.86

1.2

1.3

11.84

12.25

u/l

0.27

539

2747

Benign neoplasm: Ascending colon

126

796

1.60

5.82

1.5

1.3

12.27

11.29

u/l

0.27

649

Hepatocellular carcinoma, including Hilmo

137

2.53

5.82

1.3

1.4

7.85

6.43

u/l

0.54

113

Gastric ulcer

163

1090

1.50

5.81

1.2

1.4

12.80

10.57

u/l

0.95

137

873

Ocular pain

154

1022

1.53

5.80

1.4

10.90

10.08

u/l

0.36

125

839

Malignant neoplasm of breast, ER-negative, including Hilmo

129

779

1.58

5.80

1.2

19.91

18.60

u/l

0.36

113

613

Viral infections of the central nervous system

130

831

1.59

5.79

1.5

1.4

9.57

9.45

u/l

0.03

108

677

268

2.07

5.73

1.4

10.48

10.15

u/l

0.06

219

Malignant neoplasm of oropharynx, including Hilmo

109

2.73

5.72

1.4

1.3

12.37

6.72

u/l

1.50

Mental and behavioural disorders due to cannabinoids

107

659

1.68

5.72

1.5

1.6

6.06

6.73

u/l

0.40

551

Other blood glucose lowering drugs, excl. Insulins

142

926

1.54

5.71

1.2

1.4

8.91

11.35

u/l

1.80

114

753

Vitamin deficiency

408

1.85

5.70

1.6

1.5

9.40

9.38

u/l

0.01

323

Vitamin deficiency, wide

408

1.85

5.70

1.6

1.5

9.40

9.38

u/l

0.01

323

Pilonidal cyst

220

1572

1.42

5.69

1.6

1.4

6.06

7.54

u/l

2.60

186

1283

Actinic keratosis

232

1538

1.40

5.68

1.4

1.3

13.11

12.97

u/l

0.05

182

1221

Use of disulfiram, acamprosate or naltrexone

171

1166

1.49

5.66

1.3

1.4

7.82

7.40

u/l

0.22

132

957

Campylobacter enteritis

276

2.05

5.66

1.5

1.3

9.66

9.36

u/l

0.05

224

Pneumonia due to other infectious organisms, not elsewhere classified

255

2.08

5.66

1.5

9.76

9.40

u/l

0.05

210

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

271

2.08

5.65

2.3

1.9

6.25

8.34

u/l

0.83

192

Invasive ventilation

104

633

1.67

5.65

1.7

1.4

8.93

8.27

u/l

0.17

494

Iron deficiency

501

1.78

5.64

1.4

6.03

9.91

u/l

6.38

406

Appendectomy

1252

10407

1.16

5.64

1.4

10.11

9.87

u/l

0.25

1054

8552

Diffuse brain injury

310

1.97

5.64

1.4

1.3

9.18

7.90

u/l

0.41

263

Insulin, fast-acting or short human

633

5196

1.22

5.64

1.4

1.5

9.68

8.24

u/l

2.23

496

4190

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

248

2.08

5.63

1.3

1.2

14.30

16.11

u/l

0.25

199

Status epilepticus

269

2.04

5.62

1.8

1.5

10.01

8.99

u/l

0.18

207

Pervasive developmental disorders excl. Autism + Asperger

291

2.06

5.60

2.1

7.01

5.84

u/l

0.45

196

Strabismus

508

4072

1.25

5.59

1.7

1.5

9.33

9.59

u/l

0.16

414

3236

Artrosis, including avohilmo

1432

6844

1.15

5.59

1.4

9.91

10.29

u/l

0.48

1184

5613

Malignant neoplasm, without specification of site, including Hilmo

164

2.34

5.58

1.5

1.3

16.01

9.50

u/l

1.47

133

Hydrocele

149

988

1.52

5.58

1.6

1.5

6.86

6.02

u/l

0.55

113

809

Gastroduodenal ulcer

240

1734

1.39

5.56

1.3

1.4

12.67

10.00

u/l

1.75

199

1401

Disorders of endocrine glands in diseases classified elsewhere

7.90

5.56

2.8

1.8

5.38

8.25

u/l

0.37

Achilles tendinitis

136

886

1.55

5.55

1.4

7.94

11.29

u/l

3.06

109

715

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

901

7626

1.18

5.53

1.4

9.77

8.97

u/l

1.03

736

6206

Hypoglycaemia, other or unspecified

125

802

1.58

5.51

1.6

1.5

11.16

8.30

u/l

1.07

642

Malignant neoplasm of other connective and soft tissue

123

2.57

5.50

1.4

1.3

10.36

8.42

u/l

0.34

Assault by bodily force

203

1440

1.43

5.50

1.5

8.57

7.47

u/l

0.63

159

1154

Nasal polyp

255

1873

1.37

5.49

1.4

9.52

9.29

u/l

0.10

218

1545

Generalized skin eruption due to drugs and medicaments

385

1.86

5.48

1.6

1.5

12.72

9.91

u/l

0.83

307

Azathioprine

291

2185

1.35

5.47

1.6

1.5

8.64

8.71

u/l

0.04

245

1782

Maternal care for known or suspected fetal abnormality and damage

431

2930

1.28

5.46

1.2

1.3

10.27

11.24

u/l

0.76

353

2371

Special screening examination for neoplasms

299

1.96

5.46

1.6

1.3

11.58

10.51

u/l

0.22

241

Malignant neoplasm of other connective and soft tissue, including Hilmo

238

2.09

5.45

1.6

1.3

11.27

9.00

u/l

0.52

189

Chronic kidney disease

293

2155

1.34

5.45

1.5

1.4

14.27

9.13

u/l

4.31

239

1706

Flat foot [pes planus] (acquired)

114

717

1.61

5.42

1.4

12.35

13.80

u/l

0.38

576

Rosacea

166

1134

1.48

5.42

1.3

9.77

12.08

u/l

1.37

131

939

Other otitis externa (chronic)

104

641

1.65

5.41

1.6

1.4

10.76

9.78

u/l

0.37

518

Other specified/unspecified dorsopathies

239

2.09

5.41

1.8

1.3

10.39

11.26

u/l

0.17

194

Familial hypercholesterolemia, with ischemic heart disease

451

1.77

5.40

1.3

1.4

9.04

8.72

u/l

0.08

363

Other diseases of stomach and duodenum

393

1.83

5.39

1.3

13.83

10.72

u/l

0.72

315

Suppurative and unspecified otitis media

978

7430

1.17

5.38

1.5

1.4

8.88

8.17

u/l

1.02

785

6066

Ischemic heart diseases

1079

5565

1.17

5.37

1.4

10.64

10.65

u/l

0.00

891

4455

Cytomegaloviral disease

234

2.11

5.37

1.7

1.5

10.15

9.70

u/l

0.09

193

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

521

1.72

5.36

1.4

9.27

9.21

u/l

0.02

429

Superficial injury of head

380

2965

1.29

5.35

1.4

9.63

9.30

u/l

0.19

294

2369

Abnormal blood-pressure reading, without diagnosis

381

1.84

5.32

1.6

1.5

9.64

10.11

u/l

0.11

303

Intestinal malabsorption

470

1.76

5.31

1.5

1.4

10.90

8.18

u/l

0.74

379

Fungal Sepsis

275

2.00

5.31

1.4

1.3

12.78

9.72

u/l

0.72

219

Certain conditions originating in the perinatal period

287

1920

1.35

5.30

1.9

1.7

7.38

7.49

u/l

0.06

223

1484

Exclusion endpoint for clefts

392

1.86

5.29

2.4

1.9

5.73

7.60

u/l

1.29

298

Traumatic subdural haemorrhage

104

616

1.63

5.28

1.3

8.11

9.93

u/l

1.21

504

Other viral diseases, not elsewhere classified

383

2994

1.29

5.26

1.6

1.5

9.33

8.83

u/l

0.33

313

2350

Other and unspecified coagulation defects

101

624

1.65

5.26

1.3

1.4

10.56

10.05

u/l

0.13

507

Other specified/unspecified inflammatory spondylopathies

570

1.68

5.25

1.3

1.4

13.58

9.81

u/l

1.29

468

Cyst of kidney

426

1.78

5.24

1.4

1.3

9.65

9.49

u/l

0.03

342

Benign neoplasm of other and unspecified sites

243

2.06

5.20

1.5

1.3

12.43

10.90

u/l

0.26

193

Focal epilepsy, strict definition

310

2365

1.32

5.20

1.5

10.43

8.99

u/l

0.98

250

1859

Conjunctivitis (acute, non atopic)

533

4328

1.24

5.18

1.5

1.4

9.89

9.45

u/l

0.36

422

3471

Superficial injury of forearm

205

1471

1.41

5.18

1.5

9.65

8.75

u/l

0.42

170

1198

Sequelae of injuries of head

603

1.66

5.18

1.3

1.4

8.41

7.64

u/l

0.30

501

Maltreatment syndromes

145

978

1.52

5.17

1.5

8.87

8.13

u/l

0.34

122

807

Wide developmental disorders

128

843

1.56

5.15

1.8

7.34

6.68

u/l

0.32

636

Any dementia

111

1200

0.64

5.12

1.3

12.96

12.33

u/l

0.15

951

Pneumocystosis

128

2.49

5.12

1.7

1.5

11.93

7.55

u/l

0.70

Atopic dermatitis, strict definition

771

6385

1.19

5.12

1.5

1.4

9.23

9.11

u/l

0.08

605

5192

Preterm labour and delivery

370

2895

1.29

5.12

1.2

1.3

12.16

14.94

u/l

3.23

313

2363

Third [oculomotor] nerve palsy

116

2.57

5.11

2.2

1.3

5.68

10.42

u/l

1.85

Other complications of labour and delivery, not elsewhere classified

400

2910

1.28

5.09

1.2

1.3

9.04

9.36

u/l

0.22

348

2371

Abscess of anal and rectal regions

155

1060

1.48

5.08

1.4

9.82

7.81

u/l

1.01

127

860

Anogenital herpesviral [herpes simplex] infection

300

2294

1.33

5.08

1.5

1.3

9.08

9.14

u/l

0.03

243

1914

Open wound of wrist and hand

920

7712

1.17

5.07

1.4

8.26

8.20

u/l

0.06

746

6329

Diseases of tongue

416

1.78

5.06

1.3

1.5

11.72

11.48

u/l

0.05

334

Corns and callosities

529

1.69

5.05

1.5

1.4

10.73

9.83

u/l

0.23

434

Vestibular neuronitis

109

691

1.60

5.05

1.4

1.3

11.04

10.76

u/l

0.07

562

Benign neoplasm of male genital organs

173

2.26

5.05

1.6

1.4

6.13

5.92

u/l

0.05

140

Other and unspecified erythematous conditions

246

2.03

5.05

1.4

1.5

9.67

10.07

u/l

0.07

192

Congenital malformations of breast

297

1.97

5.05

1.3

1.4

10.50

10.23

u/l

0.06

246

Maternal care for cervical incompetence

418

1.78

5.05

1.3

1.2

9.84

11.88

u/l

1.06

337

Otitis media, unspecified

307

2166

1.32

5.04

1.8

1.6

7.44

8.10

u/l

0.66

251

1703

Autism

588

1.67

5.04

1.6

1.7

7.90

7.01

u/l

0.37

468

Benign neoplasm: Tongue

186

2.20

5.03

1.4

12.90

10.79

u/l

0.34

147

Labour and delivery complicated by fetal stress [distress]

702

3846

1.21

5.03

1.2

1.3

10.58

11.37

u/l

0.85

616

3115

Carcinoma in situ of other and unspecified sites

186

2.19

5.01

1.3

9.48

7.71

u/l

0.56

143

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

178

1252

1.44

5.00

1.4

1.3

11.62

11.00

u/l

0.23

150

1031

Haemorrhage, not elsewhere classified

206

2.12

4.99

1.7

1.5

10.48

7.71

u/l

0.56

164

Ptosis of eyelid

102

638

1.61

4.98

1.4

1.3

9.28

12.03

u/l

1.40

503

Other and unspecified nail disorders

174

2.24

4.98

1.4

9.19

10.32

u/l

0.25

143

Motor neuron disease (with DMD)

3.08

4.97

2.0

1.2

5.97

8.35

u/l

0.49

Early onset COPD

253

1887

1.35

4.97

1.4

9.67

9.52

u/l

0.07

192

1520

Sequelae of injuries of neck and trunk

304

1.92

4.96

1.2

1.4

8.50

8.30

u/l

0.05

253

Fracture of lower leg, including ankle

857

7246

1.18

4.96

1.5

1.4

10.03

9.86

u/l

0.14

694

5925

Cholecystectomy

913

6750

1.17

4.95

1.3

12.46

12.25

u/l

0.15

735

5522

Wilms' tumor, including Hilmo

4.46

4.93

2.8

1.5

16.78

4.99

u/l

—

Car occupant injured in other and unspecified transport accidents

400

3180

1.27

4.93

1.4

8.34

8.87

u/l

0.48

327

2633

Other erythematous conditions

269

1.97

4.93

1.4

1.6

10.78

10.28

u/l

0.08

211

Malignant neoplasm of breast, HER-negative

104

642

1.60

4.92

1.2

20.86

18.66

u/l

0.59

507

Cerebrovascular diseases (FINNGEN)

433

2441

1.26

4.92

1.4

1.3

10.95

10.78

u/l

0.08

343

2022

Ulcer of vagina/vulva

270

1.98

4.91

1.2

1.3

14.18

11.96

u/l

0.35

218

Hemiplegia

413

1.77

4.91

1.9

1.4

11.50

10.58

u/l

0.22

329

Symptoms and signs involving emotional state

400

1.79

4.91

1.4

1.5

9.95

8.37

u/l

0.40

326

Other epidermal thickening

377

1.81

4.90

1.4

12.34

8.39

u/l

1.08

296

Diabetic maculopathy, excluding more controls

168

1175

1.45

4.90

1.3

1.4

9.02

8.10

u/l

0.48

130

955

Early lumbar disc prolapse operation

269

2036

1.34

4.89

1.4

8.44

8.67

u/l

0.11

224

1684

Seborrhoeic keratosis

187

1331

1.41

4.89

1.5

1.3

11.41

12.54

u/l

0.52

157

1078

652

0.44

4.88

1.6

1.4

6.68

7.20

u/l

0.16

527

Effects of foreign body entering through natural orifice

461

3728

1.25

4.87

1.5

9.36

7.70

u/l

1.89

376

3026

Acute myeloid leukaemia and myelodysplastic syndromes

2.87

4.85

3.0

1.3

15.80

7.83

u/l

0.69

Other specified congenital malformation syndromes affecting multiple systems

338

1.89

4.84

2.3

2.0

5.56

7.46

u/l

1.13

251

Other coagulation defects

131

876

1.52

4.83

1.4

10.86

9.99

u/l

0.24

102

712

Other keratitis

204

1481

1.39

4.83

1.5

1.4

8.77

9.18

u/l

0.18

171

1200

Focal epilepsy

342

2672

1.29

4.82

1.5

10.23

9.06

u/l

0.82

279

2114

Malignant neoplasm of brain

307

1.89

4.81

2.4

1.6

6.52

7.85

u/l

0.49

254

Subacute thyroiditis

258

1.97

4.77

1.9

1.2

10.72

12.46

u/l

0.39

206

Postmenopausal atrophic vaginitis

152

566

1.49

4.76

1.1

1.3

24.39

23.78

u/l

0.14

124

449

Budesonide

242

1808

1.35

4.76

1.4

9.15

9.49

u/l

0.17

198

1497

Pneumothorax

562

1.64

4.73

1.3

1.4

9.94

7.79

u/l

0.91

469

Long labour

542

3822

1.22

4.73

1.2

1.3

12.14

12.51

u/l

0.21

460

3101

Carbimazole or st.post thyroidectomy, condition for graves disease

299

2303

1.31

4.72

1.4

1.3

12.47

12.25

u/l

0.08

242

1877

Other and unspecified myopathies

100

632

1.60

4.72

1.6

1.4

8.75

8.46

u/l

0.07

519

Trochanteric bursitis

130

870

1.50

4.72

1.2

1.3

13.15

15.28

u/l

0.87

101

702

Complications predominantly related to the puerperium

512

4203

1.23

4.71

1.2

12.11

11.80

u/l

0.18

424

3510

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

488

3984

1.23

4.71

1.4

8.88

8.64

u/l

0.17

412

3261

Slow fetal growth and fetal malnutrition

168

2.34

4.70

2.8

2.5

4.58

5.51

u/l

0.50

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

280

1.91

4.69

1.3

1.4

9.46

7.89

u/l

0.56

225

Mental disorders, not otherwise specified

187

1347

1.41

4.69

1.4

9.62

9.12

u/l

0.20

152

1112

Gonarthrosis [arthrosis of knee](FG)

962

4815

1.16

4.69

1.4

1.3

11.14

11.70

u/l

0.56

790

3925

Gout, idiopatic and unspecified

242

1810

1.34

4.68

1.4

8.66

8.21

u/l

0.25

186

1452

Other disorders of bone density and structure

282

1.93

4.68

1.6

1.4

9.40

9.54

u/l

0.03

227

Diseases of arteries, arterioles and capillaries (FINNGEN)

288

1518

1.32

4.67

1.3

1.4

10.68

9.48

u/l

0.67

229

1268

Viral warts

196

1424

1.39

4.65

1.5

8.19

8.93

u/l

0.34

163

1145

Other diseases of pericardium

303

1.88

4.64

1.4

1.5

10.42

8.35

u/l

0.56

249

Disorders of vitreous body

452

3536

1.24

4.63

1.3

13.03

12.91

u/l

0.05

353

2857

Other specified/unspecified soft tissue disorders

289

1.89

4.62

1.2

1.3

13.29

11.38

u/l

0.37

232

Chronic ulcer of skin, not elsewhere classified

436

1.72

4.60

1.4

1.3

10.58

9.26

u/l

0.38

347

Autoimmune thyroiditis

194

2.12

4.58

1.6

1.3

15.69

11.15

u/l

0.74

154

Other strabismus

440

3554

1.24

4.58

1.7

1.5

9.37

9.22

u/l

0.08

360

2828

Gout, unspecified

198

1441

1.38

4.58

1.5

1.4

8.91

8.14

u/l

0.39

152

1151

Spinal instabilities

207

2.07

4.57

1.5

1.3

12.58

11.27

u/l

0.17

167

Manic episode

364

1.80

4.57

1.4

9.00

8.95

u/l

0.01

304

Pacemaker

254

1839

1.33

4.55

1.4

11.65

10.08

u/l

0.93

199

1456

Other disorders of pigmentation

298

1.87

4.55

1.3

1.4

13.24

9.59

u/l

1.03

234

Separation of retinal layers (serosa)

379

1.77

4.54

1.4

6.24

7.17

u/l

0.34

310

Other heart diseases, wide

1811

9962

1.11

4.53

1.4

10.67

9.57

u/l

2.49

1460

8142

Ehlers-Danlos syndrome

210

2.10

4.53

1.5

1.3

9.14

10.75

u/l

0.42

172

Hernia

1519

9075

1.12

4.52

1.4

9.27

10.13

u/l

1.77

1231

7408

Postprocedural musculoskeletal disorders, not elsewhere classified

386

1.75

4.51

1.5

1.3

11.43

11.47

u/l

0.01

310

Degenerative diseases of the nervous system

1089

0.64

4.51

1.3

12.39

11.84

u/l

0.13

865

Other and unspecified urticaria

371

2958

1.26

4.49

1.5

1.4

10.10

10.04

u/l

0.03

317

2380

DVT of lower extremities

200

1464

1.37

4.47

1.4

1.3

12.55

10.83

u/l

0.76

169

1199

Other congenital malformations of male genital organs

152

2.34

4.47

2.6

2.2

4.77

4.00

u/l

0.37

100

Viral meningitis

488

1.68

4.46

1.6

1.4

10.82

9.04

u/l

0.52

401

Other and unspecified mononeuropathies, also in other diseases

182

2.12

4.46

1.2

1.4

13.94

10.70

u/l

0.43

154

Herpesviral [herpes simplex] infections

460

3759

1.23

4.45

1.4

1.3

11.30

10.42

u/l

0.62

370

3091

Other female pelvic inflammatory diseases

196

1433

1.38

4.44

1.2

15.34

14.41

u/l

0.31

166

1178

Acute suppurative otitis media

766

6122

1.18

4.42

1.6

1.5

8.89

7.88

u/l

1.40

601

4998

Nummular dermatitis

106

691

1.55

4.41

1.6

1.4

10.24

9.03

u/l

0.45

552

Ganglion

339

2679

1.27

4.41

1.3

10.99

10.87

u/l

0.06

291

2188

Otitis externa, unspecified

200

1471

1.37

4.41

1.6

1.4

9.67

9.43

u/l

0.11

171

1182

Specific development disorders of speech and language

163

1118

1.43

4.41

1.9

1.8

7.24

6.99

u/l

0.11

113

843

Disorders of speech understanding and production

112

729

1.54

4.38

2.0

1.8

7.45

7.01

u/l

0.14

521

Event of undetermined intent

137

946

1.47

4.38

1.5

1.4

7.91

8.03

u/l

0.04

102

757

Autism spe

595

1.62

4.37

1.6

1.8

8.02

6.92

u/l

0.48

480

Disorders of orbit

361

1.77

4.37

1.3

1.4

13.59

10.84

u/l

0.60

290

Scissor bite

102

660

1.58

4.36

1.9

2.1

5.43

6.29

u/l

0.46

485

Hyperkalaemia

259

1.91

4.36

1.5

1.4

13.22

9.62

u/l

0.66

208

Superficial injury of lower leg

448

3659

1.23

4.35

1.4

9.52

9.32

u/l

0.12

356

2954

Lichen ruber planus, wide definition including periferal and oral lichen planus

223

1668

1.34

4.35

1.3

11.31

12.17

u/l

0.40

182

1347

Examination and encounter for administrative purposes

339

1.79

4.35

1.6

1.3

8.54

8.02

u/l

0.13

279

Benign neoplasm of eye and adnexa

110

725

1.53

4.35

1.4

10.43

11.11

u/l

0.19

597

Malignant neoplasm of tonsil, including Hilmo

2.59

4.35

1.4

1.3

11.42

6.57

u/l

1.03

Follow-up care involving plastic surgery

303

1.84

4.34

1.1

1.2

18.37

13.06

u/l

1.31

240

Autonomic disorders

198

2.07

4.34

1.6

1.4

10.85

8.68

u/l

0.35

162

Fracture of skull and facial bones

376

3015

1.26

4.34

1.5

8.22

8.24

u/l

0.01

303

2456

Disorders of synovium and tendon in diseases classified elsewhere

158

2.20

4.33

1.4

1.3

9.02

8.24

u/l

0.16

126

Sicca syndrome [Sjögren]

536

1.62

4.33

1.2

1.3

13.69

15.00

u/l

0.35

435

Hepatocellular carcinoma

2.57

4.33

1.3

8.73

7.10

u/l

0.46

Other embolism and thrombosis

150

1053

1.44

4.32

1.5

1.4

8.85

10.93

u/l

1.34

118

861

Coronary revascularization (ANGIO or CABG)

969

5150

1.15

4.30

1.4

10.10

10.42

u/l

0.28

801

4117

Congenital malformations of the nervous system

403

1.74

4.30

1.6

1.8

7.68

8.39

u/l

0.21

307

Arthropathies in other diseases classified elsewhere

297

1.85

4.30

1.4

1.3

11.18

9.99

u/l

0.22

235

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

632

1.57

4.29

1.2

1.3

13.93

11.72

u/l

0.67

512

Antepartum haemorrhage, not elsewhere classified

213

1592

1.36

4.29

1.2

1.3

12.42

11.74

u/l

0.25

182

1290

Thiazolidinediones

103

671

1.55

4.29

1.4

1.3

9.44

9.89

u/l

0.16

535

Sequelae of injuries of upper limb

155

1098

1.43

4.28

1.4

10.04

9.02

u/l

0.34

129

893

Fall on same level involving ice and snow

870

7537

1.16

4.27

1.4

10.22

10.23

u/l

0.00

724

6155

Percutaneous Coronary Intervention

966

5143

1.15

4.26

1.4

10.09

10.42

u/l

0.30

798

4110

Other chromosome abnormalities, not elsewhere classified

2.86

4.26

2.8

2.0

8.30

7.61

u/l

0.05

Plantar fascial fibromatosis

120

810

1.50

4.25

1.3

11.74

13.24

u/l

0.47

674

Thyrotoxicosis with toxic multinodular goitre

276

1.87

4.24

1.3

1.2

17.85

14.56

u/l

0.65

217

Lichen simplex chronicus and prurigo

455

1.67

4.22

1.7

1.3

14.13

10.39

u/l

1.12

370

Presence of other devices

207

1532

1.35

4.22

1.2

1.3

10.97

11.39

u/l

0.19

182

1235

Social disorders starting during childhood or adolecense, excluding more controls

169

2.20

4.21

2.0

1.8

5.03

6.56

u/l

0.82

128

Carcinoma in situ, bladder

173

2.12

4.20

1.3

9.53

7.57

u/l

0.58

132

Streptococcal septicaemia

105

691

1.53

4.20

1.6

1.4

11.35

8.49

u/l

1.45

556

COPD, hospital admissions

396

2700

1.24

4.19

1.3

1.4

10.13

10.30

u/l

0.09

296

2161

Nail disorders

136

946

1.46

4.17

1.4

1.5

10.48

8.55

u/l

1.03

114

775

Other osteochondrodysplasias

136

2.33

4.17

1.6

1.5

12.91

8.72

u/l

0.55

100

Alzheimer disease, including avohilmo

948

0.64

4.17

1.3

12.70

13.01

u/l

0.07

743

Carrier of infectious disease

294

1.85

4.16

1.5

1.3

7.60

8.89

u/l

0.43

235

Bicipital tendinitis

359

1.75

4.16

1.6

1.3

8.43

9.04

u/l

0.16

289

Implicit fungal Sepsis

257

1.90

4.16

1.5

1.3

13.65

9.59

u/l

0.96

205

Congenital malformations of breast

325

1.82

4.14

1.3

10.31

10.42

u/l

0.02

271

Crohn disease

256

1972

1.31

4.14

1.4

8.64

8.87

u/l

0.11

220

1602

Other symptoms and signs involving the circulatory and respiratory systems

598

1.57

4.14

1.3

1.4

9.68

9.93

u/l

0.07

467

Focal epilepsy, mode (most common among epilepsy diagnosis)

287

2242

1.29

4.12

1.5

10.52

8.97

u/l

1.00

234

1765

Heterophoria

164

1183

1.41

4.12

1.4

1.5

10.49

9.19

u/l

0.52

138

938

Nontoxic diffuse goitre

161

2.14

4.12

1.2

16.86

13.94

u/l

0.55

131

Keratitis

579

4873

1.19

4.12

1.4

9.72

9.46

u/l

0.17

482

3985

Other inflammatory liver diseases

600

1.57

4.09

1.6

1.4

8.41

9.68

u/l

0.49

481

Undescended testis, unilateral

164

2.20

4.09

3.0

2.1

6.59

4.32

u/l

0.86

111

Superficial injury of abdomen, lower back and pelvis

277

2159

1.29

4.09

1.5

1.4

8.80

8.66

u/l

0.07

218

1757

Other arrhythmias

1007

6655

1.15

4.09

1.4

10.55

10.35

u/l

0.19

829

5468

Other osteochondrodysplasias

150

2.22

4.08

1.5

13.93

8.69

u/l

0.77

111

Inflammatory diseases of the central nervous system

131

909

1.46

4.07

1.7

1.4

10.35

9.34

u/l

0.34

110

740

Disorders of vitreous body and globe

462

3656

1.22

4.06

1.3

12.84

12.79

u/l

0.02

361

2954

Cholecystitis

137

957

1.44

4.06

1.3

11.74

10.32

u/l

0.57

108

776

COPD, early/later onset

399

2725

1.24

4.06

1.3

1.4

10.19

10.29

u/l

0.05

299

2181

Outcome of delivery

379

1884

1.25

4.06

1.2

1.3

11.31

12.73

u/l

0.99

305

1494

Malignant neoplasm of breast

335

1729

1.27

4.05

1.2

22.47

18.44

u/l

3.64

284

1389

Hypertensive Heart Disease

190

1094

1.37

4.03

1.3

9.14

9.84

u/l

0.31

135

868

Left bundle-branch block

377

1.71

4.02

1.2

1.4

11.48

11.34

u/l

0.03

310

Striking against or struck by other objects

702

6015

1.17

4.02

1.5

8.27

7.90

u/l

0.34

563

4869

All chronic kidney diseases

717

5022

1.17

4.00

1.5

1.4

12.76

9.14

u/l

6.27

589

4002

Lesion of radial nerve

297

1.81

3.99

1.5

1.3

11.63

10.07

u/l

0.28

248

Paralytic strabismus

541

1.59

3.97

2.1

1.4

8.92

9.40

u/l

0.13

432

Artificial joint re-operation

275

1.83

3.97

1.3

12.59

12.12

u/l

0.07

215

Supervision of normal pregnancy

464

2179

1.22

3.96

1.2

1.3

13.22

12.84

u/l

0.21

393

1728

Hypertensive heart and/or renal disease

215

1205

1.34

3.95

1.3

9.82

9.81

u/l

0.00

156

955

Other specified/unspecified bacterial intestinal infections

534

1.59

3.95

1.5

9.04

9.83

u/l

0.25

436

Acute tubulo-interstitial nephritis

949

7172

1.15

3.94

1.4

1.3

11.13

10.58

u/l

0.52

765

5808

Superficial injury of wrist and hand

431

3549

1.22

3.94

1.5

8.70

8.71

u/l

0.01

347

2882

Emergency coronary revascularization (for ACS)

1012

5394

1.14

3.93

1.4

10.26

10.52

u/l

0.23

831

4310

Hallux rigidus

114

774

1.48

3.93

1.3

13.43

14.36

u/l

0.25

619

Spirochaetal infections, other/unspecified

105

703

1.51

3.91

1.6

1.4

10.89

11.49

u/l

0.14

570

Oesophageal varices

277

1.83

3.91

1.3

1.5

11.60

7.74

u/l

0.63

216

Other facial nerve disorders

213

1.96

3.91

1.2

7.95

10.98

u/l

0.87

176

Hydrocephalus

434

1.65

3.90

2.6

1.5

8.54

9.90

u/l

0.38

338

Infections with a predominantly sexual mode of transmission

719

6187

1.17

3.90

1.4

1.3

9.46

9.40

u/l

0.04

576

5155

Injuries involving multiple body regions

467

1.64

3.89

1.3

1.4

10.01

8.07

u/l

0.62

388

Benign neoplasm: Appendix

3.05

3.89

1.1

1.2

10.22

8.23

u/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

160

1163

1.39

3.88

1.2

11.30

13.25

u/l

0.95

135

953

Contraceptive management

749

4524

1.17

3.87

1.3

1.4

11.29

9.38

u/l

3.22

623

3671

Benign lipomatous neoplasm of other sites/unspecified

529

1.58

3.85

1.4

1.3

8.82

11.08

u/l

0.93

427

Ehlers-Danlos syndrome

161

2.15

3.84

1.3

1.4

9.69

10.72

u/l

0.18

133

Unspecific neurodegenerative disorder

128

1245

0.70

3.84

1.4

1.3

10.81

12.57

u/l

0.79

983

Other gastritis (incl. Duodenitis)

239

1842

1.30

3.83

1.3

1.4

11.42

10.16

u/l

0.72

189

1500

Autoimmune diseases excluding thyroid diseases

2004

9973

1.10

3.83

1.4

9.91

8.93

u/l

2.67

1644

8086

Behavioural disorders, excluding more controls

385

1.71

3.82

1.5

1.6

9.07

7.88

u/l

0.33

310

Alzheimer’s disease, strict definition

642

0.55

3.81

1.3

13.63

13.40

u/l

0.03

500

Monosomies and deletions from the autosomes, not elsewhere classified

3.09

3.81

2.7

8.39

5.11

u/l

0.42

Impacted teeth

660

5038

1.18

3.80

1.5

8.00

7.70

u/l

0.33

544

4141

Lesion of lateral popliteal nerve

415

1.66

3.80

1.4

1.3

9.26

8.85

u/l

0.11

350

Macular pucker

109

739

1.48

3.80

1.3

13.94

11.98

u/l

0.50

590

Intussusception

147

2.15

3.79

1.3

14.91

13.70

u/l

0.14

115

Other disorders of urethra and urinary system

1091

6970

1.13

3.78

1.3

13.05

11.16

u/l

3.23

871

5749

Combinations of oral blood glucose lowering drugs

292

2312

1.27

3.78

1.4

1.3

7.94

9.70

u/l

2.74

229

1872

Benign neoplasm: Skin of ear and external auricular canal

251

1.86

3.78

1.3

7.99

10.31

u/l

0.74

196

Dementia

155

1466

0.73

3.78

1.3

12.22

12.38

u/l

0.05

118

1160

Other ill-defined and unspecified causes of mortality

384

1.68

3.78

1.4

8.76

8.40

u/l

0.12

308

Acute nasopharyngitis (common cold)

239

1838

1.30

3.76

1.4

1.5

6.59

6.26

u/l

0.25

210

1500

Focal brain injury

462

1.62

3.75

1.3

1.4

8.05

8.41

u/l

0.08

381

Benign neoplasm: Rectosigmoid junction

209

1.94

3.74

1.4

1.3

11.06

9.99

u/l

0.14

166

Malignant neoplasm of breast, HER2-negative

322

1677

1.26

3.74

1.2

22.52

18.72

u/l

3.17

274

1344

Other and unspecified injuries of ankle and foot

656

1.52

3.73

1.4

1.5

10.02

8.39

u/l

0.66

519

Other enthesopathy of foot (+metatarsalgia)

134

950

1.42

3.72

1.3

1.4

10.19

12.00

u/l

0.80

113

772

Angina pectoris

533

2981

1.19

3.72

1.4

1.3

9.59

10.19

u/l

0.49

431

2390

Malignant neoplasm of breast, HER2-negative, including Hilmo

348

1811

1.25

3.72

1.2

22.17

18.18

u/l

3.77

296

1451

Malignant neoplasm of breast, including Hilmo

348

1811

1.25

3.71

1.2

22.17

18.18

u/l

3.77

296

1451

Congenital malformations of the musculoskeletal system, not elsewhere classified

284

1.82

3.71

1.6

1.5

8.86

10.47

u/l

0.47

235

Cirrhosis of liver, NAS

334

1.73

3.70

1.5

1.4

13.47

8.54

u/l

0.94

270

Type 1 diabetes, wide definition, subgroup 1

428

3542

1.22

3.70

1.4

1.6

9.06

7.92

u/l

1.11

334

2852

!Aliquae complicationes praecoces traumatis

474

1.61

3.67

1.5

1.4

7.57

7.69

u/l

0.03

388

Early complications of trauma

474

1.61

3.67

1.5

1.4

7.57

7.69

u/l

0.03

388

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

600

1.53

3.66

1.4

1.3

11.86

11.43

u/l

0.12

480

Lichen planus

113

778

1.46

3.66

1.3

13.04

12.88

u/l

0.04

632

Vitreous haemorrhage

117

812

1.45

3.66

1.3

10.71

9.12

u/l

0.57

657

Other peripheral vertigo

600

1.53

3.66

1.3

9.44

12.25

u/l

1.52

488

Other surgical follow-up care

405

1.66

3.65

1.4

1.5

9.17

9.07

u/l

0.03

326

Pleural plaque

450

1.61

3.64

1.3

1.4

11.51

8.43

u/l

1.49

360

Diabetic retinopathy

322

2491

0.80

3.63

1.3

1.4

11.12

9.03

u/l

1.83

244

2033

Leukaemia of unspecified cell type

2.74

3.62

2.3

1.9

9.38

7.37

u/l

0.32

Congenital hypothyroidism without goiter

2.97

3.62

1.7

1.9

5.78

10.23

u/l

1.07

Mixed disorders of conduct and emotions, excluding more controls

518

1.59

3.62

1.6

1.5

5.99

6.68

u/l

0.50

417

Sensorineural hearing loss

849

5031

1.15

3.62

1.5

1.4

10.66

11.10

u/l

0.38

669

4068

Other specified disorders of external ear

292

1.78

3.62

1.8

1.4

7.66

9.08

u/l

0.34

233

Complications of other internal prosthetic devices, implants and grafts

255

1.83

3.61

2.1

1.3

8.91

9.88

u/l

0.27

201

Heartburn

157

1151

1.38

3.59

1.4

9.68

9.53

u/l

0.05

128

947

Polyarthrosis

129

846

1.42

3.59

1.3

17.06

16.94

u/l

0.02

103

667

Cardiac murmurs and other cardiac sounds

184

1369

1.34

3.57

1.6

1.7

8.74

9.01

u/l

0.11

140

1062

Dementia, including avohilmo

175

1607

0.75

3.56

1.3

11.74

12.33

u/l

0.20

134

1275

L04AA Selective immunosuppressants

347

2827

1.24

3.55

1.6

1.4

11.21

10.07

u/l

0.81

292

2276

Failed induction of labour

180

1359

1.35

3.51

1.2

1.3

9.15

10.02

u/l

0.54

157

1109

COPD related to multimorbidity

316

2147

1.25

3.50

1.3

1.4

10.81

10.37

u/l

0.22

236

1717

Barrett oesophagus

340

1.70

3.49

1.6

1.4

7.83

8.61

u/l

0.24

276

Gout, strict definition

165

1225

1.35

3.48

1.4

8.45

7.90

u/l

0.25

129

987

Fracture of foot, except ankle

456

3825

1.20

3.47

1.4

9.72

8.99

u/l

0.58

380

3094

Care involving dialysis

105

723

1.47

3.45

1.6

1.5

13.19

7.99

u/l

1.88

562

Injury of muscle and tendon at wrist and hand level

214

1655

1.30

3.43

1.5

1.4

9.65

8.31

u/l

0.80

173

1346

Transitory endocrine and metabolic disorders specific to fetus and newborn

362

1.70

3.42

2.4

2.3

4.12

5.73

u/l

1.48

224

Other salmonella infections

412

1.62

3.41

1.4

13.43

9.24

u/l

0.85

339

COPD-related respiratory insufficiency

610

1.50

3.40

1.2

1.3

8.23

10.09

u/l

0.90

497

Other disorders of the genitourinary system

594

1.51

3.39

1.2

17.96

16.89

u/l

0.20

472

Open wound of lower leg

236

1851

1.28

3.39

1.6

1.5

10.02

8.59

u/l

0.82

192

1478

Congenital malformations of the musculoskeletal system, not elsewhere classified

226

1.88

3.38

1.6

9.22

10.18

u/l

0.20

188

Postpartum hemorraghe, all women as controls

626

5320

1.17

3.38

1.2

10.67

11.34

u/l

0.73

550

4404

Metatarsalgia

121

859

1.42

3.38

1.3

1.4

10.82

12.36

u/l

0.56

101

699

Lung diseases due to external agents

131

942

1.40

3.37

1.3

1.4

12.24

9.02

u/l

1.63

105

765

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

349

1.71

3.37

2.2

2.3

4.06

5.78

u/l

1.58

217

Second line medication for Crohn's disease

939

8328

1.13

3.34

1.5

1.4

10.84

10.11

u/l

0.83

778

6772

Diabetic retinopathy, excluding more controls

283

1977

0.80

3.33

1.3

1.4

11.08

8.88

u/l

1.75

219

1630

482

1.59

3.33

1.7

1.6

7.82

7.55

u/l

0.09

373

Other and unspecified vasculitis limited to skin

162

2.01

3.33

1.3

1.4

12.53

8.96

u/l

0.69

125

Toxic effects of substances chiefly nonmedicinal as to source

215

1673

1.30

3.32

1.5

8.67

8.26

u/l

0.18

175

1351

Nystagmus and other irregular eye movements

170

2.00

3.31

2.2

1.9

9.25

8.58

u/l

0.08

131

Other disorders of the musculoskeletal system and connective tissue

160

1193

1.35

3.31

1.3

11.55

10.73

u/l

0.31

129

979

Malignant neoplasm of thyroid gland

478

1.56

3.31

1.6

1.3

14.47

11.05

u/l

1.04

389

Other specified and unspecified disorders of eye and adnexa

308

1.71

3.30

1.4

1.3

13.04

10.39

u/l

0.49

243

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

785

5988

1.14

3.30

1.2

12.00

13.10

u/l

1.31

675

4958

Other and unspecified nonscarring hair loss

2.54

3.29

1.2

1.3

7.39

12.23

u/l

1.18

Other and/or unspecified nontoxic goitre

384

1.63

3.29

1.1

1.2

17.08

16.06

u/l

0.12

309

Hypermobility syndrome

118

842

1.42

3.27

1.3

11.32

10.82

u/l

0.12

687

Melanocytic naevi of other and unspecified parts of face

609

1.50

3.27

1.5

1.4

8.57

11.41

u/l

1.68

491

Scoliosis

168

1267

1.34

3.27

1.6

1.5

11.67

8.81

u/l

1.40

134

1015

Congenital malformations of eyelid, lacrimal apparatus and orbit

179

1.99

3.26

1.9

2.2

6.34

6.97

u/l

0.20

134

Fracture at wrist and hand level

646

5592

1.16

3.26

1.6

1.5

8.09

8.23

u/l

0.11

525

4536

Other and unspecified disorders of vitreous body

329

2652

1.23

3.24

1.3

13.32

14.15

u/l

0.39

255

2143

Any dementia, excluding more controls

108

1053

0.70

3.23

1.3

13.11

12.65

u/l

0.10

838

Malignant neoplasm of adrenal gland

3.46

3.23

2.5

2.6

18.55

9.55

u/l

—

Acute and transient psychotic disorders

197

1521

1.31

3.23

1.3

1.4

9.87

9.22

u/l

0.29

139

1257

Ischaemic heart disease, wide definition

835

4547

1.14

3.21

1.4

10.32

10.43

u/l

0.07

676

3702

Periapical abscess

716

6262

1.15

3.21

1.4

9.71

9.58

u/l

0.10

572

5096

Benign neoplasm of ovary

131

951

1.38

3.21

1.2

1.3

18.12

17.88

u/l

0.06

106

767

LeFortI or BSSO operation

605

1.50

3.20

1.2

1.4

11.21

10.36

u/l

0.23

501

Postprocedural disorders of digestive system, not elsewhere classified

236

1.81

3.20

1.5

1.4

12.88

9.85

u/l

0.41

182

Myopia

282

2279

1.25

3.19

1.4

10.13

9.10

u/l

0.56

234

1856

Stenosis and insufficiency of lacrimal passages

685

1.46

3.19

1.6

1.5

12.82

12.12

u/l

0.15

543

ILD, hospital admission 2, with pulmonary infections

530

1.52

3.18

1.5

1.4

10.19

9.33

u/l

0.28

420

Family history of other conditions

216

1.86

3.18

1.6

1.5

8.19

8.50

u/l

0.06

174

Agoraphobia

574

1.51

3.18

1.5

1.4

6.38

8.59

u/l

2.09

473

Glomerular diseases

244

1938

1.27

3.18

1.5

1.4

11.48

8.50

u/l

2.28

196

1562

Benign neoplasm: Caecum

579

1.50

3.18

1.3

13.40

11.24

u/l

0.61

466

Persistent delusional disorders

678

1.46

3.18

1.4

10.33

9.11

u/l

0.34

550

Melanoma in situ of trunk

2.46

3.17

1.2

7.85

9.62

u/l

0.39

Crohn's disease of small intestine

136

999

1.38

3.17

1.4

8.03

8.53

u/l

0.21

116

812

Trigger finger

163

1228

1.34

3.16

1.3

13.48

12.01

u/l

0.54

129

1002

Lichen planus, including avohilmo

180

1375

1.32

3.16

1.3

11.54

12.12

u/l

0.21

147

1108

Ménière disease

588

1.49

3.16

1.5

1.3

11.79

12.72

u/l

0.28

470

Dislocation, sprain and strain of joint and ligaments of hip

237

1.80

3.16

1.5

1.4

9.84

8.91

u/l

0.15

189

Abnormal findings in nipple discharge synovial fluid wound secretions

152

2.03

3.16

1.3

1.4

8.79

10.08

u/l

0.21

125

Total colectomy operation

461

1.56

3.15

1.5

1.4

10.23

7.90

u/l

0.54

377

Total colectomy

461

1.56

3.15

1.5

1.4

10.23

7.90

u/l

0.54

377

Myeloproliferative diseases

508

1.53

3.14

1.6

1.3

12.58

10.14

u/l

0.85

409

Panniculitis affecting regions of neck and back

290

1.71

3.13

1.4

1.3

10.68

10.71

u/l

0.00

234

Disorder of the sleep-wake schedule

269

1.76

3.13

1.5

1.7

5.24

7.87

u/l

2.13

222

Disorders of acoustic nerve

173

1.94

3.12

1.6

1.3

12.54

10.58

u/l

0.22

139

Hypoplasia of dental enamel, prenatal

3.26

3.12

2.8

2.5

3.17

2.92

u/l

—

Major anomalies of jaw size

345

1.66

3.12

1.7

1.6

11.81

9.06

u/l

0.62

282

Other congenital malformations, not elsewhere classified

140

2.10

3.11

2.2

2.1

11.59

6.17

u/l

0.71

105

Haemolytic anaemias

314

1.68

3.10

1.5

10.35

9.15

u/l

0.27

256

Other benign neoplasms of connective and other soft tissue

124

899

1.39

3.10

1.5

1.3

8.71

11.28

u/l

1.64

109

733

Other and unspecified paralytic syndromes

119

2.15

3.09

1.4

12.35

9.17

u/l

0.39

100

Malignant neoplasm of thyroid gland, including Hilmo

559

1.50

3.08

1.5

1.3

13.86

11.41

u/l

0.71

462

Right bundle-branch block

224

1.81

3.08

1.4

9.37

8.99

u/l

0.08

183

Malignant neoplasm of liver and intrahepatic bile ducts

132

2.07

3.08

1.3

1.4

8.18

7.17

u/l

0.28

108

Olecranon bursitis

527

1.51

3.08

1.3

1.4

8.36

6.67

u/l

0.83

423

Papulosquamous disorders

506

4328

1.17

3.08

1.4

10.51

10.48

u/l

0.02

411

3508

Vertical strabismus

338

1.65

3.08

1.6

1.4

10.81

9.85

u/l

0.15

267

Anxious personality disorder

324

1.68

3.07

1.4

6.55

8.37

u/l

0.86

270

Congenital malformations of uterus and cervix

371

1.63

3.07

1.1

1.3

7.92

11.01

u/l

1.99

299

Post-traumatic wound infection, not elsewhere classified

285

1.72

3.07

1.5

1.4

8.45

7.86

u/l

0.11

237

Moderate visual impairment, binocular

160

1.96

3.06

2.6

1.6

7.42

9.82

u/l

0.66

128

Pregnancy hypertension

743

5854

1.14

3.05

1.2

12.09

12.90

u/l

0.80

638

4847

Tobacco use

644

1.46

3.05

1.5

1.3

7.65

9.05

u/l

1.12

529

Need for other prophylactic measures

619

1.47

3.04

1.5

1.6

6.97

8.09

u/l

0.44

479

ILD, hospital admissions 3, with pneumonia sepsis

424

1.57

3.04

1.4

10.67

9.74

u/l

0.27

342

Congenital malformations of spine and bony thorax

108

2.26

3.03

1.4

2.0

8.06

9.17

u/l

0.16

Other salmonella infections

316

1.67

3.03

1.4

12.92

9.26

u/l

0.58

256

Atrophic disorders of skin

162

1229

1.33

3.02

1.5

1.4

12.29

12.77

u/l

0.14

127

1006

Von Willebrand disease

148

2.02

3.01

1.7

1.4

13.53

11.38

u/l

0.17

119

Acute pharyngitis

383

3185

1.20

3.01

1.4

1.5

7.61

7.64

u/l

0.02

307

2562

Intentional self-harm by unspecified means

228

1.82

3.01

1.4

1.5

6.81

8.96

u/l

1.16

192

Calcific tendinitis of shoulder

402

1.58

3.00

1.2

1.4

14.36

13.51

u/l

0.15

332

Injuries to the hip and thigh

579

4536

1.16

3.00

1.4

9.45

9.67

u/l

0.16

468

3675

Polymyalgia rheumatica

513

1.51

3.00

1.4

1.3

12.28

12.89

u/l

0.14

408

L04AX Other immunosuppressants

886

7889

1.13

3.00

1.5

1.4

11.00

10.23

u/l

0.86

736

6412

Spondyloarthritis

280

2275

1.24

3.00

1.4

10.22

9.56

u/l

0.33

233

1879

Pleural plaque with presence of asbestos

355

1.62

2.99

1.4

1.3

10.71

8.26

u/l

1.02

277

Vasculitis limited to skin, not elsewhere classified

176

1.90

2.98

1.3

1.4

12.92

9.03

u/l

0.81

138

Tooth eruption problems

469

3909

1.18

2.98

1.8

1.5

7.93

7.74

u/l

0.07

374

3170

Muscular dystrophy

2.41

2.98

2.4

1.8

7.79

8.17

u/l

0.04

Injury of muscle and tendon at hip and thigh level

136

1009

1.36

2.97

1.5

1.4

9.82

9.42

u/l

0.13

103

820

Other cataract

412

2622

1.19

2.96

1.4

11.70

11.40

u/l

0.16

330

2118

Malignant neoplasm of renal pelvis

4.85

2.95

1.1

1.2

17.31

7.88

u/l

—

Gonarthrosis,primary

952

5230

1.12

2.94

1.4

1.3

11.13

12.50

u/l

2.12

781

4248

Congenital malformations of spine and bony thorax

116

2.18

2.94

1.4

2.0

8.87

9.07

u/l

0.03

Abnormal serum enzyme levels

348

2821

1.21

2.93

1.4

7.89

8.33

u/l

0.31

281

2262

Cysts of oral region, not elsewhere classified

641

1.45

2.92

1.5

11.66

8.45

u/l

1.18

525

Striae atrophicae

136

2.05

2.92

1.3

12.97

10.61

u/l

0.30

109

Type 1 diabetes

480

4106

1.17

2.92

1.4

1.5

8.82

8.01

u/l

0.77

379

3305

Thyrotoxicosis with toxic single thyroid nodule

2.58

2.92

1.4

1.1

16.72

14.92

u/l

0.17

Disorders of breast

679

5407

1.14

2.91

1.3

1.2

14.59

13.84

u/l

0.60

579

4447

Acute appendicitis

1274

10829

1.10

2.90

1.4

9.24

9.74

u/l

0.69

1054

8908

Alzheimer’s disease (Late onset)

540

0.57

2.90

1.2

1.3

14.92

14.04

u/l

0.12

414

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

199

1.82

2.90

1.3

1.4

10.71

6.89

u/l

1.37

162

Dermatophytosis

160

1220

1.32

2.90

1.6

1.4

9.67

8.97

u/l

0.32

135

980

Fibrosis and cirrhosis of liver

510

1.50

2.90

1.4

12.39

10.18

u/l

0.44

409

Disturbances of smell and taste

297

1.67

2.89

1.2

1.3

11.99

12.00

u/l

0.00

238

Gluteal tendinitis

244

1.74

2.88

1.1

1.3

14.10

15.17

u/l

0.16

189

Other and unspecified epidermal thickening

260

1.72

2.87

1.5

1.4

11.71

8.16

u/l

0.60

206

Type 1 diabetes, wide definition

433

3680

1.18

2.87

1.4

1.6

9.06

7.98

u/l

1.03

338

2950

Alzheimer disease

775

0.67

2.87

1.3

13.42

13.04

u/l

0.07

606

Hard cardiovascular diseases

1110

5962

1.11

2.87

1.4

10.41

10.79

u/l

0.35

910

4775

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

2.41

2.86

1.8

14.69

7.25

u/l

0.86

Adverse effects, not elsewhere classified

361

3026

1.20

2.86

1.5

1.4

10.48

9.96

u/l

0.28

291

2452

Superficial injury of ankle and foot

263

2139

1.24

2.85

1.6

1.5

9.59

8.24

u/l

1.28

225

1708

Conductive and sensorineural hearing loss

946

5707

1.12

2.85

1.5

1.4

10.51

10.87

u/l

0.33

747

4621

Appendicitis, broad definition

1343

11084

1.10

2.85

1.4

9.36

9.76

u/l

0.52

1109

9118

Other disorders of prostate

186

1.85

2.85

1.6

1.3

5.24

6.40

u/l

0.58

157

Other specified/unspecified systemic involvement of connective tissue

456

1.53

2.84

1.3

1.4

12.18

12.15

u/l

0.01

368

Tongue abnormality

400

1.56

2.84

1.2

1.4

12.79

11.38

u/l

0.29

313

Ill-defined and unknown causes of mortality

440

1.53

2.82

1.4

8.57

8.46

u/l

0.03

347

Malignant neoplasm of eye and adnexa, including Hilmo

2.44

2.82

1.6

1.3

11.41

8.28

u/l

0.24

Volvulus

151

1.95

2.82

1.7

1.2

10.30

11.88

u/l

0.25

120

Iridocyclitis

314

2600

1.21

2.82

1.4

10.94

9.89

u/l

0.63

260

2112

Paraplegia, diplegia of upper limbs

180

1.87

2.81

1.5

10.08

9.10

u/l

0.16

144

Other symptoms and signs involving general sensations and perceptions

354

1.60

2.81

1.4

1.5

7.21

8.09

u/l

0.34

279

Other neurotic disorders

338

1.61

2.81

1.5

1.3

10.26

9.74

u/l

0.09

278

Dependent personality disorder

173

1.89

2.81

1.3

1.2

8.43

10.61

u/l

0.55

140

Other bursal cyst

2.21

2.80

1.0

1.2

16.29

11.38

u/l

0.54

Asthma mixed form (mode)

482

1.51

2.79

1.6

1.4

8.60

8.79

u/l

0.05

392

All kidney diseases

1789

11289

1.09

2.79

1.4

11.16

9.63

u/l

4.13

1465

9205

COPD, hospital admission 2, with asthma infections

264

1838

1.23

2.79

1.3

1.4

10.77

9.99

u/l

0.40

202

1472

Diseases of appendix

1348

11102

1.10

2.78

1.4

9.37

9.77

u/l

0.51

1113

9130

Other specified/unspecified arthritis

376

3169

1.19

2.78

1.4

11.16

10.42

u/l

0.47

308

2542

Mental retardation

687

1.43

2.77

2.5

1.8

7.23

6.89

u/l

0.13

494

Myocarditis

491

1.50

2.77

1.7

1.4

11.49

7.86

u/l

0.96

401

Other abnormal findings of blood chemistry

419

1.55

2.77

1.5

1.3

10.64

9.26

u/l

0.26

342

Mental retardation, wide definition

704

1.42

2.77

2.5

1.8

7.48

6.97

u/l

0.20

508

Drug-induced hypopituitarism

4.89

2.77

3.3

1.9

8.53

5.16

u/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

364

1.59

2.76

1.4

1.5

7.80

8.63

u/l

0.29

301

Fracture of femur

206

1478

1.27

2.76

1.5

1.4

10.55

9.96

u/l

0.23

166

1187

Presence of other functional implants

512

3057

1.16

2.76

1.4

1.3

12.83

11.63

u/l

0.85

416

2449

631

1.45

2.75

2.3

2.2

5.74

5.81

u/l

0.03

414

Otalgia

127

946

1.36

2.74

1.5

10.23

10.35

u/l

0.04

729

Autoimmune diseases excluding thyroid diseases, strict definition

1862

9426

1.08

2.74

1.4

9.88

8.93

u/l

2.39

1533

7657

Anaemia in chronic diseases classified elsewhere

160

1.91

2.74

1.6

1.4

16.06

8.09

u/l

1.06

120

Disorders in reading

376

1.60

2.73

2.0

1.9

5.23

6.62

u/l

1.15

295

Foreign body on external eye

270

2213

1.23

2.73

1.4

1.5

7.56

6.58

u/l

0.79

219

1812

Palmar fascial fibromatosis [Dupuytren]

127

945

1.35

2.72

1.4

9.50

8.99

u/l

0.17

103

762

Other disorders of amniotic fluid and membranes

338

2766

1.20

2.72

1.1

1.3

10.08

11.09

u/l

0.92

297

2246

Sixth [abducent] nerve palsy

234

1.73

2.71

2.3

1.5

11.71

9.53

u/l

0.37

178

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

295

1.65

2.71

1.2

1.4

9.86

9.17

u/l

0.12

239

Major coronary heart disease event

1002

5438

1.11

2.70

1.4

10.36

10.56

u/l

0.16

828

4348

Congenital deformities of feet

391

1.57

2.70

1.6

8.77

8.52

u/l

0.05

311

Chronic periodontitis, including avohilmo

1492

9176

1.09

2.70

1.4

11.15

10.12

u/l

1.89

1203

7566

Mesial bite

177

1.88

2.69

1.8

7.11

8.29

u/l

0.34

145

Suggestive for eosinophilic asthma

104

752

1.39

2.69

1.5

1.4

11.10

9.20

u/l

0.60

613

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

175

1.84

2.69

1.2

1.3

9.21

8.79

u/l

0.07

143

Tooth agenesis EXCLUDE clefts and syndromes

120

893

1.37

2.68

2.0

1.7

6.50

7.89

u/l

1.31

696

Bilateral sagittal split ramus osteotomy operation

472

1.51

2.68

1.2

1.4

11.90

10.49

u/l

0.33

388

Dystonia

471

1.50

2.67

1.4

7.90

10.91

u/l

1.44

384

Congenital malformations of eyelid, lacrimal apparatus and orbit

156

1.94

2.66

1.9

2.2

6.61

6.93

u/l

0.08

122

Autoimmune hyperthyroidism

612

1.44

2.65

1.4

1.3

11.94

12.15

u/l

0.04

510

Disorders of iron metabolism

134

1.98

2.64

1.8

1.3

3.53

7.13

u/l

3.61

111

Other puerperal infections

221

1784

1.25

2.64

1.1

1.3

10.32

9.93

u/l

0.16

174

1480

Recurrent dislocation of patella

137

1041

1.34

2.64

1.4

10.51

9.17

u/l

0.47

106

855

Benign neoplasm: Cranial nerves

184

1.82

2.63

1.5

1.3

12.89

10.68

u/l

0.24

149

Asthma mixed form (mode), excluding more controls

489

1.49

2.63

1.6

1.4

8.60

8.72

u/l

0.03

396

Oral lichen planus, including avohilmo , including avohilmo

408

1.53

2.62

1.3

11.40

12.82

u/l

0.31

325

Residual foreign body in soft tissue

606

1.44

2.61

1.3

1.4

6.66

7.66

u/l

0.60

493

Hepatic failure, not elsewhere classified

275

1.66

2.61

1.3

1.4

8.37

9.25

u/l

0.18

223

Other mental disorders due to brain damage and dysfunction and to physical disease

680

1.40

2.61

1.4

10.49

9.93

u/l

0.15

547

Other necrotizing vasculopathies (FG)

337

1.59

2.60

1.4

13.71

11.32

u/l

0.43

272

Extracorporeal dialysis

548

1.46

2.60

1.7

1.5

13.07

7.68

u/l

1.63

434

Graves disease, strict definition

157

1216

1.30

2.59

1.5

1.3

10.97

12.07

u/l

0.44

132

1021

Monoplegia

121

2.03

2.59

1.4

1.2

14.43

10.13

u/l

0.53

severe traumatic brain injury, does not include concussion

225

1817

1.24

2.59

1.4

8.04

8.73

u/l

0.44

181

1458

Other and unspecified psoriasis

565

1.45

2.59

1.5

1.4

13.36

10.09

u/l

0.94

447

Other and unspecified injuries of abdomen, lower back and pelvis

186

1.82

2.59

1.4

1.5

9.43

8.99

u/l

0.07

156

Congenital deformities of feet

609

1.44

2.58

1.5

7.75

8.37

u/l

0.19

487

Helminthiases

609

1.44

2.58

1.3

1.5

9.93

9.04

u/l

0.24

481

Phlebitis and thrombophlebitis (not including DVT)

257

2108

1.22

2.57

1.5

1.3

11.89

11.13

u/l

0.32

206

1735

Osteomyelitis

533

1.46

2.56

1.5

10.46

8.04

u/l

0.96

432

Contact with other sharp object(s)

149

1151

1.31

2.55

1.4

1.5

7.38

8.00

u/l

0.32

120

930

D07AA Corticosteroids, weak (group I)

324

2719

1.20

2.54

1.5

9.33

9.10

u/l

0.14

257

2165

Other congenital malformations of circulatory system

239

1.70

2.54

1.9

1.3

13.25

9.59

u/l

0.50

193

Late syphilis

129

1.98

2.54

1.2

1.3

8.86

7.68

u/l

0.24

106

Periodontitis

1494

9197

1.09

2.54

1.4

11.15

10.12

u/l

1.89

1202

7584

Spontaneous rupture of synovium and tendon

542

1.45

2.53

1.3

1.4

12.27

11.37

u/l

0.22

437

Bruxism

240

1.71

2.53

1.6

1.3

14.47

11.21

u/l

0.48

191

Overjet

585

1.45

2.53

2.0

2.1

6.17

6.91

u/l

0.33

420

Retinal breaks without detachment

150

1158

1.30

2.52

1.4

1.3

12.26

11.58

u/l

0.19

119

935

Maternal care for other conditions predominantly related to pregnancy

462

3922

1.16

2.52

1.2

11.07

11.82

u/l

0.59

385

3221

Puerperal sepsis

125

942

1.33

2.50

1.2

15.39

16.37

u/l

0.27

105

784

Chronic pancreatitis

142

1090

1.31

2.50

1.3

1.4

9.97

7.80

u/l

1.30

114

879

Social disorders starting during childhood or adolescence

205

1.79

2.50

2.0

1.8

5.03

7.01

u/l

1.11

151

Congenital malformations of eye, ear, face and neck

148

1146

1.31

2.50

1.7

1.6

8.98

8.40

u/l

0.19

116

896

Benign neoplasm: Skin of other and unspecified parts of face

103

754

1.37

2.49

1.6

1.3

11.01

11.29

u/l

0.07

613

Peroneal tendinitis

137

1.94

2.49

1.2

1.3

9.32

12.22

u/l

0.56

108

Toxic liver disease

130

1.96

2.49

1.5

1.2

14.05

9.55

u/l

0.66

104

Other specified/unspecified hearing loss

545

1.44

2.47

1.3

1.4

9.98

10.59

u/l

0.14

445

Bacterial, viral and other infectious agents

168

1323

1.28

2.47

1.5

1.4

8.36

7.76

u/l

0.24

127

1075

Mild mental retardation

433

1.51

2.46

2.5

1.8

6.92

7.42

u/l

0.18

328

Family history of certain disabilities and chronic diseases leading to disablement

109

810

1.36

2.46

1.4

9.11

9.31

u/l

0.06

100

666

Allergic urticaria

147

1139

1.30

2.45

1.5

10.73

9.82

u/l

0.32

119

901

Other disorders of ear

1358

8166

1.09

2.45

1.5

1.4

10.23

10.51

u/l

0.30

1076

6621

Benign neoplasm: Transverse colon

655

1.40

2.44

1.4

1.3

10.58

10.51

u/l

0.02

529

Parkinson's disease, strict definition, excluding more controls

464

1.46

2.44

1.3

9.79

11.76

u/l

0.88

377

Other vitreous opacities

257

1.65

2.44

1.5

1.2

16.84

10.17

u/l

0.99

199

Maxillary retrognathism

338

1.58

2.43

1.7

1.8

8.23

7.89

u/l

0.07

260

Infective dermatitis

143

1105

1.30

2.42

1.4

9.97

9.92

u/l

0.02

117

899

Postpartum haemorrhage due to retained placenta

289

2419

1.20

2.41

1.2

11.17

11.65

u/l

0.27

257

2063

Bacterial pneumonia (organism specified)

557

4436

1.14

2.41

1.5

1.4

10.03

9.35

u/l

0.63

461

3593

Other specified/unspecified disorders of bone/cartilage

235

1.68

2.41

1.5

1.4

6.70

9.11

u/l

0.96

192

Other nonscarring hair loss

104

2.08

2.41

1.1

1.3

7.55

11.57

u/l

1.10

Cholangitis (primary sclerosing, PSC)

507

1.45

2.41

1.3

1.5

8.33

8.54

u/l

0.04

399

Unspecified urinary incontinence

515

1.45

2.40

1.4

14.65

13.37

u/l

0.18

408

Oral leukoplakia, including avohilmo

190

1.76

2.40

1.4

13.10

8.86

u/l

0.59

152

N06DA Anticholinesterases

1022

0.73

2.39

1.4

1.3

10.75

12.77

u/l

0.79

803

Use of anticholinesterases

1022

0.73

2.39

1.4

1.3

10.75

12.77

u/l

0.79

803

Superficial injuries involving multiple body regions

330

1.57

2.39

1.3

1.4

9.49

8.13

u/l

0.27

266

Other disorders of veins

438

3767

1.16

2.39

1.3

12.71

13.42

u/l

0.42

341

3091

Primary gonarthrosis, bilateral

396

2906

1.17

2.39

1.3

11.94

13.37

u/l

1.15

321

2336

Disorders resulting from impaired renal tubular function

298

1.60

2.38

1.8

1.6

12.57

8.54

u/l

0.93

235

Other other unspecified disorders of the circulatory system

228

1.68

2.38

1.3

1.4

17.66

11.95

u/l

1.04

172

Chronic lymphocytic leukaemia

2.08

2.38

1.2

1.3

15.67

6.21

u/l

1.97

Chronic lymphocytic leukaemia, helper endpoint

2.08

2.38

1.2

1.3

15.67

6.21

u/l

1.97

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.08

2.38

1.2

1.3

15.67

6.21

u/l

1.97

Spondylopathies (FG)

241

1984

1.22

2.38

1.4

9.67

9.43

u/l

0.10

202

1644

Other/unspecified enthesopathies of lower limb, excluding foot

702

1.38

2.37

1.5

1.4

10.32

10.75

u/l

0.12

578

Sacroiliitis, not elsewhere classified

729

1.38

2.37

1.5

1.4

9.17

8.77

u/l

0.11

600

Diabetic nephropathy, excluding more controls

147

1545

0.78

2.36

1.3

1.4

9.94

8.16

u/l

1.12

111

1272

Chondropathies

258

2141

1.21

2.35

1.5

1.4

8.73

9.22

u/l

0.28

202

1751

Other necrotizing vasculopathies

419

1.49

2.35

1.4

15.45

10.39

u/l

1.13

338

Dermatographic urticaria

111

833

1.35

2.34

1.6

1.3

11.62

10.66

u/l

0.26

684

Personal history of risk-factors, not elsewhere classified

200

1.75

2.34

1.6

1.4

5.59

7.73

u/l

1.57

158

Injuries to unspecified part of trunk, limb or body region

148

1155

1.29

2.34

1.6

1.5

7.75

9.06

u/l

0.90

116

934

Acute alcohol intoxication

392

3373

1.17

2.33

1.4

9.04

7.98

u/l

1.03

303

2769

Motorcycle rider injured in other and unspecified transport accidents

136

1053

1.31

2.33

1.4

1.5

6.55

6.77

u/l

0.12

112

859

Early syphilis

178

1.79

2.32

1.5

1.6

8.48

6.32

u/l

0.47

153

Unspecified event, undetermined intent

325

1.57

2.31

1.4

7.52

8.54

u/l

0.22

265

Other congenital malformations of brain

2.21

2.31

2.2

2.1

7.86

7.89

u/l

—

Other immunodeficiencies

127

1.94

2.31

1.4

12.74

11.53

u/l

0.14

Fasciculation

127

1.94

2.31

1.4

1.2

7.57

10.77

u/l

0.84

105

Emphysema

372

1.51

2.30

1.3

7.45

9.29

u/l

0.83

296

Corneal ulcer

295

2484

1.19

2.30

1.5

1.4

10.38

9.23

u/l

0.73

250

2036

Lesion of plantar nerve

285

1.59

2.28

1.2

1.3

12.13

16.38

u/l

1.10

235

Type of accident

474

4143

1.15

2.28

1.4

9.55

9.00

u/l

0.46

392

3362

Supplementary factors related to causes of morbidity and mortality classified elsewhere

524

4612

1.14

2.28

1.4

9.79

8.86

u/l

0.94

432

3754

Acute and subacute iridocyclitis

261

2175

1.21

2.27

1.4

11.52

9.90

u/l

0.94

216

1775

Other acute viral hepatitis

172

1.79

2.26

1.6

1.4

10.62

8.82

u/l

0.25

139

Bacterial pneumoniae

519

4020

1.14

2.26

1.5

1.4

9.96

9.21

u/l

0.71

431

3283

Renal tubulo-interstitial diseases

1406

9675

1.08

2.26

1.4

11.43

10.12

u/l

2.47

1139

7875

Other/unspecified synovitis and tenosynovitis

147

1152

1.28

2.25

1.3

9.96

10.66

u/l

0.28

119

943

Open wound of head

828

7212

1.11

2.25

1.4

1.5

8.45

8.53

u/l

0.07

638

5812

Other infective otitis externa

599

1.40

2.25

1.3

1.4

10.74

9.63

u/l

0.36

483

Benign neoplasm of breast

119

907

1.32

2.25

1.3

16.52

15.43

u/l

0.29

744

Ulcerative enterocolitis

368

1.52

2.23

1.2

1.3

6.81

8.51

u/l

0.80

299

Defects in the complement system

2.15

2.23

1.2

1.5

10.43

10.80

u/l

0.04

Other and unspecified mononeuropathies of upper limb

249

1.63

2.21

1.4

8.43

9.69

u/l

0.23

212

Open wound of hip and thigh

468

1.45

2.21

1.5

7.28

7.62

u/l

0.13

382

Dementia in Alzheimer disease

417

0.59

2.21

1.3

16.58

12.59

u/l

0.68

321

Other arthritis (FG)

433

3772

1.15

2.19

1.4

11.15

10.42

u/l

0.52

354

3052

Degeneration of macula and posterior pole

302

2029

1.19

2.19

1.3

1.4

13.11

12.27

u/l

0.36

231

1626

SLE (Finngen)

281

1.58

2.19

1.4

11.35

11.73

u/l

0.05

228

Injury of nerves and spinal cord at neck level

196

1.71

2.18

1.5

8.28

7.48

u/l

0.19

159

Diseases of peritoneum

103

773

1.34

2.17

1.3

1.4

13.00

10.84

u/l

0.56

630

Tubulo-interstitial nephritis, not specified as acute or chronic

535

1.41

2.17

1.3

11.20

11.29

u/l

0.02

421

ILD, hospital admissions 1, main diag only

103

773

1.34

2.17

1.4

11.24

10.50

u/l

0.22

621

Other or ill-defined heart diseases

519

1.42

2.16

1.3

1.5

8.26

7.45

u/l

0.24

435

Other infectious diseases

105

792

1.33

2.15

1.3

1.4

10.64

9.36

u/l

0.46

651

Coronary atherosclerosis

630

3547

1.13

2.15

1.4

9.70

9.91

u/l

0.14

511

2864

Intracranial and intraspinal abscess and granuloma

2.09

2.14

1.6

1.3

6.23

8.63

u/l

0.60

Traumatic subarachnoid haemorrhage

189

1.71

2.14

1.3

1.4

8.78

8.55

u/l

0.05

151

Meralgia paraesthetica

259

1.60

2.14

1.3

9.59

9.99

u/l

0.07

218

Overexertion and strenuous or repetitive movements

155

1234

1.27

2.13

1.4

8.44

8.75

u/l

0.13

124

996

Alcohol abuse, main dg

271

2284

1.19

2.13

1.4

8.71

7.72

u/l

0.66

210

1854

Hydronephrosis

120

924

1.31

2.12

1.6

1.4

15.13

9.62

u/l

2.34

114

753

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

214

1.68

2.12

1.3

1.5

7.61

7.52

u/l

0.02

179

Other disorders of conjunctiva

129

1003

1.29

2.12

1.4

12.22

11.35

u/l

0.27

112

820

Other and unspecified injuries of lower leg

134

1049

1.29

2.12

1.4

1.5

9.39

9.05

u/l

0.11

117

858

Degenerative macular diseases

588

1.38

2.11

1.4

13.04

11.35

u/l

0.34

479

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

176

1.75

2.11

1.7

1.4

11.48

8.84

u/l

0.30

147

Postpartum haemorrhage due to anatomy

302

2576

1.18

2.10

1.2

9.81

9.85

u/l

0.02

264

2206

Convalescence

447

1.44

2.10

1.3

9.79

11.43

u/l

0.50

364

Episcleritis

531

1.41

2.09

1.4

10.94

10.88

u/l

0.01

437

Acute inflammation of orbit

2.25

2.09

1.5

11.55

7.60

u/l

—

Somnolence

154

1.80

2.08

1.3

1.4

6.63

9.31

u/l

1.10

129

Myositis

191

1.70

2.08

1.9

1.5

7.72

9.05

u/l

0.39

149

Intermittent heterotropia

138

1087

1.28

2.08

2.2

1.6

5.68

7.94

u/l

3.06

108

820

Calculus of lower urinary tract

357

1.50

2.08

1.4

11.31

8.31

u/l

1.02

292

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

768

4376

1.11

2.07

1.4

1.3

11.88

10.62

u/l

1.42

625

3631

Ankylosing spondylitis

127

990

1.29

2.07

1.3

1.4

8.18

8.89

u/l

0.29

103

809

Acquired absence of limb

2.37

2.07

1.4

1.2

9.09

5.97

u/l

—

Haemangioma, any site

109

833

1.32

2.06

1.4

9.37

10.89

u/l

0.61

673

Coeliac disease

185

1508

1.23

2.06

1.5

11.08

9.96

u/l

0.43

147

1199

Parkinson's disease, excluding more controls

508

1.40

2.05

1.3

9.68

11.89

u/l

1.09

411

Papillary adenocarcinoma of thyroid gland

342

1.50

2.05

1.6

1.3

14.77

11.01

u/l

0.85

277

5-aminosalicylic acid

381

3310

1.16

2.05

1.4

8.47

8.60

u/l

0.09

318

2726

Retinoschisis and retinal cysts

125

1.86

2.04

1.2

1.3

14.16

8.52

u/l

0.73

Conductive hearing loss, unspecified

111

852

1.31

2.04

1.5

9.97

9.86

u/l

0.03

684

Other fall from one level to another

409

3572

1.15

2.03

1.6

1.5

9.06

8.05

u/l

0.96

327

2850

Mumps

271

1.57

2.03

1.2

1.3

14.11

9.00

u/l

0.69

223

Other superficial mycoses

207

1711

1.22

2.03

1.3

1.4

7.83

8.56

u/l

0.51

164

1406

Ulcerative ileocolitis

535

1.40

2.03

1.6

1.4

8.38

8.74

u/l

0.08

444

Necrosis of pulp, including avohilmo

1057

9696

1.09

2.03

1.4

9.77

9.78

u/l

0.01

861

7986

Single spontaneous delivery

477

2870

0.88

2.02

1.2

1.3

11.75

11.81

u/l

0.04

394

2260

Haemangioma and lymphangioma, any site

119

923

1.30

2.02

1.4

9.52

10.63

u/l

0.40

743

Asthma/COPD (KELA code 203)

1782

11440

1.07

2.02

1.4

9.97

9.50

u/l

0.78

1458

9335

Decubitus ulcer and pressure area

335

1.50

2.02

1.2

1.4

10.15

8.07

u/l

0.68

265

Viral pneumonia

174

1413

1.24

2.01

1.5

1.4

9.12

8.58

u/l

0.22

135

1129

Assault by hanging, strangulation and suffocation

2.63

2.01

1.2

1.5

13.70

8.99

u/l

—

Benign neoplasm: Skin of eyelid, including canthus

133

1047

1.28

2.00

1.3

1.4

12.66

12.45

u/l

0.05

847

Dermatitis due to ingested food

117

873

1.31

2.00

2.0

1.9

5.99

6.94

u/l

1.09

639

Covid-19 suspected case

430

3776

1.14

2.00

1.3

1.4

11.38

9.32

u/l

1.97

347

3092

Cerebral aneurysm, nonruptured

595

1.37

1.99

1.6

1.3

11.04

12.09

u/l

0.24

482

Struck by thrown, projected or falling objec

717

1.34

1.99

1.3

1.5

6.03

7.41

u/l

1.34

584

Other articular cartilage disorders

171

1.72

1.98

1.3

1.4

8.32

9.67

u/l

0.26

134

Traumatic ischaemia of muscle

149

1.79

1.98

1.4

6.15

8.96

u/l

1.18

121

Injury of unspecified body region

107

821

1.31

1.98

1.5

8.08

8.98

u/l

0.39

656

Other diseases of oesophagus

690

1.34

1.98

1.4

10.53

9.55

u/l

0.25

560

STROKE

663

4049

1.12

1.97

1.4

11.17

10.74

u/l

0.31

531

3311

Excessive earwax

687

6049

1.11

1.97

1.5

1.4

8.66

9.81

u/l

1.64

543

4866

Basal cell carcinoma, including avohilmo

303

1779

1.18

1.97

1.3

12.92

10.78

u/l

1.58

240

1402

Bacterial pneumonia, not elsewhere classified

478

3718

1.13

1.97

1.5

1.4

10.08

9.32

u/l

0.64

398

3035

Idiopathic gout

605

1.36

1.97

1.4

8.35

7.54

u/l

0.25

486

Type1 diabetes, definitions combined, early onset

142

1760

0.79

1.96

1.5

1.7

7.12

7.07

u/l

0.02

109

1359

Carcinoma in situ of breast, intraductal

337

1.49

1.96

1.1

1.2

20.53

21.82

u/l

0.21

272

Crohn's disease NAS

117

911

1.30

1.96

1.3

1.5

8.80

8.44

u/l

0.12

732

Glomerulonephritis

130

1025

1.28

1.95

1.6

1.5

12.33

8.45

u/l

1.73

114

819

Ankylosis of joint

3.04

1.95

1.4

1.2

6.65

6.39

u/l

—

Acute appendicitis, no complications

1041

9544

1.09

1.95

1.5

1.4

9.29

9.67

u/l

0.43

868

7863

Colectomy operation

152

1220

1.25

1.95

1.4

12.66

10.00

u/l

1.05

123

994

Arthropod-borne viral fevers and viral haemorrhagic fevers

122

955

1.29

1.95

1.4

11.71

8.73

u/l

1.36

101

778

Crohn's disease of large intestine

694

1.34

1.94

1.4

8.35

8.74

u/l

0.13

569

Pneumonia due to Streptococcus pneumoniae

388

1.46

1.94

1.4

1.5

10.66

8.18

u/l

0.69

322

Burns and corrosions

250

2113

1.19

1.94

1.4

1.5

8.60

7.86

u/l

0.60

193

1700

Bursitis of shoulder

180

1.69

1.93

1.3

8.96

10.11

u/l

0.25

145

Unspecified privation

146

1169

1.26

1.93

1.2

1.4

8.95

8.83

u/l

0.04

113

948

Foreign body in respiratory tract

591

1.37

1.93

1.8

1.5

12.89

9.32

u/l

1.23

458

Assault by other specified means

151

1.77

1.92

1.2

1.4

10.38

7.76

u/l

0.57

126

Foreign body in alimentary tract

566

1.37

1.92

1.6

10.47

8.50

u/l

0.45

449

Maternal care for known or suspected malpresentation of fetus

483

3101

1.14

1.91

1.2

1.3

11.30

11.78

u/l

0.32

425

2515

Scleritis and episcleritis

618

1.35

1.90

1.4

10.44

11.06

u/l

0.11

506

Other retinal disorders

702

4944

1.11

1.90

1.4

10.88

9.94

u/l

0.91

547

4006

Helminthiases

174

1.70

1.89

1.2

1.6

11.87

9.63

u/l

0.36

141

Crowding of teeth, including avohilmo

279

1972

1.18

1.89

2.0

1.6

6.71

7.91

u/l

1.57

214

1536

Other inflammation of vagina/vulva

509

1.39

1.88

1.2

11.26

11.44

u/l

0.04

424

Benign neoplasm of middle ear and respiratory system

619

1.35

1.88

1.2

1.4

9.47

9.35

u/l

0.03

497

Other noninflammatory disorders of cervix uteri

151

1.73

1.87

1.1

1.2

21.52

22.27

u/l

0.06

114

Chalazion

160

1301

1.24

1.86

1.6

1.4

9.07

9.83

u/l

0.31

121

1054

Kidney transplant status

630

1.35

1.86

1.9

1.6

10.81

7.05

u/l

1.66

503

Acute gastritis

543

1.37

1.86

1.2

1.4

11.02

10.08

u/l

0.17

446

Other disorders of binocular movement

327

1.49

1.85

1.4

16.79

9.47

u/l

0.42

269

Fracture of shoulder and upper arm

465

4119

1.13

1.85

1.6

1.5

9.55

9.28

u/l

0.18

386

3301

Other and unspecified mononeuropathies of lower limb

167

1.69

1.85

1.5

1.2

11.18

12.64

u/l

0.14

133

Disorders of optic nerve, not elsewhere classified

137

1.78

1.85

2.1

1.2

19.80

8.95

u/l

0.70

106

ILD, hospital admissions

112

873

1.29

1.85

1.4

10.94

10.40

u/l

0.16

705

Acute peritonitis

493

1.39

1.84

1.3

1.4

13.57

9.02

u/l

1.01

400

Acanthosis nigricans

2.69

1.84

1.4

9.68

7.73

u/l

—

Congenital malformations of the respiratory system

191

1.65

1.84

1.6

2.1

8.44

8.26

u/l

0.03

138

Other diseases of spinal cord

254

1.55

1.83

1.5

8.55

9.10

u/l

0.12

207

Carcinoma in situ of skin

351

1.46

1.83

1.4

1.3

9.95

11.64

u/l

0.44

273

Other congenital malformations of the digestive system

697

1.33

1.83

1.8

1.9

8.23

7.67

u/l

0.17

490

Nonsuppurative otitis media

619

4834

1.11

1.82

1.6

1.5

7.54

7.95

u/l

0.51

493

3907

COPD, hospital admissions 3, with asthma pneumonia sepsis

193

1365

1.21

1.82

1.3

1.4

10.88

10.25

u/l

0.26

150

1095

Superficial injury of thorax

202

1685

1.20

1.82

1.4

8.52

8.95

u/l

0.23

156

1373

Failed attempted abortion

216

1.62

1.82

1.2

11.40

12.67

u/l

0.18

182

Arthropod-borne viral fevers and viral haemorrhagic fevers

251

2134

1.18

1.81

1.5

1.4

10.90

9.13

u/l

1.10

194

1705

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

333

1955

1.16

1.81

1.3

13.32

10.52

u/l

2.55

263

1544

Open wound of abdomen, lower back and pelvis

437

1.42

1.81

1.4

1.5

7.55

7.49

u/l

0.01

361

Conduct disorder

455

1.41

1.81

1.5

1.7

9.07

7.05

u/l

0.67

357

Open wound of ankle and foot

173

1425

1.22

1.79

1.3

1.5

8.50

7.76

u/l

0.41

140

1137

Scar conditions and fibrosis of skin

437

1.41

1.79

1.7

1.4

11.24

10.48

u/l

0.13

352

Acute lymphadenitis

107

835

1.29

1.79

1.7

1.5

8.27

8.82

u/l

0.17

671

Benign neoplasm of bone and articular cartilage

123

977

1.27

1.78

1.4

10.17

9.75

u/l

0.13

105

811

Diseases of arteries, arterioles and capillaries

681

4558

1.11

1.77

1.4

11.35

9.95

u/l

1.56

541

3711

Ascites

454

1.40

1.77

1.4

14.69

10.00

u/l

1.77

365

Personal history of certain other diseases

356

1.46

1.77

1.6

1.3

7.49

8.63

u/l

0.35

292

Contusion of other and unspecified parts of foot

110

864

1.29

1.77

1.6

1.5

8.20

8.32

u/l

0.05

687

Other diseases of gallbladder

248

1.54

1.76

1.3

11.67

10.70

u/l

0.18

194

Inflammatory bowel disease

554

4983

1.12

1.76

1.4

8.90

8.93

u/l

0.02

461

4066

Viral haemorrhagic fevers, not elsewhere classified/unspecified

221

1864

1.19

1.76

1.5

10.87

9.07

u/l

1.00

168

1488

Polyarthritis, unspecified

289

1.50

1.76

1.4

12.83

10.29

u/l

0.49

228

Crohn disease (strict definition, require KELA)

124

989

1.27

1.75

1.5

6.93

8.33

u/l

0.95

104

817

Other infectious diseases

627

1.33

1.75

1.3

1.4

10.87

9.20

u/l

0.54

505

Eustachian salpingitis and obstruction

173

1431

1.22

1.75

1.4

8.59

8.33

u/l

0.09

137

1173

Mixed connective tissue disease

524

1.37

1.74

1.3

11.92

12.67

u/l

0.17

422

Unspecified visual impairment (binocular)

140

1.74

2.1

1.7

7.15

8.08

u/l

0.21

108

Additional codes for the location of defect, injury or illness

576

1.35

1.74

1.5

9.44

9.48

u/l

0.01

467

Fracture of neck

473

1.38

1.74

1.4

8.77

8.07

u/l

0.19

381

Childhood allergy (age < 16)

563

4183

1.12

1.74

1.7

1.5

6.71

7.37

u/l

1.43

445

3376

Bronchiectasis

355

1.44

1.74

1.4

13.36

11.99

u/l

0.20

283

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

150

1221

1.23

1.74

1.4

11.05

8.24

u/l

1.34

111

981

Anterior Iridocyclitis

271

2329

1.17

1.74

1.4

11.55

9.88

u/l

1.01

223

1898

Other osteochondropathies

113

892

1.28

1.73

1.6

1.5

9.04

9.09

u/l

0.01

735

Superficial injury of hip and thigh

161

1320

1.22

1.73

1.3

1.4

10.14

9.37

u/l

0.35

136

1080

Benign neoplasm: Choroid

364

1.44

1.73

1.6

1.3

10.61

11.98

u/l

0.29

291

Other diseases of pancreas

559

1.35

1.73

1.2

1.4

10.02

9.23

u/l

0.20

456

Flatulence and related conditions

1.95

1.72

1.5

1.6

8.52

9.43

u/l

0.10

Psoriasis

374

3291

1.14

1.72

1.4

9.90

9.92

u/l

0.01

301

2662

Duodenal ulcer

628

1.33

1.72

1.3

1.4

12.22

9.01

u/l

1.09

507

Leisure time condition

276

2378

1.17

1.72

1.4

1.5

9.18

9.02

u/l

0.08

230

1930

Meningitis

543

1.36

1.72

1.8

1.4

11.44

9.02

u/l

0.65

441

Radial styloid tenosynovitis [de Quervain]

586

1.34

1.72

1.2

1.3

11.11

11.99

u/l

0.23

485

Other superficial mycoses

267

1.52

1.72

1.5

1.4

8.64

8.81

u/l

0.03

218

Hypertrophy of breast

219

1852

1.19

1.71

1.2

1.3

14.52

15.49

u/l

0.41

185

1513

Simple and mucopurulent chronic bronchitis

226

1.56

1.71

1.5

8.01

9.47

u/l

0.35

176

Hyperkinetic disorders (excl. ADHD)

439

1.41

1.71

1.5

2.0

6.63

6.23

u/l

0.10

316

Interstitial lung disease endpoints

112

885

1.27

1.69

1.4

10.94

10.38

u/l

0.17

713

Interstitial lung disease

112

885

1.27

1.69

1.4

10.94

10.38

u/l

0.17

713

Other interstitial pulmonary diseases

112

885

1.27

1.69

1.4

10.94

10.39

u/l

0.16

712

Cardiodefibrillation

293

2532

1.16

1.68

1.4

9.44

9.13

u/l

0.15

232

2027

Behavioural disorders

470

1.39

1.68

1.5

1.7

9.07

7.22

u/l

0.59

368

Crohn disease (strict definition, require KELA, min 2 HDR)

122

977

1.26

1.68

1.4

1.5

7.00

8.22

u/l

0.77

102

806

Cardiovascular disorders originating in the perinatal period

106

1.92

1.68

2.2

2.6

9.67

5.11

u/l

0.47

Perioral dermatitis

236

1.55

1.68

1.2

1.3

16.56

10.29

u/l

0.87

194

Secondary thrombocytopenia

1.92

1.67

1.4

11.23

9.01

u/l

0.27

Ulcerative colitis, NAS

237

2024

1.18

1.67

1.4

1.5

8.84

8.93

u/l

0.04

197

1641

Benign leiomyoma with endometriosis

107

842

1.28

1.67

1.2

20.73

18.83

u/l

0.46

688

Glomerular disorders in diseases classified elsewhere

141

1147

1.24

1.66

1.4

10.55

8.16

u/l

1.48

106

937

Chondrocostal junction syndrome [Tietze]

351

1.44

1.66

1.4

1.3

11.45

10.51

u/l

0.18

284

Myotonic dystrophy (Steinert)

2.51

1.66

2.0

1.3

12.24

8.72

u/l

—

Abnormal spermatozoa

119

950

1.26

1.66

1.4

8.71

6.90

u/l

0.61

772

L02BB Anti-androgens

514

0.66

1.66

2.5

1.3

8.18

8.15

u/l

0.01

416

558

1.35

1.66

2.4

2.2

5.92

5.98

u/l

0.02

359

Acute alcohol intoxication, ICD10

341

2993

1.14

1.66

1.4

8.84

7.71

u/l

1.01

261

2450

Scabies

634

1.32

1.66

1.8

1.5

7.97

7.79

u/l

0.06

513

Muscle strain

360

1.43

1.65

1.7

1.4

8.30

8.43

u/l

0.03

297

Other noninfective disorders of lymphatic vessels and lymph nodes

277

1.49

1.65

1.4

1.3

12.12

10.48

u/l

0.31

221

Erythema nodosum

261

1.51

1.65

1.5

1.3

13.13

10.49

u/l

0.56

212

Impacted maxillary molar

188

1580

1.20

1.65

1.4

7.46

8.09

u/l

0.51

157

1315

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

750

1.30

1.65

1.7

1.6

7.73

7.81

u/l

0.02

560

Other and unspecified haemorrhagic conditions

135

1.73

1.64

1.2

1.4

14.04

10.03

u/l

0.66

106

Other and unspecified intracranial injuries

294

1.48

1.64

1.4

11.56

8.55

u/l

0.62

236

Speech disturbances, not elsewhere classified

634

1.32

1.63

1.5

1.4

9.90

9.87

u/l

0.01

515

Other disorders originating in the perinatal period

256

1.54

1.63

1.9

2.2

5.94

6.95

u/l

0.30

149

Infliximab

304

1.48

1.63

1.3

1.5

7.00

7.54

u/l

0.15

257

Anogenital herpesviral [herpes simplex] infection

142

1162

1.23

1.62

1.5

1.3

7.89

9.30

u/l

0.93

112

979

Benign neoplasm: Liver

238

1.53

1.62

1.2

10.65

10.97

u/l

0.05

192

Perforation of oesophagus

2.57

1.61

1.3

1.2

17.55

6.96

u/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

645

1.32

1.61

2.1

1.8

6.12

7.36

u/l

0.81

490

conjunctival haemorrhage

463

1.37

1.61

1.5

1.3

13.87

10.79

u/l

0.88

376

Xerosis cutis

106

1.82

1.60

1.2

13.79

8.01

u/l

0.87

Other/unspecified enthesopathies, not elsewhere classified

636

1.31

1.60

1.2

1.3

9.59

10.94

u/l

0.55

523

Obstructed labour due to malposition and malpresentation of fetus

445

3711

1.12

1.60

1.2

12.48

12.96

u/l

0.25

393

3017

Phakomatoses, not elsewhere classified

160

1.67

1.60

2.3

1.7

7.21

7.72

u/l

0.10

123

Open bite that required surgery (Lefort1 or BSSO)

176

1.64

1.60

1.4

9.61

u/l

0.00

145

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

103

1294

0.79

1.59

1.3

1.2

11.02

11.53

u/l

0.16

1106

Postinfectious hypothyroidism

2.75

1.59

1.4

1.2

29.11

12.37

u/l

—

Vitamin B12 deficiency anaemia

515

1.34

1.59

1.5

1.3

15.72

11.34

u/l

1.35

407

303

1.45

1.58

2.3

1.3

9.63

9.50

u/l

0.02

238

Feeding problems of newborn

139

1.76

1.58

1.6

2.1

5.81

6.53

u/l

0.23

Viral pneumonia (unknown virus, not influenza)

102

806

1.28

1.58

1.5

7.33

7.95

u/l

0.25

654

Melanocytic naevi of scalp and neck

289

1.47

1.58

1.5

1.4

10.22

9.14

u/l

0.19

244

Ectopic testis

131

1.77

1.57

2.1

2.2

4.29

3.58

u/l

0.26

Hypoplasia of dental enamel, prenatal , including avohilmo

116

1.82

1.57

2.4

2.5

5.14

5.53

u/l

—

Myeloproliferative diseases (CML excluded)

448

1.37

1.57

1.4

1.3

12.69

10.20

u/l

0.88

360

Personality and behavioural disorders due to brain disease, damage and dysfunction

137

1.71

1.57

1.7

1.3

5.87

8.16

u/l

0.60

106

Retinal detachments and breaks

302

2640

1.15

1.56

1.3

1.4

13.06

10.92

u/l

1.13

231

2142

Palindromic rheumatism

2.07

1.56

1.3

1.2

12.33

11.78

u/l

—

Dialysis

407

1.39

1.55

1.6

13.02

7.69

u/l

1.06

328

Infections specific to the perinatal period

292

1.48

1.55

2.1

2.4

6.61

5.48

u/l

0.66

189

Impetigo

721

1.29

1.54

1.9

1.5

9.56

8.31

u/l

0.37

552

Other congenital malformations of the digestive system

100

786

1.28

1.54

1.8

8.08

7.79

u/l

0.09

552

Other respiratory diseases principally affecting the interstitium

133

1085

1.23

1.54

1.4

11.51

10.61

u/l

0.27

108

870

Noninfective disorders of pinna

3.00

1.53

1.2

5.63

5.79

u/l

—

Ulcer of lower limb, not elsewhere classified

117

942

1.25

1.53

1.3

1.4

10.84

8.92

u/l

0.85

770

Later onset COPD

147

963

1.22

1.53

1.2

1.3

11.14

11.63

u/l

0.16

107

750

Procedures for purposes other than remedying health state

193

1.57

1.53

1.2

1.3

16.33

12.97

u/l

0.40

153

Basal cell carcinoma

274

1643

1.16

1.52

1.3

13.30

10.68

u/l

1.97

219

1297

Allergic contact dermatitis

202

1718

1.18

1.52

1.3

11.29

11.74

u/l

0.16

164

1418

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

129

1053

1.24

1.52

1.5

6.96

8.60

u/l

1.25

108

868

Other malignant neoplasms of skin (=non-melanoma skin cancer)

293

1750

1.15

1.52

1.3

13.48

10.53

u/l

2.47

234

1380

Exophthalmic conditions

1.93

1.51

1.3

9.00

8.88

u/l

—

Assault by unspecified means

368

1.41

1.51

1.3

1.5

8.00

7.28

u/l

0.20

310

Bacterial, viral and other infectious agents

149

1235

1.22

1.51

1.5

1.4

8.13

7.74

u/l

0.13

113

1004

Effects of other external causes

479

1.35

1.51

1.5

7.54

7.29

u/l

0.07

397

Other specified and unspecified retinal disorders

242

1.50

1.51

1.6

1.4

7.50

9.18

u/l

0.43

188

Congenital malformations of the respiratory system

210

1.55

1.50

1.6

2.0

8.21

8.11

u/l

0.02

153

Disorders of lacrimal system and orbit in diseases classified elsewhere

162

1.62

1.50

1.3

1.2

16.51

12.63

u/l

0.49

128

Nephrotic syndrome

359

1.41

1.50

1.6

11.17

7.70

u/l

0.69

276

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

137

1127

1.22

1.49

1.3

1.4

8.27

9.58

u/l

0.71

112

928

Paralytic ileus

218

1.52

1.49

1.1

1.3

12.31

10.40

u/l

0.27

175

Multiple myeloma, including Hilmo

178

1.58

1.49

1.6

1.3

12.35

9.17

u/l

0.51

145

Sequelae of injuries of lower limb

128

1046

1.23

1.49

1.4

9.28

9.25

u/l

0.01

100

858

Other sexually transmitted chlamydial diseases

321

2836

1.14

1.49

1.4

8.31

7.83

u/l

0.41

262

2354

Other disorders of breast and lactation associated with childbirth

370

1.41

1.48

1.2

9.96

10.13

u/l

0.04

303

Myotonic disorders

102

1.81

1.48

1.9

1.4

8.63

9.51

u/l

0.15

therapeutic use

147

1.65

1.48

1.3

1.2

9.44

11.77

u/l

0.37

112

Benign neoplasm: Skin of scalp and neck

219

1.52

1.48

1.7

1.4

12.47

10.30

u/l

0.31

173

Mandibular hypoplasia

1.85

1.47

1.3

1.5

9.37

9.12

u/l

0.03

Contact with nonpowered hand tool

524

1.33

1.47

1.5

6.40

6.95

u/l

0.28

433

Malignant neoplasm of oesophagus, including Hilmo

179

1.58

1.46

1.3

11.17

6.08

u/l

1.68

148

Other orthopaedic follow-up care

489

1.34

1.46

1.6

1.4

11.18

10.03

u/l

0.23

401

Herpesviral [herpes simplex] infections

155

1294

1.20

1.46

1.5

1.3

11.60

10.75

u/l

0.28

120

1064

Benign neoplasm: Descending colon

403

1.37

1.45

1.5

1.3

14.45

10.42

u/l

0.74

325

Presbyopia

559

1.31

1.45

1.4

1.3

14.82

12.09

u/l

0.42

445

Other papulosquamous disorders

1.82

1.45

1.8

1.5

12.69

9.52

u/l

0.24

Mixed disorders of conduct and emotions

624

1.31

1.44

1.6

1.7

5.99

6.79

u/l

0.59

493

Aortic aneurysm

199

1665

1.18

1.44

1.4

10.36

7.91

u/l

1.46

154

1334

Other protozoal intestinal diseases

270

1.47

1.44

1.5

1.4

8.31

9.15

u/l

0.20

213

Heart failure,strict

450

2853

1.11

1.44

1.4

11.69

9.54

u/l

2.28

355

2287

Previous suicide attempt

173

1.60

1.44

1.6

5.84

8.80

u/l

1.65

142

Other melanin hyperpigmentation

1.81

1.44

1.1

1.2

17.48

11.24

u/l

0.86

Other specified/unspecified necrotizing vasculopathies

1.84

1.43

1.3

1.2

14.58

10.63

u/l

—

Patellar tendinitis

246

1.49

1.43

1.5

10.32

7.41

u/l

0.42

211

Peripheral arterial reconstruction

106

852

1.25

1.43

1.3

1.4

14.19

9.54

u/l

1.85

684

IgA nephropathy (IgA glomerulonephritis)

279

1.45

1.42

1.8

1.4

9.81

7.84

u/l

0.43

228

Enterobiasis

433

1.37

1.42

1.3

1.5

8.99

9.00

u/l

0.00

349

Hirsprung

2.87

1.42

2.0

1.9

11.02

3.59

u/l

—

Colitis, primary sclerosing, strict definition

134

1.68

1.42

1.5

1.4

5.06

7.62

u/l

1.15

111

Burns and corrosions of external body surface, specified by site

189

1612

1.18

1.41

1.4

1.5

8.44

7.86

u/l

0.37

149

1290

Colon adenocarcinoma

474

1.33

1.41

1.3

16.47

9.33

u/l

2.41

380

Accessory breast

1.85

1.41

1.3

1.2

9.66

13.54

u/l

0.54

Benign neoplasm of major salivary glands

712

1.27

1.40

1.3

9.71

10.73

u/l

0.30

579

Other congenital malformations of nervous system

199

1.55

1.40

1.3

1.8

7.84

9.41

u/l

0.33

156

Artificial joint operation, meniscal resection

1136

6905

1.07

1.40

1.3

1.4

10.13

10.65

u/l

0.67

933

5626

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lutropin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS